Document:

EX-10.2

 Exhibit 10.2 

Execution Version 
  

 
  

KERYX BIOPHARMACEUTICALS, INC. 

ZERO COUPON CONVERTIBLE SENIOR NOTES DUE 2021 
  

 
 INDENTURE 

DATED AS OF MAY 9, 2018 
  

 
 THE BANK OF NEW
YORK MELLON TRUST COMPANY, N.A., 
 AS TRUSTEE 
  

 
  

 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	PAGE	 
		
	 ARTICLE 1 Definitions And Incorporation By Reference
	  	 	1	 
			
	 Section 1.01.
	 	Definitions	  	 	1	 
	 Section 1.02.
	 	Other Definitions	  	 	11	 
	 Section 1.03.
	 	Rules of Construction	  	 	11	 
		
	 ARTICLE 2 The Securities
	  	 	12	 
			
	 Section 2.01.
	 	Form and Dating	  	 	12	 
	 Section 2.02.
	 	Execution and Authentication; Payments of Defaulted Amounts	  	 	14	 
	 Section 2.03.
	 	Registrar, Paying Agent and Conversion Agent	  	 	16	 
	 Section 2.04.
	 	Paying Agent to Hold Money in Trust	  	 	16	 
	 Section 2.05.
	 	Holder	  	 	16	 
	 Section 2.06.
	 	Transfer and Exchange; Transfer Restrictions	  	 	17	 
	 Section 2.07.
	 	Replacement Securities	  	 	21	 
	 Section 2.08.
	 	Outstanding Securities	  	 	22	 
	 Section 2.09.
	 	Treasury Securities	  	 	22	 
	 Section 2.10.
	 	Temporary Securities	  	 	22	 
	 Section 2.11.
	 	Cancellation; Repurchase	  	 	23	 
	 Section 2.12.
	 	Additional Transfer and Exchange Requirements	  	 	23	 
	 Section 2.13.
	 	CUSIP Numbers	  	 	25	 
		
	 ARTICLE 3 No Redemption; Repurchase Upon a Fundamental Change
	  	 	26	 
			
	 Section 3.01.
	 	No Optional Redemption	  	 	26	 
	 Section 3.02.
	 	Repurchase At Option of The Holder Upon A Fundamental Change	  	 	26	 
	 Section 3.03.
	 	[Reserved]	  	 	28	 
	 Section 3.04.
	 	[Reserved]	  	 	28	 
	 Section 3.05.
	 	Repayment to the Company	  	 	28	 
	 Section 3.06.
	 	Partial Repurchase	  	 	28	 
		
	 ARTICLE 4 Conversion
	  	 	28	 
			
	 Section 4.01.
	 	Conversion Rights	  	 	28	 
	 Section 4.02.
	 	Settlement Upon Conversion; Conversion Procedures	  	 	29	 
	 Section 4.03.
	 	Company to Provide Stock	  	 	31	 
	 Section 4.04.
	 	[Reserved]	  	 	31	 
	 Section 4.05.
	 	Conversion Rate Adjustments	  	 	31	 
	 Section 4.06.
	 	Adjustments of Prices	  	 	40	 
	 Section 4.07.
	 	Effect of Recapitalizations, Reclassifications and Changes of the Common Stock	  	 	40	 
	 Section 4.08.
	 	Cancellation of Converted Securities	  	 	42	 
	 Section 4.09.
	 	Shareholders Rights	  	 	42	 
	 Section 4.10.
	 	Trustee’s Disclaimer	  	 	42	 
		
	 ARTICLE 5 Covenants
	  	 	43	 

  
 i 

							
	 Section 5.01.
	 	Payment on the Securities	  	 	43	 
	 Section 5.02.
	 	SEC Reports and Rule 144A Information Requirement	  	 	43	 
	 Section 5.03.
	 	Compliance Certificates	  	 	44	 
	 Section 5.04.
	 	Further Instruments and Acts	  	 	44	 
	 Section 5.05.
	 	Maintenance of Corporate Existence	  	 	44	 
	 Section 5.06.
	 	Stay, Extension and Usury Laws	  	 	44	 
	 Section 5.07.
	 	Additional Amounts	  	 	45	 
	 Section 5.08.
	 	Limitation on the Incurrence of Additional Indebtedness	  	 	47	 
	 Section 5.09.
	 	Limitation on the Prepayments, Etc. of Indebtedness	  	 	47	 
	 Section 5.10.
	 	Restricted Payments	  	 	47	 
	 Section 5.11.
	 	Asset Sales	  	 	48	 
	 Section 5.12.
	 	Conduct of Business	  	 	48	 
	 Section 5.13.
	 	Certain Tax Matters	  	 	49	 
		
	 ARTICLE 6 Consolidation, Merger, Sale, Conveyance, Transfer or Lease
	  	 	49	 
			
	 Section 6.01.
	 	Company May Consolidate, Etc., Only on Certain Terms	  	 	49	 
	 Section 6.02.
	 	Successor Substituted	  	 	50	 
		
	 ARTICLE 7 Default and Remedies
	  	 	50	 
			
	 Section 7.01.
	 	Events Of Default	  	 	50	 
	 Section 7.02.
	 	Acceleration	  	 	52	 
	 Section 7.03.
	 	Other Remedies	  	 	53	 
	 Section 7.04.
	 	[Reserved]	  	 	53	 
	 Section 7.05.
	 	Waiver of Defaults and Events of Default	  	 	53	 
	 Section 7.06.
	 	Control by Majority	  	 	53	 
	 Section 7.07.
	 	Limitations on Suits	  	 	54	 
	 Section 7.08.
	 	Rights of Holders to Receive Payment and to Convert	  	 	54	 
	 Section 7.09.
	 	Collection Suit By Trustee	  	 	54	 
	 Section 7.10.
	 	Trustee May File Proofs of Claim	  	 	54	 
	 Section 7.11.
	 	Priorities	  	 	55	 
	 Section 7.12.
	 	Undertaking For Costs	  	 	55	 
		
	 ARTICLE 8 Trustee
	  	 	56	 
			
	 Section 8.01.
	 	Duties of Trustee	  	 	56	 
	 Section 8.02.
	 	Rights of Trustee	  	 	57	 
	 Section 8.03.
	 	Individual Rights of Trustee	  	 	58	 
	 Section 8.04.
	 	Trustee’s Disclaimer	  	 	58	 
	 Section 8.05.
	 	Notice of Default or Events of Default	  	 	58	 
	 Section 8.06.
	 	[Reserved]	  	 	58	 
	 Section 8.07.
	 	Compensation and Indemnity	  	 	58	 
	 Section 8.08.
	 	Replacement of Trustee	  	 	59	 
	 Section 8.09.
	 	Successor Trustee by Merger, Etc.	  	 	60	 
	 Section 8.10.
	 	Eligibility; Disqualification	  	 	60	 
		
	 ARTICLE 9 Satisfaction and Discharge of Indenture
	  	 	61	 
			
	 Section 9.01.
	 	Satisfaction and Discharge of Indenture	  	 	61	 
	 Section 9.02.
	 	Application of Trust Money	  	 	61	 

  
 ii 

							
	 Section 9.03.
	 	Repayment to Company	  	 	61	 
	 Section 9.04.
	 	Reinstatement	  	 	62	 
		
	 ARTICLE 10 Amendments, Supplements and Waivers
	  	 	62	 
			
	 Section 10.01.
	 	Without Consent of Holders	  	 	62	 
	 Section 10.02.
	 	With Consent of Holders	  	 	63	 
	 Section 10.03.
	 	[Reserved]	  	 	64	 
	 Section 10.04.
	 	Revocation and Effect of Consents	  	 	64	 
	 Section 10.05.
	 	Notation on or Exchange of Securities	  	 	64	 
	 Section 10.06.
	 	Trustee to Sign Amendments, Etc.	  	 	65	 
	 Section 10.07.
	 	Effect of Supplemental Indentures	  	 	65	 
		
	 ARTICLE 11 Miscellaneous
	  	 	65	 
			
	 Section 11.01.
	 	[Reserved]	  	 	65	 
	 Section 11.02.
	 	Notices	  	 	65	 
	 Section 11.03.
	 	Communications by Holders With Other Holders	  	 	67	 
	 Section 11.04.
	 	Certificate and Opinion as to Conditions Precedent	  	 	67	 
	 Section 11.05.
	 	Record Date for Vote or Consent of Holders	  	 	68	 
	 Section 11.06.
	 	Rules by Trustee, Paying Agent, Registrar and Conversion Agent	  	 	68	 
	 Section 11.07.
	 	Legal Holidays	  	 	68	 
	 Section 11.08.
	 	Governing Law; Jurisdiction	  	 	68	 
	 Section 11.09.
	 	No Personal Liability of Directors, Officers, Employees or Shareholders	  	 	69	 
	 Section 11.10.
	 	Successors	  	 	69	 
	 Section 11.11.
	 	Multiple Counterparts	  	 	69	 
	 Section 11.12.
	 	Separability	  	 	69	 
	 Section 11.13.
	 	Tax Treatment	  	 	69	 
	 Section 11.14.
	 	Table of Contents, Headings, Etc.	  	 	69	 
	 Section 11.15.
	 	Force Majeure	  	 	69	 
	 Section 11.16.
	 	Waiver of Jury Trial	  	 	70	 
	 Section 11.17.
	 	Calculations	  	 	70	 

 EXHIBIT 
  

					
	Exhibit A	  	Form of Security	  	A-1

  

  
 iii 

 INDENTURE, dated as of May 9, 2018, between KERYX BIOPHARMACEUTICALS, INC., a Delaware
corporation (the “Company”), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association, as Trustee (the “Trustee”). 

The Company and the Trustee agree as follows for the benefit of each other and for the equal and ratable benefit of the Holders of the
Company’s Zero Coupon Convertible Senior Notes due 2021 (as are issued under this Indenture, and as amended or supplemented from time to time, the “Securities”). 

ARTICLE 1 
 DEFINITIONS AND
INCORPORATION BY REFERENCE 
 Section 1.01. Definitions. 

“ABL Facility” means a revolving credit facility to be entered into between the Company and its operating subsidiaries as co-borrowers and certain lenders thereunder, which may be secured by a security interest in all of the borrowers’ assets and which may include a negative pledge respecting the borrowers’ intellectual
property. 
 “Additional Amounts” shall have the meaning specified in Section 5.07(a). 

“Affiliate” means, with respect to any specified Person, any other Person directly or indirectly controlling or controlled by
or under direct or indirect common control with such specified Person. For the purposes of this definition, “control,” when used with respect to any Person, means the power to direct the management and policies of such Person,
directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. 

“Agent” means any Registrar, Paying Agent or Conversion Agent. 

“Applicable Procedures” means, with respect to any transfer or exchange of beneficial ownership interests in a Global
Security, the rules and procedures of the Depositary, in each case to the extent applicable to such transfer or exchange. 
 “Asset
Sale” means: 
 (A) the sale, conveyance, transfer or other disposition, whether in a single transaction or a series
of related transactions, of property or assets of the Company or any of its Subsidiaries (each referred to in this definition as a “disposition”); or 

(B) the issuance or sale of Capital Stock of any Subsidiary of the Company, whether in a single transaction or a series of
related transactions (other than directors’ qualifying shares and shares issued to foreign nationals as required under applicable law); 

  
 1 

 in each case, other than: 

(a) any disposition of (i) Cash, (ii) surplus, obsolete, damaged or worn out property or equipment in the ordinary course of business or
any disposition of inventory or goods (or other assets) held for sale in the ordinary course of business and (iii) property no longer used or useful in the conduct of business of the Company and its Subsidiaries; 

(b) the disposition of all or substantially all of the assets of the Company in a manner permitted pursuant to Section 6.01 or any
disposition that constitutes a Fundamental Change; 
 (c) (i) the lease, assignment, sublease, license or sublicense of any real or personal
property in the ordinary course of business and (ii) the termination of leases in the ordinary course of business; 
 (d) any
disposition arising from foreclosure, casualty, condemnation or any similar action or transfers by reason of eminent domain with respect to any property or other asset of the Company or any of its Subsidiaries or exercise of termination rights under
any lease, sublease, license, sublicense, concession or other agreement; 
 (e) the issuance by any Subsidiary of the Company of Disqualified
Stock that is permitted under Section 5.08; 
 (f) dispositions of receivables in connection with the compromise, settlement or
collection thereof in the ordinary course of business or in bankruptcy or similar proceedings; 
 (g) transfers of assets constituting
collateral to the secured party under the ABL Facility; and 
 (h) the abandonment of intellectual property rights in the ordinary course of
business which in the reasonable good faith determination of the Company are not material to the conduct of the business of the Company and its Subsidiaries taken as a whole. 

“Authorized Officer” shall have the meaning specified in Section 11.02. 

“Bankruptcy Law” means Title 11 of the United States Code (or any successor thereto) or any similar federal or state law for
the relief of debtors. 
 “Board of Directors” means either the board of directors of the Company or any committee of the
Board of Directors authorized to act for it with respect to this Indenture. 
 “Business Day” means each day that is not a
Legal Holiday. 
 “Capital Stock” of any Person means: (a) in the case of a corporation, corporate stock of such
Person; (b) in the case of an association or business entity, shares, interests, participations, rights or other equivalents (however designated) of corporate stock of such Person; (c) in the case of a partnership or limited liability
company, partnership or membership interests (whether general or limited) of such Person; and (d) in the case of any other legal form, any other interest or participation of such Person that confers the right to receive a share of the profits
and losses of, or distribution of assets of, such Person. 

  
 2 

 “Cash” or “cash” means such coin or currency of the United
States as at any time of payment is legal tender for the payment of public and private debts. 
 “Certificated Security”
means a Security that is in substantially the form attached hereto as Exhibit A and that does not include the text or the schedule called for by footnotes 1 through 5 thereof. 

“close of business” means 5:00 p.m. (New York City time). 

“Common Equity” of any Person means Capital Stock of such Person that is generally entitled (a) to vote in the election
of directors of such Person or (b) if such Person is not a corporation, to vote or otherwise participate in the selection of the governing body, partners, managers or others who will control the management or policies of such Person. 

“Common Stock” means the common stock of the Company, $0.001 par value per share, subject to Section 4.07. 

“Company” means the party named as such in the first paragraph of this Indenture until a successor replaces it pursuant to
the applicable provisions of this Indenture, and thereafter “Company” shall mean such successor Company. 

“Company Action” shall have the meaning specified in Section 5.13. 

“Corporate Trust Office” means the office of the Trustee at the address specified in Section 11.02 or such other address
as to which the Trustee may give notice to the Company. 
 “Custodian” means any receiver, trustee, assignee, liquidator,
sequestrator or similar official under any Bankruptcy Law. 
 “Daily VWAP” means the per share volume-weighted average
price as displayed under the heading “Bloomberg VWAP” on Bloomberg page “KERX <equity> AQR” (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the
scheduled close of trading of the primary trading session on such Trading Day (or if such volume-weighted average price is unavailable, the market value of one share of Common Stock on such Trading Day determined, using a volume-weighted average
method, by a nationally recognized independent investment banking firm retained for this purpose by the Company). The “Daily VWAP” shall be determined without regard to after-hours trading or any other trading outside of the regular
trading session trading hours. 
 “Default” or “default” means, when used with respect to the Securities,
any event that is or, after notice or passage of time or both, would be an Event of Default. 
 “Defaulted Amounts” means
any amounts on any Securities (including, without limitation, the Fundamental Change Repurchase Price and principal) that are payable but are not punctually paid or duly provided for. 

  
 3 

 “Disqualified Stock” means, as to any Person, any class of Capital Stock of such
Person that, by its terms (or by the terms of any security into which it is convertible or for which it is exchangeable), or upon the happening of any event or the passage of time, matures or is redeemable (other than upon a Fundamental Change), in
whole or in part, on or prior to the date that is 91 days after the Maturity Date; provided, however, that any class of Capital Stock of such Person that, by its terms, authorizes such Person to satisfy in full its obligations with
respect to the payment of dividends or upon maturity, redemption (pursuant to a sinking fund or otherwise) or repurchase thereof or otherwise by the delivery of Capital Stock that are not Disqualified Stock (other than the payment of cash in lieu of
delivery of fractional shares of Capital Stock), and that is not convertible into or exchangeable for Disqualified Stock or Indebtedness, will not be deemed to be Disqualified Stock so long as such Person satisfies its obligations with respect
thereto solely by the delivery of Capital Stock that are not Disqualified Stock (other than the payment of cash in lieu of delivery of fractional shares of Capital Stock); provided further, however, that if such Capital Stock is issued
to any employee or to any plan for the benefit of employees of such Person or any of the Subsidiaries of such Person or by any such plan to such employees, such Capital Stock shall not constitute Disqualified Stock solely because they may be
required to be repurchased by such Person or any of the Subsidiaries of such Person in order to satisfy applicable statutory or regulatory obligations or as a result of such employee’s termination, death or disability. 

“Electronic Means” shall have the meaning specified in Section 11.02. 

“Ex-Dividend Date” means the first date on which the shares of the Common Stock trade
on the applicable exchange or in the applicable market, regular way, without the right to receive the issuance, dividend or distribution in question, from the Company or, if applicable, from the seller of Common Stock on such exchange or market (in
the form of due bills or otherwise) as determined by such exchange or market. 
 “Exchange Act” means the Securities and
Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, as in effect from time to time. 

“FATCA” shall have the meaning specified in Section 5.07(a)(i)(F). 

“Fundamental Change” shall be deemed to have occurred at the time after the Securities are originally issued and remain
outstanding if any of the following occurs: 
 (a) the Common Stock (or other common stock into which the Securities are then convertible)
ceases to be listed on any of The New York Stock Exchange, The Nasdaq Global Select Market, The Nasdaq Global Market or The Nasdaq Capital Market (or any of their successors); 

(b) any Person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Exchange Act, acquires
beneficial ownership, directly or indirectly, through a purchase, merger or other acquisition transaction or series of transactions, of shares of the Company’s Capital Stock entitling the Person to exercise 50% or more of the total voting power
of all shares of the Company’s Capital Stock entitled to vote generally in elections of directors, other than an acquisition by the Company, any of its wholly owned Subsidiaries or the Purchaser; 

  
 4 

 (c) the Company merges or consolidates with or into any other Person (other than one of its
wholly owned Subsidiaries), another Person merges or consolidates with or into the Company, or the Company conveys, sells, transfers or leases all or substantially all of its assets to another Person in one transaction or a series of related
transactions, other than any transaction: 
 (i) that does not result in a reclassification, conversion, exchange or
cancellation of the outstanding Common Stock; or 
 (ii) pursuant to which the holders of all classes of the Company’s
Common Equity immediately prior to the transaction have the entitlement to exercise, directly or indirectly, 50% or more of the total voting power of all classes of the Capital Stock of the continuing or surviving entity or transferee or parent
thereof entitled to vote generally in the election of directors or managers of the continuing or surviving entity or transferee or parent thereof immediately after the transaction in substantially the same proportions as such entitlement immediately
prior to such transaction; or 
 (d) the Company’s shareholders approve any plan or proposal for the liquidation or dissolution of the
Company; 
 provided, however, that a transaction or transactions described in clause (b) or (c) above shall not constitute a Fundamental
Change and Holders shall not have the right to require the Company to repurchase any Securities (and the Company shall not be required to deliver the Fundamental Change Repurchase Right Notice incidental thereto) if at least 90% of the consideration
paid for the Common Stock (excluding cash payments for fractional shares and cash payments made pursuant to dissenters’ or appraisal rights) in connection with such transaction or transactions consists of shares of common stock that are listed
or quoted on any of The New York Stock Exchange, The Nasdaq Global Select Market, The Nasdaq Global Market or The Nasdaq Capital Market (or any of their successors) or will be so traded or quoted immediately following such transaction or
transactions and, as a result of such transaction or transactions, such consideration, excluding cash payments for fractional shares and cash payments made pursuant to dissenters’ or appraisal rights, becomes the Reference Property as described
in Section 4.07. For purposes of this definition, whether a Person is a “beneficial owner” will be determined in accordance with Rule 13d-3 under the Exchange Act, and “Person”
includes any syndicate or group that would be deemed to be a “person” under Section 13(d)(3) of the Exchange Act. 

“GAAP” means generally accepted accounting principles in the United States of America as in effect as of the date of this
Indenture, including those set forth in (1) the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants, (2) the statements and pronouncements of the Financial Accounting
Standards Board, (3) such other statements by such other entity as approved by a significant segment of the accounting profession and (4) the rules and regulations of the SEC governing the inclusion of financial statements (including pro
forma financial statements) in registration statements filed under the Securities Act and periodic reports required to be filed pursuant to Section 13 of the Exchange Act, including opinions and pronouncements in staff accounting bulletins and
similar written statements from the accounting staff of the SEC. 

  
 5 

 “Global Security” means a permanent Global Security that is in substantially the
form attached hereto as Exhibit A and that includes the text and the schedule called for by footnotes 1 through 5 thereof and that is deposited with the Depositary or its custodian and registered in the name of the Depositary or its nominee.

 “Guarantee” means, as applied to any Indebtedness of another Person, (i) a guarantee, direct or indirect, in any
manner, of any part or all of such Indebtedness, or (ii) any direct or indirect obligation, contingent or otherwise, of a Person guaranteeing or having the effect of guaranteeing the Indebtedness of any other Person in any manner (other than in
each case, by endorsement of negotiable instruments for collection in the ordinary course of business) (and “Guaranteed” and “Guaranteeing” shall have meanings that correspond to the foregoing). 

“Holder” means the Person in whose name a Security is registered on the Primary Registrar’s books. 

“Indebtedness” means, as to any Person, all of the following: (i) all obligations for borrowed money and all obligations
evidenced by bonds, debentures, notes, or other similar instruments; (ii) all obligations under capital or synthetic leases of such Person; (iii) all obligations of such Person to pay the deferred purchase price of property or services
(other than trade accounts payable in the ordinary course of business); (iv) indebtedness (excluding prepaid interest thereon) of others secured by a non-statutory lien on property owned or being
purchased by such Person (including indebtedness arising under conditional sale or other title retention agreements), whether or not such indebtedness shall have been assumed by such Person or is limited in recourse; (v) direct or contingent
obligations of such Person arising under letters of credit (including standby and commercial), bankers’ acceptances, bank guaranties, surety bonds and similar instruments; (vi) net obligations of such Person under any hedging or swap
contracts; and (vii) all Guarantees of such Person in respect of any of the foregoing. For all purposes hereof, the Indebtedness of any Person shall include the Indebtedness of any partnership or joint venture (other than a joint venture that
is itself a corporation or limited liability company) in which such Person is a general partner or a joint venturer to the extent such Indebtedness is recourse to such Person. 

“Indenture” means this Indenture, as amended or supplemented from time to time pursuant to the terms of this Indenture. 

“Instructions” shall have the meaning specified in Section 11.02. 

“Last Reported Sale Price” of the Common Stock on any date means the closing sale price per share (or if no closing sale
price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the average ask prices) on that date as reported in composite transactions for the principal U.S. national or regional
securities exchange on which the Common Stock is traded. If the Common Stock is not listed for trading on a U.S. national or regional securities exchange on the relevant date, the “Last Reported Sale Price” shall be the last quoted
bid price for the Common Stock in the over-the-counter market on the relevant date as reported by OTC Markets Group Inc. or a similar organization. If the Common Stock
is not so quoted, the “Last Reported Sale Price” shall be the average of the mid-point of the last bid and ask prices for the Common Stock on the relevant date from each of at least three
nationally recognized independent investment banking firms selected by the Company for this purpose. 

  
 6 

 “Legal Holiday” is a Saturday, Sunday or a day on which state or federally
chartered banking institutions in New York, New York and the state in which the Corporate Trust Office is located are not required to be open. 

“Market Disruption Event” means (a) a failure by the primary U.S. national or regional securities exchange or market on
which the Common Stock is listed or admitted for trading to open for trading during its regular trading session or (b) the occurrence or existence prior to 1:00 p.m., New York City time, on any Scheduled Trading Day for the Common Stock for
more than one half-hour period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant stock exchange or otherwise) in the Common
Stock or in any options, contracts or future contracts relating to the Common Stock. 
 “Maturity Date” means
October 15, 2021. 
 “Notes Exchange Agreement” means that certain Notes Exchange Agreement, dated as of May 8,
2018, between the Company and the Purchaser. 
 “Officer” means the Chairman of the Board, the Chief Executive Officer, the
President, any Vice President, the Chief Operating Officer, the Chief Financial Officer, the Treasurer, any Assistant Treasurer, the Controller, the Secretary or any Assistant Secretary of the Company. 

“Officers’ Certificate” means a certificate signed on behalf of the Company by two Officers, at least one of whom shall
be the principal executive officer, principal financial officer or principal accounting officer of the Company, that meets the requirements of Section 11.04. 

“open of business” means 9:00 a.m. (New York City time). 

“Opinion of Counsel” means a written opinion that meets the requirements of Section 11.04 from legal counsel. The
counsel may be an employee of or counsel to the Company or any Subsidiary of the Company. 
 “Pari/Junior Financing
Documentation” means any documentation governing any Pari/Junior Financing. 
 “Person” means any individual,
corporation, partnership, limited liability company, joint venture, association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. 

“Permitted Indebtedness” means: (i) Indebtedness under the ABL Facility, and any Permitted Refinancing thereof, in a
maximum principal amount not to exceed $40,000,000 at any one time outstanding; (ii) Indebtedness in respect of the Securities; (iii) Indebtedness outstanding on the date of the initial issuance of the Securities; (iv) unsecured
Indebtedness, which, by its terms, expressly subordinated to the Securities; provided, that no principal of such Indebtedness is scheduled to mature (or subject to mandatory repurchase or put rights, other than repurchase

  
 7 

 
rights upon a Fundamental Change) no earlier than the date that is one year after the Maturity Date; (v) other unsecured Indebtedness, which, by its terms, ranks equally in right of payment
with the Securities, in an aggregate principal amount not to exceed $5,000,000 at any one time outstanding; (vi) intercompany Indebtedness among the Company and any of its Subsidiaries; provided, that any Indebtedness owed by the Company
to its Subsidiaries shall be subordinated to the Securities; (vii) Indebtedness arising from the honoring by a bank or other financial institution of a check, draft or similar instrument inadvertently (except in the case of daylight overdrafts)
drawn against insufficient funds in the ordinary course of business; provided, that such Indebtedness is extinguished within two Business Days of incurrence; (viii) Indebtedness under hedging or swap contracts entered into in the
ordinary course of business to hedge or mitigate risks to which the Company or any of its Subsidiaries are exposed in the conduct of their business or the management of their liabilities and not for speculative purposes; (ix) Indebtedness in
respect of letters of credit, bankers’ acceptances, bank guarantees, surety bonds and similar instruments incurred in the ordinary course of business; (x) Guarantees by the Company or any of its Subsidiaries of Indebtedness of the Company
or any of its Subsidiaries (other than Indebtedness that is required to be non-recourse to the Company or its Subsidiaries) to the extent that the Guaranteed Indebtedness is permitted to be incurred by another
of the clauses above in this definition of Permitted Indebtedness; provided, that if the Indebtedness being Guaranteed ranks equally in right of payment or is expressly subordinated to the Securities, then the Guarantee must rank equally in
right of payment or be expressly subordinated, as applicable, to the same extent as the Indebtedness Guaranteed; and (xi) Indebtedness (other than Indebtedness for money borrowed) in respect of workers’ compensation claims, self-insurance
obligations, bankers’ acceptances, performance and surety bonds in the ordinary course of business. 
 “Permitted
Refinancing” means refinancings, renewals or extensions of Indebtedness so long as: 
 (a) such refinancings, renewals or extensions
do not result in an increase in the principal amount of the Indebtedness so refinanced, renewed or extended, other than by the amount of accrued interest and premiums thereon and the fees and expenses incurred in connection therewith; 

(b) such refinancings, renewals or extensions do not result in a shortening of the final stated maturity or the average weighted maturity
(measured as of the refinancing, renewal or extension) of the Indebtedness so refinanced, renewed or extended; 
 (c) such refinancings,
renewals or extensions do not result in an obligor of such refinancing Indebtedness that was not an obligor with respect to the Indebtedness so refinanced, renewed or extended; 

(d) such refinancings, renewals or extensions are otherwise on terms not materially less favorable to the Company and its Subsidiaries, taken
as a whole, than those of the Indebtedness so refinanced, renewed or extended; 
 (e) if the Indebtedness that is refinanced, renewed or
extended was subordinated in right of payment to the Securities, then the terms and conditions of the refinancing, renewal or extension must include subordination terms and conditions that are at least as favorable to the Holders as those that were
applicable to the refinanced, renewed or extended Indebtedness; and 

  
 8 

 (f) if the Indebtedness that is refinanced, renewed or extended was unsecured, such refinancing,
renewal or extension shall be unsecured. 
 “Principal” or “principal” of a debt security, including the
Securities, means the principal of the security, plus, when appropriate, the premium, if any, on such security. 

“Purchaser” means Baupost Group Securities, L.L.C. and its Affiliates, other than the Company and its subsidiaries. 

“Record Date” means, with respect to any dividend, distribution or other transaction or event in which the holders of Common
Stock (or other security) have the right to receive any cash, securities or other property or in which the Common Stock (or other applicable security) is exchanged for or converted into any combination of cash, securities or other property, the date
fixed for determination of shareholders entitled to receive such cash, securities or other property (whether such date is fixed by the Board of Directors, by statute, by contract or otherwise). 

“Registration Rights Agreement” means that certain Registration Rights Agreement, dated as of the date hereof, between the
Company and the Purchaser. 
 “Relevant Taxing Jurisdiction” shall have the meaning specified in Section 5.07(a). 

“Resale Restriction Termination Date” shall have the meaning specified in Section 2.06(d). 

“Responsible Officer” when used with respect to the Trustee, means any officer within the Corporate Trust Office of the
Trustee, including any vice president, assistant vice president, assistant secretary, assistant treasurer or any other officer of the Trustee who customarily performs functions similar to those performed by the Persons who at the time shall be such
officers, respectively, or to whom such matter is referred because of his or her knowledge of and familiarity with the particular subject and who shall have direct responsibility for the administration of this Indenture. 

“Restricted Securities” shall have the meaning specified in Section 2.06(d). 

“Rule 144A” means Rule 144A as promulgated under the Securities Act. 

“Scheduled Trading Day” means a day that is scheduled to be a Trading Day on the principal U.S. national or regional
securities exchange or market on which the Common Stock is listed or admitted for trading. If the Common Stock is not so listed or admitted for trading, “Scheduled Trading Day” means a Business Day. 

“SEC” means the U.S. Securities and Exchange Commission. 

“Securities Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, as
in effect from time to time. 

  
 9 

 “Securities Custodian” means the Trustee, as custodian for DTC, with respect to
the Securities in global form, or any successor thereto. 
 “Significant Subsidiary” means, in respect of any Person, a
Subsidiary of such Person that would constitute a “significant subsidiary,” as such term is defined in Rule 1-02 of Regulation S-X under the Exchange Act. 

“Subsidiary” means, in respect of any Person, any corporation, association, partnership or other business entity of which
more than 50% of the total voting power of shares of Capital Stock or other interests (including partnership interests) entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, general partners
or trustees thereof is at the time owned or controlled, directly or indirectly, by (a) such Person; (b) such Person and one or more Subsidiaries of such Person; or (c) one or more Subsidiaries of such Person. 

“Successor Company” shall have the meaning specified in Section 6.01(a). 

“Tax” shall have the meaning specified in Section 5.07(a). 

“Trading Day” means a day on which (a) trading in the Common Stock (or other security for which a closing sale price
must be determined) generally occurs on The Nasdaq Capital Market or, if the Common Stock (or such other security) is not then listed on The Nasdaq Capital Market, on the principal other U.S. national or regional securities exchange on which the
Common Stock (or such other security) is then listed or, if the Common Stock (or such other security) is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock (or such other
security) is then traded and (b) a Last Reported Sale Price for the Common Stock (or such other security) is available on such securities exchange or market; provided that if the Common Stock (or such other security) is not so listed or
traded, “Trading Day” means a Business Day; and provided, further, that for purposes of determining amounts due upon conversion only, “Trading Day” means a day on which (i) there is no Market
Disruption Event and (ii) trading in the Common Stock generally occurs on The Nasdaq Capital Market or, if the Common Stock is not then listed on The Nasdaq Capital Market, on the principal other U.S. national or regional securities exchange on
which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock is then listed or admitted for trading, except that if the
Common Stock is not so listed or admitted for trading, “Trading Day” means a Business Day. 
 “transfer”
shall have the meaning specified in Section 2.06(d). 
 “Trustee” means the party named as such in the first paragraph
of this Indenture until a successor replaces it in accordance with the provisions of this Indenture, and thereafter means the successor. 

“Vice President,” when used with respect to the Company or the Trustee, means any vice president, whether or not designated
by a number or a word or words added before or after the title “vice president.” 

  
 10 

 “Wholly Owned Subsidiary” of any Person means a Subsidiary of such Person, 100%
of the outstanding Capital Stock of which (other than directors’ qualifying shares and shares issued to foreign nationals as required under applicable law) shall at the time be owned by such Person or by one or more Wholly Owned Subsidiaries of
such Person or by such Person and one or more Wholly Owned Subsidiaries of such Person. 
 Section 1.02. Other
Definitions. 
  

			
	 Term
	  	Where Defined
	“Agent Members”	  	2.01(b)
	“Applicable Tax Law”	  	5.13
	“Clause A Distribution”	  	4.05(c)
	“Clause B Distribution”	  	4.05(c)
	“Clause C Distribution”	  	4.05(c)
	“Company Order”	  	2.02(c)
	“Conversion Agent”	  	2.03
	“Conversion Date”	  	4.02(c)
	“Conversion Notice”	  	4.02(b)
	“Conversion Obligation”	  	4.01(a)
	“Conversion Rate”	  	4.01(a)
	“Distributed Property”	  	4.05(c)
	“DTC”	  	2.01(b)
	“Depositary”	  	2.01(b)
	“Event of Default”	  	7.01
	“Fundamental Change Repurchase Date”	  	3.02(d)
	“Fundamental Change Repurchase Price”	  	3.02(a)
	“Fundamental Change Repurchase Right Notice”	  	3.02(b)
	“Merger Event”	  	4.07(a)
	“Non-Separate Rights”	  	4.09
	“Pari/Junior Financing”	  	5.09
	“Paying Agent”	  	2.03
	“Primary Registrar”	  	2.03
	“Reference Property”	  	4.07(a)
	“Repurchase Exercise Notice”	  	3.02(c)
	“Registrar”	  	2.03
	“Restricted Payments”	  	5.09
	“Securities”	  	Recitals
	“Spin-Off”	  	4.05(c)
	“TIA”	  	11.02
	“Trigger Event”	  	4.05(c)
	“unit of Reference Property”	  	4.07(a)
	“Valuation Period”	  	4.05(c)

 Section 1.03. Rules of Construction. Unless the context otherwise requires: 

(a) a term has the meaning assigned to it; 

  
 11 

 (b) an accounting term not otherwise defined has the meaning assigned to it in accordance with
GAAP; 
 (c) words in the singular include the plural, and words in the plural include the singular; 

(d) provisions apply to successive events and transactions; 

(e) the term “merger” includes a statutory share exchange and the term “merged” has a correlative meaning; 

(f) the masculine gender includes the feminine and the neuter; 

(g) references to agreements and other instruments include subsequent amendments thereto; and 

(h) “herein,” “hereof” and other words of similar import refer to this Indenture as a whole and not to any particular
Article, Section or other subdivision. 
 ARTICLE 2 

THE SECURITIES 

Section 2.01. Form and Dating. (a) The Securities and the Trustee’s certificate of authentication
shall be substantially in the respective forms set forth in Exhibit A, which Exhibit is incorporated in and made part of this Indenture. The Securities may have notations, legends or endorsements required by law, stock exchange rule or usage.
The Company shall provide any such notations, legends or endorsements to the Trustee in writing. Each Security shall be dated the date of its authentication. The terms and provisions contained in the Securities shall constitute, and are hereby
expressly made, a part of this Indenture, and the Company and the Trustee, by their execution and delivery of this Indenture, expressly agree to such terms and provisions and to be bound thereby. However, to the extent any provision of any Security
conflicts with the express provisions of this Indenture, the provisions of this Indenture shall govern and be controlling. 
 (b) All of the
Securities shall be issued initially in the form of one or more Certificated Securities, registered in such names and authorized in such denominations as the Purchaser shall request, duly executed by the Company and authenticated by the Trustee as
hereinafter provided. 
 Upon request of the Purchaser, all of the Securities may be exchanged for one or more Global Securities which shall
be assigned a CUSIP number and be deposited on behalf of the purchasers of the Securities represented thereby with the Trustee, at its Corporate Trust Office, as custodian for the depositary, The Depository Trust Company (“DTC”)
(such depositary, or any successor thereto, being hereinafter referred to as the “Depositary”), duly executed by the Company and authenticated by the Trustee as hereinafter provided. Each Certificated Security or Global Security, as
applicable, shall represent such of the outstanding Securities as shall be specified therein and each shall provide that it shall represent the aggregate amount of 

  
 12 

 
outstanding Securities from time to time endorsed thereon and that the aggregate amount of outstanding Securities represented thereby may from time to time be reduced or increased, as
appropriate, to reflect exchanges, purchases or conversions of such Securities. Any adjustment of the aggregate principal amount of a Global Security to reflect the amount of any increase or decrease in the amount of outstanding Securities
represented thereby shall be made by the Trustee in accordance with instructions given by the Holder thereof as required by Section 2.12 and shall be made on the records of the Trustee and the Depositary. 

Members of, or participants in, the Depositary (“Agent Members”) shall have no rights under this Indenture with respect to
any Global Security held on their behalf by the Depositary or under the Global Security, and the Depositary (including, for this purpose, its nominee) may be treated by the Company, the Trustee and any agent of the Company or the Trustee as the
absolute owner and Holder of such Global Security for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall (1) prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to any written
certification, proxy or other authorization furnished by the Depositary or (2) impair, as between the Depositary and its Agent Members, the operation of customary practices governing the exercise of the rights of a Holder of any Security. 

(c) The Company shall execute and the Trustee shall, in accordance with this Section 2.01(c), authenticate and deliver initially one or
more Certificated Securities that (1) shall be registered in such names and authorized in such denominations as the Purchaser shall request, and (2) shall be delivered by the Trustee to the Purchaser or pursuant to the Purchaser’s
instructions. 
 (d) If requested by the Purchaser, the Company shall execute and the Trustee shall, in accordance with this
Section 2.01(d), authenticate and deliver one or more Global Securities in exchange for the Certificated Securities that (1) shall be registered in the name of the Depositary, (2) shall be delivered by the Trustee to the Depositary or
pursuant to the Depositary’s instructions, (3) shall be assigned a restricted or unrestricted CUSIP number, as applicable and (4) shall bear a legend substantially to the following effect: 

“UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE COMPANY OR ITS AGENT FOR
REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY PAYMENT HEREON
IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE

  
 13 

 
THEREOF. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND
UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DEFINITIVE FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR
ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.” 

Section 2.02. Execution and Authentication; Payments of Defaulted Amounts. (a) The Securities shall be
issuable only in registered form without coupons and only in denominations of $1,000 principal amount and any integral multiple thereof. An Officer shall sign the Securities for the Company by manual or facsimile signature attested by the manual or
facsimile signature of the Secretary or an Assistant Secretary of the Company. Typographic and other minor errors or defects in any such facsimile signature shall not affect the validity or enforceability of any Security which has been authenticated
and delivered by the Trustee. If an Officer whose signature is on a Security no longer holds that office at the time the Trustee authenticates the Security, the Security shall be valid nevertheless. A Security shall not be valid until an authorized
signatory of the Trustee manually signs the certificate of authentication on the Security. The signature shall be conclusive evidence that the Security has been authenticated under this Indenture. 

(b) The Trustee shall act as the initial authenticating agent. Thereafter, the Trustee may appoint an authenticating agent acceptable to the
Company to authenticate Securities. An authenticating agent may authenticate Securities whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent. An authenticating agent
shall have the same rights as an Agent to deal with the Company or an Affiliate of the Company. 
 (c) The Trustee shall authenticate and
make available for delivery Securities for original issue in the aggregate principal amount of up to $164,746,000 upon receipt of a written order or orders of the Company signed by two Officers, at least one of whom shall be the principal executive
officer, principal financial officer or principal accounting officer of the Company (a “Company Order”). The Company Order shall specify the amount of Securities to be authenticated, shall provide that all such Securities will be
represented initially by a Certificated Security and the date on which each original issue of Securities is to be authenticated. In authenticating such Securities, the Trustee shall receive, and, shall be fully protected in relying upon: (a) an
Officers’ Certificate delivered in accordance with Section 2.01 and Section 11.04 and (b) an Opinion of Counsel which shall state (1) that the form and terms of such Securities have been established by or pursuant to a
resolution of the Board of Directors in accordance with Section 2.01 and Section 2.02 and in conformity with the provisions of this Indenture, (2) that such Securities, when authenticated and delivered by the Trustee and issued by the
Company in the manner and subject to any conditions specified in such Opinion of 

  
 14 

 
Counsel, will constitute valid and legally binding obligations of the Company, enforceable in accordance with their terms, subject to bankruptcy, insolvency, reorganization and other laws of
general applicability relating to or affecting the enforcement of creditors’ rights and to general equity principles, and (3) that all conditions precedent under this Indenture in respect of the execution and delivery by the Company of
such Securities have been complied with. 
 (d) Any Defaulted Amounts shall forthwith cease to be payable to the Holder on the relevant
payment date, but shall accrue interest per annum at the rate of one percent, subject to the enforceability thereof under applicable law, from, and including, such relevant payment date to, but excluding, the date on which such Defaulted Amounts
shall have been paid by the Company, at its election in each case, as provided in subsection (i) or (ii) below: 
 (i)
The Company may elect to make payment of any Defaulted Amounts to the Persons in whose names the Securities (or their respective predecessor Securities) are registered at the close of business on a special record date for the payment of such
Defaulted Amounts, which shall be fixed in the following manner. The Company shall notify the Trustee in writing of the amount of the Defaulted Amounts proposed to be paid on each Security and the date of the proposed payment (which shall be not
less than 25 days after the receipt by the Trustee of such notice, unless the Trustee shall consent to an earlier date), and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount to be paid in
respect of such Defaulted Amounts or shall make arrangements satisfactory to the Trustee for such deposit on or prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the Persons entitled to such
Defaulted Amounts as in this clause provided. Thereupon the Company shall fix a special record date for the payment of such Defaulted Amounts which shall be not more than 15 days and not less than 10 days prior to the date of the proposed payment,
and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment. The Company shall promptly notify the Trustee of such special record date and the Trustee, in the name and at the expense of the Company, shall cause
notice of the proposed payment of such Defaulted Amounts and the special record date therefor to be delivered to each Holder, not less than 10 days prior to such special record date. Notice of the proposed payment of such Defaulted Amounts and the
special record date therefor having been so delivered, such Defaulted Amounts shall be paid to the Persons in whose names the Securities (or their respective predecessor Securities) are registered at the close of business on such special record date
and shall no longer be payable pursuant to the following subsection (ii) of this Section 2.02(d). 
 (ii) The
Company may make payment of any Defaulted Amounts in any other lawful manner not inconsistent with the requirements of any securities exchange or automated quotation system on which the Securities may be listed or designated for issuance, and upon
such notice as may be required by such exchange or automated quotation system, if, after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee.

  
 15 

 Section 2.03. Registrar, Paying Agent and Conversion Agent.
The Company shall maintain one or more offices or agencies where Securities may be presented for registration of transfer or for exchange (each, a “Registrar”), one or more offices or agencies where Securities may be presented
for payment (each, a “Paying Agent”), one or more offices or agencies where Securities may be presented for conversion (each, a “Conversion Agent”) and one or more offices or agencies where notices and demands to or
upon the Company in respect of the Securities and this Indenture may be served, such offices and agencies to be maintained in the contiguous United States. The Company will at all times maintain a Paying Agent, Conversion Agent, Registrar and an
office or agency where notices and demands to or upon the Company in respect of the Securities and this Indenture may be served in the Borough of Manhattan, The City of New York. One of the Registrars (the “Primary Registrar”) shall
keep a register of the Securities and of their registration of transfer and exchange. The Company shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. 

The Company shall enter into an appropriate agency agreement with any Agent not a party to this Indenture. The agreement shall implement the
provisions of this Indenture that relate to such Agent. The Company shall give prompt written notice to the Trustee of the name and address of any Agent not a party to this Indenture. If the Company fails to maintain a Registrar, Paying Agent,
Conversion Agent or agent for service of notices and demands in any place required by this Indenture, or fails to give the foregoing notice, the Trustee shall act as such. The Company or any Affiliate of the Company may act as Paying Agent (except
for the purposes of Section 5.01 and Article 9). 
 The Company hereby initially designates the Trustee as Paying Agent, Primary
Registrar, Securities Custodian and Conversion Agent and each of the Corporate Trust Office of the Trustee and the office or agency of the Trustee in the Borough of Manhattan, The City of New York, as an office or agency of the Company for each of
the aforesaid purposes. 
 Section 2.04. Paying Agent to Hold Money in Trust. Prior to 11:00 a.m., New
York City time on the Maturity Date, the Company shall deposit with a Paying Agent a sum sufficient to pay such principal so becoming due. A Paying Agent shall hold in trust for the benefit of the Holders or the Trustee all money held by the Paying
Agent for the payment of principal of the Securities, and shall notify the Trustee of any default by the Company (or any other obligor on the Securities) in making any such payment. If the Company or an Affiliate of the Company acts as Paying Agent,
it shall, before 11:00 a.m., New York City time on the Maturity Date, segregate the money and hold it as a separate trust fund for the benefit of the Holders. The Company at any time may require a Paying Agent to pay all money held by it to the
Trustee, and the Trustee may at any time during the continuance of any default, upon written request to a Paying Agent, require such Paying Agent to pay forthwith to the Trustee all sums so held in trust by such Paying Agent. Upon doing so, the
Paying Agent (other than the Company) shall have no further liability for the money. 
 Section 2.05. Holder.
The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of the Holders. If the Trustee is not the Primary Registrar, the Company shall furnish to the Trustee,
at such times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of the Holders. 

  
 16 

 Section 2.06. Transfer and Exchange; Transfer Restrictions.
(a) Subject to compliance with any applicable additional requirements contained in Section 2.12, when a Security is presented to a Registrar with a request to register a transfer thereof or to exchange such Security for an equal
principal amount of Securities of other authorized denominations, the Registrar shall register the transfer or make the exchange as requested; provided, however, that every Security presented or surrendered for registration of transfer
or exchange shall be duly endorsed or accompanied by an assignment form in form satisfactory to the Registrar duly executed by the Holder thereof or its attorney duly authorized in writing. To permit registration of transfers and exchanges, upon
surrender of any Security for registration of transfer or exchange at an office or agency maintained pursuant to Section 2.03, the Company shall execute and the Trustee shall authenticate Securities of a like aggregate principal amount at the
Registrar’s request. Any exchange or registration of transfer shall be without charge, except that the Company or the Registrar may require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in
relation thereto; provided, that this sentence shall not apply to any exchange pursuant to Section 2.07, Section 2.10, Section 3.06, Section 4.02(d) or Section 10.05. 

Neither the Company, any Registrar nor the Trustee shall be required to exchange or register a transfer of any Securities or portions thereof
in respect of which a Repurchase Exercise Notice pursuant to Section 3.02(c) has been delivered and not withdrawn by the Holder thereof (except, in the case of the purchase of a Security in part, the portion thereof not to be purchased). 

All Securities issued upon any transfer or exchange of Securities shall be valid obligations of the Company, evidencing the same debt and
entitled to the same benefits under this Indenture, as the Securities surrendered upon such transfer or exchange. 
 (b) Any Registrar
appointed pursuant to Section 2.03 shall provide to the Trustee such information as the Trustee may reasonably require in connection with the delivery by such Registrar of Securities upon transfer or exchange of Securities. 

(c) Each Holder agrees to indemnify the Company, each Registrar and the Trustee against any liability that may result from the registration of
transfer, exchange or assignment of such Holder’s Security in violation of any provision of this Indenture and/or, except as contemplated by the Registration Rights Agreement in a transaction registered under the Securities Act or in a
transaction exempt from registration under Rule 144A, applicable United States federal or state securities law. 
 (d) Every Security that
bears or is required under this Section 2.06(d) to bear the legend set forth in this Section 2.06(d) (together with any Common Stock issued upon conversion of the Securities that is required to bear the legend set forth in
Section 2.06(e), collectively, the “Restricted Securities”) shall be subject to the restrictions on transfer set forth in this Section 2.06(d) (including the legend set forth below), unless (1) such transfer is made
to a Permitted Transferee under clause (i) or (iii) of such definition (as defined in the Registration 

  
 17 

 
Rights Agreement) or (2) such restrictions on transfer shall be eliminated or otherwise waived by written consent of the Company, and the Holder of each such Restricted Security, by such
Holder’s acceptance thereof, agrees to be bound by all such restrictions on transfer. As used in this Section 2.06(d) and Section 2.06(e), the term “transfer” encompasses any sale, pledge, transfer or other
disposition whatsoever of any Restricted Security. 
 Until the date (the “Resale Restriction Termination Date”) that is
the later of (1) the date that is one year after the last date of original issuance of the Securities, or such shorter period of time as permitted by Rule 144 under the Securities Act or any successor provision thereto, and (2) such later
date, if any, as may be required by applicable law, any certificate evidencing such Security (and all securities issued in exchange therefor or substitution thereof, other than Common Stock issued upon conversion thereof, which shall bear the legend
set forth in Section 2.06(e), if applicable) shall bear a legend in substantially the following form (unless such Securities have been transferred pursuant to a registration statement that has become or been declared effective under the
Securities Act and that continues to be effective at the time of such transfer, or sold pursuant to the exemption from registration provided by Rule 144 or any other applicable exemption then in force under the Securities Act, or unless otherwise
agreed by the Company in writing, with notice thereof to the Trustee): 
 THIS SECURITY AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF
THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS
ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER: 
 (1) AGREES FOR THE BENEFIT OF KERYX
BIOPHARMACEUTICALS, INC. (THE “COMPANY”) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN PRIOR TO THE DATE THAT IS THE LATER OF (X) ONE YEAR AFTER THE LAST ORIGINAL
ISSUE DATE HEREOF OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY RULE 144 UNDER THE SECURITIES ACT OR ANY SUCCESSOR PROVISION THERETO AND (Y) SUCH LATER DATE, IF ANY, AS MAY BE REQUIRED BY APPLICABLE LAW, EXCEPT: 

(A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF; OR 

(B) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT; OR 

(C) TO A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT; OR 

  
 18 

 (D) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE
SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. 
 PRIOR TO THE REGISTRATION OF
ANY TRANSFER IN ACCORDANCE WITH CLAUSE (1)(D) ABOVE, THE COMPANY AND THE TRUSTEE RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED
TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. 

No transfer of any Security prior to the Resale Restriction Termination Date will be registered by the Security Registrar unless the
applicable box on the Form of Assignment and Transfer has been checked. 
 Any Security (or security issued in exchange or substitution
therefor) as to which such restrictions on transfer shall have expired in accordance with their terms may, upon surrender of such Security for exchange to the Security Registrar in accordance with the provisions of this Section 2.06, be
exchanged for a new Security or Securities, of like tenor and aggregate principal amount, which shall not bear the restrictive legend required by this Section 2.06(d) and shall not be assigned a restricted CUSIP number. The Company shall be
entitled to instruct the Custodian in writing to so surrender any Security as to which such restrictions on transfer shall have expired in accordance with their terms for exchange, and, upon such instruction, the Custodian shall so surrender such
Security for exchange; and any new Security so exchanged therefor shall not bear the restrictive legend specified in this Section 2.06(d) and shall not be assigned a restricted CUSIP number. The Company shall promptly notify the Trustee upon
the occurrence of the Resale Restriction Termination Date and promptly after a registration statement, if any, with respect to the Securities or any Common Stock issued upon conversion of the Securities has been declared effective under the
Securities Act. 
 (e) Until the Resale Restriction Termination Date, any stock certificate representing Common Stock issued upon conversion
of such Security shall bear a legend in substantially the following form (unless the Security or such Common Stock has been transferred pursuant to a registration statement that has become or been declared effective under the Securities Act and that
continues to be effective at the time of such transfer, or pursuant to the exemption from registration provided by Rule 144 or any other applicable exemption then in force under the Securities Act, or such Common Stock has been issued upon
conversion of Securities that have been transferred pursuant to a registration statement that has become or been declared effective under the Securities Act and that continues to be effective at the time of such transfer, or pursuant to the
exemption from registration provided by Rule 144 or any other applicable exemption then in force under the Securities Act, or unless otherwise agreed by the Company with written notice thereof to the Trustee and any transfer agent for the Common
Stock): 

  
 19 

 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER: 

(1) AGREES FOR THE BENEFIT OF KERYX BIOPHARMACEUTICALS, INC. (THE “COMPANY”) THAT IT WILL NOT OFFER, SELL,
PLEDGE OR OTHERWISE TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN PRIOR TO THE DATE THAT IS THE LATER OF (X) ONE YEAR AFTER THE LAST ORIGINAL ISSUE DATE OF THE SERIES OF NOTES UPON THE CONVERSION OF WHICH THIS SECURITY WAS ISSUED OR
SUCH SHORTER PERIOD OF TIME AS PERMITTED BY RULE 144 UNDER THE SECURITIES ACT OR ANY SUCCESSOR PROVISION THERETO AND (Y) SUCH LATER DATE, IF ANY, AS MAY BE REQUIRED BY APPLICABLE LAW, EXCEPT: 

(A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF; OR 

(B) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT; OR 

(C) TO A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT; OR 

(D) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION
FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. 
 PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (1)(D)
ABOVE, THE COMPANY AND THE TRANSFER AGENT FOR THE COMPANY’S COMMON STOCK RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED
TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. 

Any such Common Stock as to which such restrictions on transfer shall have expired in accordance with their terms may, upon surrender of the
certificates representing such shares of Common Stock for exchange in accordance with the procedures of the transfer agent for the Common Stock, be exchanged for a new certificate or certificates for a like aggregate number of shares of Common
Stock, which shall not bear the restrictive legend required by this Section 2.06(e). 

  
 20 

 Any Security or Common Stock issued upon the conversion or exchange of a Security that is
repurchased or owned by any Affiliate of the Company (or any Person who was an Affiliate of the Company at any time during the three months preceding), other than the Purchaser, may not be resold by such Affiliate (or such Person, as the case may
be) unless registered under the Securities Act or resold pursuant to an exemption from the registration requirements of the Securities Act in a transaction that results in such Security or Common Stock, as the case may be, no longer being a
“restricted security” (as defined under Rule 144 under the Securities Act). The Company shall cause any Security that is repurchased or owned by it to be surrendered to the Trustee for cancellation in accordance with Section 2.11.

 The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed
under this Indenture or under applicable law with respect to any transfer of any interest in any Security (including any transfers between or among Agent Members or other beneficial owners of interests in any Global Security) other than to require
delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine the same to determine substantial compliance as to form with
the express requirements hereof. 
 Neither the Trustee nor any Agent shall have any responsibility for any actions taken or not taken by
the Depositary. 
 Section 2.07. Replacement Securities. If any mutilated Security is surrendered to the
Company, a Registrar or the Trustee, or the Trustee receives evidence to its satisfaction of the destruction, loss or theft of any Security, and there is delivered to the Company, the applicable Registrar and the Trustee such security or indemnity
as will be required by them to save each of them harmless, then, in the absence of notice to the Company, such Registrar or the Trustee that such Security has been acquired by a protected purchaser, the Company shall execute, and upon its written
request the Trustee shall authenticate and deliver, in exchange for any such mutilated Security or in lieu of any such destroyed, lost or stolen Security, a new Security of like tenor and principal amount, bearing a number not contemporaneously
outstanding. 
 In case any such mutilated, destroyed, lost or stolen Security has become or is about to become due and payable, or is about
to be repurchased by the Company pursuant to Article 3, the Company in its discretion may, instead of issuing a new Security, pay or repurchase such Security, as the case may be. 

Upon the issuance of any new Securities under this Section 2.07, the Company may require the payment of a sum sufficient to cover any tax
or other governmental charge that may be imposed in relation thereto and any other reasonable expenses (including the reasonable fees and expenses of the Trustee or the Registrar) in connection therewith. 

  
 21 

 Every new Security issued pursuant to this Section 2.07 in lieu of any mutilated, destroyed,
lost or stolen Security shall constitute an original additional contractual obligation of the Company, whether or not the mutilated, destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall be entitled to all benefits
of this Indenture equally and proportionately with any and all other Securities duly issued hereunder. 
 The provisions of this
Section 2.07 are (to the extent lawful) exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities. 

Section 2.08. Outstanding Securities. Securities outstanding at any time are all Securities authenticated by
the Trustee, except for those canceled by it, those converted pursuant to Article 4, those delivered to it for cancellation or surrendered for transfer or exchange and those described in this Section 2.08 as not outstanding. 

If a Security is replaced pursuant to Section 2.07, it ceases to be outstanding unless the Trustee receives proof satisfactory to it that
the replaced Security is held by a protected purchaser. 
 If a Paying Agent (other than the Company or an Affiliate of the Company) holds
on the Maturity Date money sufficient to pay the principal of the Securities (or portions thereof) payable on that date, then on and after such Maturity Date such Securities (or portions thereof, as the case may be) shall cease to be outstanding.

 Subject to the restrictions contained in Section 2.09, a Security does not cease to be outstanding because the Company or an
Affiliate of the Company holds the Security. 
 Section 2.09. Treasury Securities. In determining whether the
Holders of the required principal amount of Securities have concurred in any notice, direction, waiver or consent, Securities owned by the Company or any other obligor on the Securities or by any Affiliate of the Company, other than Purchaser, or of
such other obligor shall be disregarded, except that, for purposes of determining whether the Trustee shall be protected in relying on any such notice, direction, waiver or consent, only Securities that a Responsible Officer of the Trustee actually
knows are so owned shall be so disregarded. Securities so owned that have been pledged in good faith shall not be disregarded if the pledgee establishes to the satisfaction of the Trustee the pledgee’s right so to act with respect to the
Securities and that the pledgee is not the Company or any other obligor on the Securities or any Affiliate of the Company, other than Purchaser, or of such other obligor. 

Section 2.10. Temporary Securities. Until definitive Securities are ready for delivery, the Company may
prepare and execute, and, upon receipt of a Company Order, the Trustee shall authenticate and deliver, temporary Securities. Temporary Securities shall be substantially in the form of Certificated Securities but may have variations that the Company
considers appropriate for temporary Securities and as shall be reasonably acceptable to the Trustee. Without unreasonable delay, the Company shall prepare and the Trustee, upon receipt of a Company Order, shall authenticate and deliver definitive
Securities in exchange for temporary Securities. Holders of temporary Securities shall be entitled to all the benefits of this Indenture. 

  
 22 

 Section 2.11. Cancellation; Repurchase. The Company shall
cause all Securities surrendered for the purpose of payment, repurchase, registration of transfer or exchange or conversion, if surrendered to any Person other than the Trustee (including any of the Company’s Agents, Subsidiaries or Affiliates,
other than Purchaser), to be delivered to the Trustee for cancellation. The Registrar, the Paying Agent and the Conversion Agent shall forward to the Trustee or its agent any Securities surrendered to them for registration of transfer, exchange,
redemption, payment or conversion. The Company shall instruct the Trustee in writing to cancel all Securities surrendered for the purpose of payment, repurchase, registration of transfer, exchange, conversion or cancellation, and the Trustee and no
one else shall promptly cancel, in accordance with its standard procedures and upon the Company’s written instruction, all Securities so surrendered and shall dispose of canceled Securities (subject to the record retention requirements of the
Exchange Act), in accordance with its standard procedures, and no Securities shall be authenticated in exchange thereof except as expressly permitted by any of the provisions of this Indenture. The Company may not hold or resell such Securities or
issue new Securities to replace Securities that it has purchased or otherwise acquired or that have been delivered to the Trustee for cancellation. 

The Company may, to the extent permitted by law, and directly or indirectly (regardless of whether such Securities are surrendered to the
Company), repurchase Securities in the open market, by tender offer or exchange offer, by private agreement through counterparties or otherwise, whether by the Company or its Subsidiaries, including by cash-settled swaps or other derivatives and, in
each case, at any price. The Company shall cause any Securities so purchased (other than Securities repurchased pursuant to cash-settled swaps or other derivatives) to be surrendered to the Trustee for cancellation in accordance with this
Section 2.11, and they shall no longer be considered outstanding under this Indenture upon their repurchase. Any Securities held by the Company or one of its Subsidiaries shall be disregarded for voting purposes in connection with any notice,
waiver, consent or direction requiring the vote or concurrence of Holders. 
 Section 2.12. Additional Transfer and
Exchange Requirements. (a) A Global Security may not be transferred, in whole or in part, to any Person other than the Depositary or a nominee or any successor thereof, and no such transfer to any such other Person may be registered;
provided that the foregoing shall not prohibit any transfer of a Security that is issued in exchange for a Global Security but is not itself a Global Security. No transfer of a Security to any Person shall be effective under this Indenture or
the Securities unless and until such Security has been registered in the name of such Person. Notwithstanding any other provisions of this Indenture or the Securities, transfers of a Global Security, in whole or in part, shall be made only in
accordance with this Section 2.12. 

  
 23 

 (b) The provisions of subsections (i), (ii), (iii), (iv) and (v) below shall apply only to
Global Securities: 
 (i) Notwithstanding any other provisions of this Indenture or the Securities, a Global Security shall
not be exchanged in whole or in part for a Security registered in the name of any Person other than the Depositary or one or more nominees thereof; provided that a Global Security may be exchanged for Certificated Securities registered in the
names of any Person designated by the Depositary in the event that (A) the Depositary has notified the Company that it is unwilling or unable to continue as Depositary for such Global Security or the Depositary has ceased to be a “clearing
agency” registered under the Exchange Act, and a successor Depositary is not appointed by the Company within 90 days or (B) an Event of Default has occurred and is continuing and a beneficial owner requests that its Securities be exchanged
for Certificated Securities. Any Global Security exchanged pursuant to clause (A) above shall be so exchanged in whole and not in part, and any Global Security exchanged pursuant to clause (B) above may be exchanged in whole or from time
to time in part as directed by the Depositary. Any Security issued in exchange for a Global Security or any portion thereof shall be a Global Security; provided that any such Security so issued that is registered in the name of a Person other
than the Depositary or a nominee thereof shall not be a Global Security. 
 (ii) Securities issued in exchange for a Global
Security or any portion thereof shall be issued in fully registered book-entry form, without interest coupons, shall have an aggregate principal amount equal to that of such Global Security or portion thereof to be so exchanged, shall be registered
in such names and be in such authorized denominations as the Depositary shall designate and shall bear any applicable legend provided for herein. Any Global Security to be exchanged in whole shall be surrendered by the Depositary to the Trustee, as
Registrar. With regard to any Global Security to be exchanged in part, either such Global Security shall be so surrendered for exchange or, if the Trustee is acting as Securities Custodian for the Depositary or its nominee with respect to such
Global Security, the principal amount thereof shall be reduced, by an amount equal to the portion thereof to be so exchanged, by means of an appropriate adjustment made on the records of the Trustee. Upon any such surrender or adjustment, the
Trustee shall authenticate and deliver the Security issuable on such exchange to or upon the order of the Depositary or an authorized representative thereof; provided, however, that any Global Security surrendered for exchange shall be
duly endorsed or accompanied by a written instrument of transfer in accordance with the proviso to the first paragraph of Section 2.06(a). 

(iii) Subject to the provisions of subsection (v) below, the registered Holder may grant proxies and otherwise authorize
any Person, including Agent Members and Persons that may hold interests through Agent Members, to take any action which a Holder is entitled to take under this Indenture or the Securities. 

(iv) In the event of the occurrence of any of the events specified in subsection (i) above, the Company will promptly make
available to the Trustee a reasonable supply of Certificated Securities in definitive, fully registered form, without interest coupons. 

  
 24 

 (v) Neither Agent Members nor any other Persons on whose behalf Agent Members may
act shall have any rights under this Indenture with respect to any Global Security registered in the name of the Depositary or any nominee thereof, or under any such Global Security, and the Depositary or such nominee, as the case may be, may be
treated by the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner and Holder of such Global Security for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the
Trustee or any agent of the Company or the Trustee from giving effect to any written certification, proxy or other authorization furnished by the Depositary or such nominee, as the case may be, or impair, as between the Depositary, its Agent Members
and any other Person on whose behalf an Agent Member may act, the operation of customary practices of such Persons governing the exercise of the rights of a Holder of any Security. 

(c) In the event that Certificated Securities are issued in exchange for beneficial interests in Global Securities and, thereafter, the events
or conditions specified in Section 2.12(b)(i) that required such exchange shall cease to exist, the Company shall deliver notice to the Trustee and to the Holders stating that Holders may exchange Certificated Securities for interests in Global
Securities by complying with the procedures set forth in this Indenture and briefly describing such procedures and the events or circumstances requiring that such notice be given. Thereafter, if Certificated Securities are presented by a Holder to a
Registrar with a request: 
 (i) to register the transfer of such Certificated Securities to a Person who will take delivery
thereof in the form of a beneficial interest in a Global Security; or 
 (ii) to exchange such Certificated Securities for an
equal principal amount of beneficial interests in a Global Security, which beneficial interests will be owned by the Holder transferring such Certificated Securities, 

the Registrar shall register the transfer or make the exchange as requested by canceling such Certificated Securities and causing, or directing the Securities
Custodian to cause, the aggregate principal amount of the applicable Global Security to be increased accordingly and, if no such Global Security is then outstanding, the Company shall issue and the Trustee, upon receipt of a Company Order, shall
authenticate and deliver a new Global Security; provided, however, that the Certificated Securities presented or surrendered for registration of transfer or exchange shall be duly endorsed or accompanied by a written instrument of
transfer in accordance with the proviso to the first paragraph of Section 2.06(a). 
 Section 2.13. CUSIP
Numbers. The Company in issuing the Securities may use one or more “CUSIP” numbers (if then generally in use), and, if so, the Trustee shall use “CUSIP” numbers in notices as a convenience to Holders; provided
that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice and that reliance may be placed only on the other identification numbers printed on
the Securities, and any such notice or related action by the Company contemplated thereby shall not be affected by any defect in or omission of such numbers. The Company will promptly notify the Trustee of any change in the “CUSIP”
numbers. 

  
 25 

 ARTICLE 3 

NO REDEMPTION; REPURCHASE UPON A FUNDAMENTAL CHANGE 

Section 3.01. No Optional Redemption. The Company shall not have the option to redeem the Securities prior to the
Maturity Date. No sinking fund is provided for the Securities. 
 Section 3.02. Repurchase At Option of The Holder
Upon A Fundamental Change. (a) Subject to the satisfaction of the requirements of this Article 3, if a Fundamental Change occurs at any time prior to the Maturity Date, each Holder shall have the right, at its option, to require the Company
to repurchase for cash all of their Securities, or any portion of the principal thereof that is equal to $1,000 or an integral multiple of $1,000, at a repurchase price (the “Fundamental Change Repurchase Price”) equal to 100% of
the principal amount of the Securities to be repurchased. The Company shall provide to the Holders of the Securities, the Trustee, the Paying Agent and the Conversion Agent (if other than the Trustee) a notice of the anticipated effective date of a
Fundamental Change (i) at least 35 Scheduled Trading Days prior to the anticipated effective date of a Fundamental Change or (ii) if the Company does not have knowledge of a Fundamental Change at least 35 Scheduled Trading Days prior to
the anticipated effective date of such transaction, within two Business Days of the earlier of (x) the date upon which the Company receives, or otherwise becomes aware, of such Fundamental Change and (y) the actual effective date of such
Fundamental Change. 
 (b) In addition to the notice required pursuant to Section 3.02(a), on or before the 2nd Business Day after the date on which a Fundamental Change becomes effective, the Company shall provide to all Holders of the Securities, the Trustee and the Conversion Agent (if other than the
Trustee) a notice of the occurrence of the Fundamental Change and of the resulting repurchase right (the “Fundamental Change Repurchase Right Notice”). The Fundamental Change Repurchase Right Notice shall state: 

(i) the event or events giving rise to the Fundamental Change; 

(ii) the Conversion Rate and any adjustments to the Conversion Rate; 

(iii) the effective date of the Fundamental Change; 

(iv) the last date on which a Holder may exercise the repurchase right; 

(v) the Fundamental Change Repurchase Price; 

(vi) the Fundamental Change Repurchase Date; 

(vii) the name and address of the Paying Agent and the Conversion Agent; 

(viii) that the Securities with respect to which a Repurchase Exercise Notice has been given by the Holder may be converted
only if the Holder withdraws the Repurchase Exercise Notice as described in Section 3.02(d); and 

  
 26 

 (ix) the procedures that Holders must follow to require the Company to repurchase
their Securities. 
 Simultaneously with providing the Fundamental Change Repurchase Right Notice, the Company shall issue a press release
and publish the information through a public medium customary for such press releases. 
 (c) To exercise the repurchase right in connection
with a Fundamental Change, a Holder must deliver, prior to the close of business, on the twentieth Business Day immediately following the effective date of the Fundamental Change, the Securities to be purchased to the Paying Agent, duly endorsed for
transfer, or effect book-entry transfer of the Securities to the Paying Agent, together with a written notice exercising its right to require the Company to repurchase its Securities or a portion thereof (a “Repurchase Exercise
Notice”), substantially in the form included in Exhibit A hereto, duly completed. The Repurchase Exercise Notice must state: 

(i) If the Securities are Certificated Securities, the certificate numbers of the Securities to be delivered for repurchase;

 (ii) the portion of the principal amount of the Securities to be repurchased, which must be equal to $1,000 or an integral
multiple thereof; and 
 (iii) that the Securities are to be repurchased by the Company as of the Fundamental Change
Repurchase Date pursuant to the applicable provisions of the Securities and this Indenture. 
 If the Securities are Global Securities, the
Repurchase Exercise Notice must comply with the Applicable Procedures. 
 A Holder may withdraw any Repurchase Exercise Notice (in whole or
in part) by a written notice of withdrawal delivered to the Paying Agent prior to the close of business on the second Business Day prior to the Fundamental Change Repurchase Date. The notice of withdrawal must state: 

(i) the principal amount of the Securities for which the Repurchase Exercise Notice has been withdrawn; 

(ii) the certificate numbers of the withdrawn Securities; and 

(iii) the principal amount, if any, that remains subject to the Repurchase Exercise Notice. 

If the Securities are Global Securities, the withdrawal notice must comply with the Applicable Procedures. 

  
 27 

 (d) The Company must repurchase on a date (the “Fundamental Change Repurchase
Date”) chosen by the Company within five Business Days of the Repurchase Exercise Notice, subject to extension to comply with applicable law. To receive payment of the Fundamental Change Repurchase Price, a Holder must either effect
book-entry transfer or deliver the Securities, together with necessary endorsements, to the office of the Paying Agent after delivery of the Repurchase Exercise Notice. Holders shall receive payment of the Fundamental Change Repurchase Price on the
later of (i) the Fundamental Change Repurchase Date and (ii) the time of book-entry transfer or the delivery of the Securities. If the Paying Agent holds money deposited by the Company sufficient to pay the Fundamental Change Repurchase
Price of the Securities on the Fundamental Change Repurchase Date, then with respect to the Securities that have been properly surrendered for repurchase and have not been validly withdrawn: 

(i) the Securities will cease to be outstanding and interest, if any, will cease to accrue (whether or not book-entry transfer
of the Securities is made or whether or not the Securities are delivered to the Paying Agent); and 
 (ii) all other rights
of the Holder of such Securities will terminate (other than the right to receive the Fundamental Change Repurchase Price upon delivery or transfer of the Securities). 

Section 3.03. [Reserved]. 

Section 3.04. [Reserved]. 

Section 3.05. Repayment to the Company. To the extent that the aggregate amount of cash deposited by the
Company pursuant to Section 3.02 exceeds the aggregate Fundamental Change Repurchase Price of the Securities or portions thereof that the Company is obligated to purchase, then promptly after the Fundamental Change Repurchase Date, the Trustee
or a Paying Agent, as the case may be, shall return any such excess cash to the Company upon the Company’s written request. 

Section 3.06. Partial Repurchase. Upon surrender of a Security that is to be repurchased in part pursuant to
Section 3.02, the Company shall execute and the Trustee shall authenticate and deliver to the Holder a new Security in an authorized denomination equal in principal amount to the unrepurchased portion of the Security surrendered. 

ARTICLE 4 
 CONVERSION 

Section 4.01. Conversion Rights. (a) Subject to and upon compliance with the provisions of this Article 4,
each Holder of a Security shall have the right, at such Holder’s option, to convert all or any portion (if the portion to be converted is $1,000 principal amount or an integral multiple thereof) of such Security at an initial conversion rate of
215.983 shares of Common Stock (subject to adjustment as provided in Section 4.05, the “Conversion Rate”) per $1,000 principal amount of Securities (subject to the settlement provisions of Section 4.02, the
“Conversion Obligation”). 

  
 28 

 (b) If a transaction or event that constitutes a Fundamental Change occurs prior to the close of
business on the Maturity Date, regardless of whether a Holder of the Securities has the right to require the Company to repurchase the Securities pursuant to Section 3.02, or if the Company is a party to a consolidation, merger, binding share
exchange, or transfer or lease of all or substantially all of the Company’s assets prior to the Maturity Date, pursuant to which Common Stock would be converted into cash, securities or other assets, then all or any portion of a Holder’s
Securities may be surrendered for conversion at any time from or after the date that is 35 Scheduled Trading Days prior to the anticipated effective date of the transaction (or, if later, the Business Day after the Company gives notice of such
transaction) until 35 Trading Days after the actual effective date of such transaction. The Company shall notify the Holders, the Trustee and the Conversion Agent (if other than the Trustee) (i) as promptly as practicable following the date the
Company publicly announces such transaction but in no event less than 35 Scheduled Trading Days prior to the anticipated effective date of such transaction; or (ii) if the Company does not have knowledge of such transaction at least 35
Scheduled Trading Days prior to the anticipated effective date of such transaction, then within two Business Days of the earlier of (x) the date upon which the Company receives notice, or otherwise becomes aware, of such transaction and
(y) the actual effective date of such transaction. 
 Section 4.02. Settlement Upon Conversion; Conversion
Procedures. (a) Subject to this Section 4.02 and Section 4.07, the converting holder may convert and the Company shall deliver to the converting Holder, in respect of each $1,000 principal amount of Securities being
converted, a number of shares of Common Stock equal to the Conversion Rate, together with cash, if applicable, in lieu of any fractional share of Common Stock in accordance with subsection (h) of this Section 4.02. 

(b) Subject to Section 4.02(e), before any Holder of a Security shall be entitled to convert a Security as set forth above, such Holder
shall (i) in the case of a Certificated Security, (A) complete and deliver an irrevocable notice to the Conversion Agent as set forth in the Form of Conversion Notice attached to the Form of Security set forth in Exhibit A hereto (a
“Conversion Notice”) at the office of the Conversion Agent and state in writing therein the principal amount of Securities to be converted and the name or names (with addresses) in which such Holder wishes the certificate or
certificates for any shares of Common Stock to be delivered by the Company or its agent upon settlement of the Conversion Obligation to be registered, and (B) deliver such Security, duly endorsed to the Company or in blank (and accompanied by
appropriate endorsement and transfer documents), to the Conversion Agent and (ii) in the case of a Global Security, comply with the Depositary’s procedures for converting a beneficial interest in a Global Security. The Trustee (and, if
different, the Conversion Agent) shall notify the Company of any conversion pursuant to this Article 4 no later than one Business Day following the Conversion Date for such conversion. No Conversion Notice with respect to any Securities may be
surrendered by a Holder thereof if such Holder has also delivered a Fundamental Change Repurchase Notice to the Company in respect of such Securities and not validly withdrawn such Fundamental Change Repurchase Notice in accordance with
Section 3.02(c). 
 If more than one Security shall be surrendered for conversion at one time by the same Holder, the Conversion
Obligation with respect to such Securities shall be computed on the basis of the aggregate principal amount of the Securities (or specified portions thereof to the extent permitted thereby) so surrendered. 

  
 29 

 (c) A Security shall be deemed to have been converted immediately prior to the close of business
on the Business Day (the “Conversion Date”) that the Holder has complied with the requirements set forth in subsection (b) above; provided that in the case of a Global Security, no Holder shall be deemed to have complied
with the requirements set forth in subsection (b) above on any Business Day that the Depositary is not open for business. The Company shall deliver the consideration due in respect of the Conversion Obligation on the third Business Day
immediately following the relevant Conversion Date (provided that, with respect to any Conversion Date occurring on or after 10 days before the Maturity Date, the Company shall settle any such conversion on the Maturity Date). The Company
shall issue or cause to be issued, and deliver to the Conversion Agent or to such Holder, or such Holder’s nominee or nominees, certificates or a book-entry transfer through the Depositary for the full number of shares of Common Stock to which
such Holder shall be entitled in satisfaction of the Company’s Conversion Obligation. 
 (d) In case any Security shall be surrendered
for partial conversion, the Company shall execute and the Trustee shall authenticate and deliver to or upon the written order of the Holder of the Security so surrendered a new Security or Securities in authorized denominations in an aggregate
principal amount equal to the unconverted portion of the surrendered Security, without payment of any service charge by the converting Holder but, if required by the Company or Trustee, with payment of a sum sufficient to cover any transfer tax or
similar governmental charge required by law or that may be imposed in connection therewith as a result of the name of the Holder of the new Securities issued upon such conversion being different from the name of the Holder of the old Securities
surrendered for such conversion. 
 (e) If a Holder submits a Security for conversion, the Company shall pay any documentary, stamp or
similar issue or transfer tax due on any issuance of any shares of Common Stock upon the conversion, unless the tax is due because the Holder requests any shares to be issued in a name other than the Holder’s name, in which case the Holder
shall pay that tax. The Company or its stock transfer agent may refuse to deliver the certificates representing the shares of Common Stock being issued in a name other than the Holder’s name until the Company or its representative receives a
sum sufficient to pay any tax that is due by such Holder in accordance with the immediately preceding sentence. 
 (f) Upon the conversion of
an interest in a Global Security, the Trustee, or the Securities Custodian at the direction of the Trustee, shall make a notation on such Global Security as to the reduction in the principal amount represented thereby. The Company shall notify the
Trustee in writing of any conversion of Securities effected through any Conversion Agent other than the Trustee. 
 (g) The Person in whose
name the certificate for any shares of Common Stock delivered upon conversion is registered shall be treated as a shareholder of record as of the close of business on the relevant Conversion Date. Upon a conversion of Securities, such Person shall
no longer be a Holder of such Securities surrendered for conversion. 

  
 30 

 (h) The Company shall not issue any fractional share of Common Stock upon conversion of the
Securities and shall instead pay cash in lieu of delivering any fractional share of Common Stock issuable upon conversion based on the Daily VWAP for the relevant Conversion Date. Promptly after the determination of the amount of cash payable in
lieu of any fractional share, the Company shall notify the Trustee and the Conversion Agent (if other than the Trustee) of the amount of cash payable in lieu of fractional shares of Common Stock. 

(i) Each conversion shall be deemed to have been effected as to any Security surrendered for conversion on the Conversion Date;
provided, however, that the Person in whose name any shares of Common Stock shall be issuable upon such conversion shall become the holder of record of such shares as of the close of business on the Conversion Date. 

Section 4.03. Company to Provide Stock. The Company shall, prior to issuance of any Securities hereunder, and from
time to time as may be necessary, reserve, out of its authorized but unissued Common Stock, a sufficient number of shares of Common Stock to permit the conversion of all outstanding Securities into shares of Common Stock (assuming that at the time
of computation of such number of shares, all such Securities would be converted by a single Holder). 
 All shares of Common Stock delivered
upon conversion of the Securities shall be newly issued shares, shall be duly authorized, validly issued, fully paid and nonassessable and shall be free from preemptive rights and free of any lien or adverse claim. 

The Company shall endeavor promptly to comply with all federal and state securities laws regulating the offer and delivery of shares of Common
Stock upon conversion of Securities, if any, and will list or cause to have quoted such shares of Common Stock on each national securities exchange, over-the-counter
market or such other market on which the Common Stock is then listed or quoted; provided, however, that if the rules of such automated quotation system or exchange permit the Company to defer the listing of such Common Stock until the
first conversion of the Securities into Common Stock in accordance with the provisions of this Indenture, the Company covenants to list such Common Stock issuable upon conversion of the Securities in accordance with the requirements of such
automated quotation system or exchange at such time. 
 Section 4.04. [Reserved]. 

Section 4.05. Conversion Rate Adjustments. The Conversion Rate shall be adjusted, without duplication, from
time to time by the Company, upon the occurrence of any of the following events, except that the Company shall not make any adjustments to the Conversion Rate if Holders of the Securities participate (other than in the case of a share split or share
combination), at the same time and upon the same terms as holders of the Common Stock and solely as a result of holding the Securities, in any of the events described in this Section 4.05 without having to convert their Securities, as if they
held a number of shares of Common Stock equal to the Conversion Rate multiplied by the principal amount (expressed in thousands) of Securities held by such Holder. 

  
 31 

 (a) If the Company exclusively issues shares of Common Stock as a dividend or distribution on
shares of its Common Stock, or if the Company effects a share split or share combination, the Conversion Rate shall be adjusted based on the following formula: 
  

 
 where: 
  

					
	CR0	  	=	  	the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date of such dividend or distribution, or immediately prior to the open of business on the effective date of such share split or share
combination, as applicable;
			
	CR’	  	=	  	the Conversion Rate in effect immediately after the open of business on such Ex-Dividend Date or effective date;
			
	OS0	  	=	  	the number of shares of Common Stock outstanding immediately prior to the open of business on such Ex-Dividend Date or effective date; and
			
	OS’	  	=	  	the number of shares of Common Stock outstanding immediately after giving effect to such dividend, distribution, share split or share combination.

 Any adjustment made under this Section 4.05(a) shall become effective immediately after the open of business on the Ex-Dividend Date for such dividend or distribution, or immediately after the open of business on the effective date for such share split or share combination, as applicable. If any dividend or distribution of the
type described in this Section 4.05(a) is declared but not so paid or made, or any share split or share combination of the type described in this Section 4.05(a) is announced but the outstanding shares of Common Stock are not split or
combined, as the case may be, the Conversion Rate shall be immediately readjusted, effective as of the date the Board of Directors determines not to pay such dividend or distribution, or not to split or combine the outstanding shares of Common
Stock, as the case may be, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared or such share split or share combination had not been announced. 

(b) If the Company issues to all or substantially all holders of its Common Stock any rights, options or warrants entitling them, for a period
of not more than 60 calendar days after the announcement date of such issuance, to subscribe for or purchase shares of Common Stock at a price per share that is less than the average of the Last Reported Sale Prices of the Common Stock for the five
consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of such issuance, the Conversion Rate shall be increased based on the following formula: 

 
 

 

  
 32 

 where: 
  

					
	CR0	  	=	  	the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such issuance;
			
	CR’	  	=	  	the Conversion Rate in effect immediately after the open of business on such Ex-Dividend Date;
			
	OS0	  	=	  	the number of shares of Common Stock outstanding immediately prior to the open of business on such Ex-Dividend Date;
			
	X	  	=	  	the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and
			
	Y	  	=	  	the number of shares of Common Stock equal to the aggregate price payable to exercise such rights, options or warrants, divided by the average of the Last Reported Sale Prices of the Common Stock over the five consecutive
Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement of the issuance of such rights, options or warrants.

 Any increase made under this Section 4.05(b) shall be made successively whenever any such rights, options or warrants are
issued and shall become effective immediately after the open of business on the Ex-Dividend Date for such issuance. To the extent that shares of the Common Stock are not delivered after the expiration of such
rights, options or warrants, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect had the increase with respect to the issuance of such rights, options or warrants been made on the basis of delivery of only the
number of shares of Common Stock actually delivered. If such rights, options or warrants are not so issued, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such
Ex-Dividend Date for such issuance had not occurred. 
 For purposes of this Section 4.05(b)
and for the purpose of Section 4.05(c), in determining whether any rights, options or warrants entitle the holders to subscribe for or purchase shares of Common Stock at less than such average of the Last Reported Sale Prices of the Common
Stock for the five consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the date of announcement for such issuance, and in determining the aggregate offering price of such shares of Common Stock, there shall
be taken into account any consideration received by the Company for such rights, options or warrants and any amount payable on exercise or conversion thereof, the value of such consideration, if other than cash, to be determined by the Board of
Directors. 
 (c) If the Company distributes shares of its Capital Stock, evidences of its indebtedness, other assets or property or rights,
options or warrants to acquire its Capital Stock or other securities, to all or substantially all holders of the Common Stock, excluding (i) dividends, distributions or issuances as to which an adjustment was effected pursuant to
Section 4.05(a) or Section 4.05(b), (ii) dividends or distributions paid exclusively in cash as to which an adjustment was effected pursuant to Section 4.05(d), (iii) Spin-Offs as to which the provisions set forth below in this
Section 4.05(c) shall apply and (iv) Non-Separate Rights (any of such shares of Capital Stock, evidences of indebtedness, other assets or property or rights, options or warrants to acquire Capital
Stock or other securities of the Company, the “Distributed Property”), then the Conversion Rate shall be increased based on the following formula: 
  

 

  
 33 

 where: 
  

					
	CR0	  	=	  	the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such distribution;
			
	CR’	  	=	  	the Conversion Rate in effect immediately after the open of business on such Ex-Dividend Date;
			
	SP0	  	=	  	the average of the Last Reported Sale Prices of the Common Stock over the five consecutive Trading Day period ending on, and including, the Trading Day immediately preceding the Ex-Dividend Date for such distribution; and
			
	FMV	  	=	  	the fair market value (as determined by the Board of Directors) of the Distributed Property with respect to each outstanding share of the Common Stock on the Ex-Dividend Date for such distribution.

 Any increase made under the portion of this Section 4.05(c) above shall become effective immediately after the open of
business on the Ex-Dividend Date for such distribution. If such distribution is not so paid or made, the Conversion Rate shall be decreased to the Conversion Rate that would then be in effect if such
distribution had not been declared. Notwithstanding the foregoing, if “FMV” (as defined above) is equal to or greater than “SP0” (as defined above), in lieu of the foregoing
increase, each Holder of a Security shall receive, in respect of each $1,000 principal amount thereof, at the same time and upon the same terms as holders of the Common Stock receive the Distributed Property, the amount of Distributed Property such
Holder would have received if such Holder owned a number of shares of Common Stock equal to the Conversion Rate in effect on the Ex-Dividend Date for the distribution. If the Board of Directors determines the
“FMV” (as defined above) of any distribution for purposes of this Section 4.05(c) by reference to the actual or when-issued trading market for any securities, it shall in doing so consider the prices in such market over the same
period used in computing the Last Reported Sale Prices of the Common Stock over the five consecutive Trading Day period ending on the Trading Day immediately preceding the Ex-Dividend Date for such
distribution. 
 With respect to an adjustment pursuant to this Section 4.05(c) where there has been a payment of a dividend or other
distribution on the Common Stock of shares of Capital Stock of any class or series, or similar equity interest, of or relating to a Subsidiary or other business unit of the Company, that are, or, when issued, will be, listed or admitted for trading
on a U.S. national securities exchange (a “Spin-Off”), the Conversion Rate shall be increased based on the following formula: 

 
 

 

  
 34 

 where: 
  

					
			
	CR0	  	=	  	the Conversion Rate in effect immediately prior to the end of the Valuation Period;
			
	CR’	  	=	  	the Conversion Rate in effect immediately after the end of the Valuation Period;
			
	FMV0	  	=	  	the average of the Last Reported Sale Prices of the Capital Stock or similar equity interest distributed to holders of the Common Stock applicable to one share of the Common Stock (determined by reference to the definition of Last
Reported Sale Price as if references therein to Common Stock were to such Capital Stock or similar equity interest) over the first five consecutive Trading Day period after, and including, the Ex-Dividend Date
of the Spin-Off (the “Valuation Period”); and
			
	MP0	  	=	  	the average of the Last Reported Sale Prices of the Common Stock over the Valuation Period.

 The adjustment to the Conversion Rate under the preceding paragraph shall occur on the last Trading Day of the Valuation
Period; provided that in respect of any conversion of Securities during the Valuation Period, references in the portion of this Section 4.05(c) related to Spin-Offs to five Trading Days shall be deemed to be replaced with such lesser
number of Trading Days as have elapsed between the Ex-Dividend Date of such Spin-Off and the Conversion Date in determining the Conversion Rate. 

For purposes of this Section 4.05(c) (and subject in all respects to Section 4.09), rights, options or warrants distributed by the
Company pursuant to a shareholder rights plan to all or substantially all holders of its Common Stock entitling them to subscribe for or purchase shares of the Company’s Capital Stock, which rights, options or warrants, until the occurrence of
a specified event or events (“Trigger Event”): (i) are deemed to be transferred with such shares of the Common Stock; (ii) are not exercisable; and (iii) are also issued in respect of future issuances of the Common Stock,
shall be deemed not to have been distributed for purposes of this Section 4.05(c) (and no adjustment to the Conversion Rate under this Section 4.05(c) will be required) until the occurrence of the earliest Trigger Event, whereupon such
rights, options or warrants shall be deemed to have been distributed and an appropriate adjustment (if any is required) to the Conversion Rate shall be made under this Section 4.05(c). If any such right, option or warrant (including any such
existing rights, options or warrants distributed prior to the date of this Indenture) is subject to events, upon the occurrence of which such rights, options or warrants become exercisable to purchase different securities, evidences of indebtedness
or other assets, then the date of the occurrence of any and each such event shall be deemed to be the date of distribution and Ex-Dividend Date with respect to new rights, options or warrants with such rights
(in which case the existing rights, options or warrants shall be deemed to terminate and expire on such date without exercise by any of the holders thereof). In addition, in the event of any distribution (or deemed distribution) of rights, options
or warrants, or any Trigger Event or other event (of the type described in the immediately preceding sentence) with respect thereto that was counted for purposes of calculating a distribution amount for which an adjustment to the Conversion Rate
under this Section 4.05(c) was made, (1) in the case of any such rights, options or warrants that shall all have been redeemed or purchased without exercise by any holders thereof, upon such final redemption or purchase (x) the
Conversion Rate shall be readjusted as if such rights, options or warrants had not been issued and (y) the Conversion Rate shall then again be readjusted to give effect to such distribution, deemed distribution or Trigger Event, as the case

  
 35 

 
may be, as though it were a cash distribution, equal to the per share redemption or purchase price received by a holder or holders of Common Stock with respect to such rights, options or warrants
(assuming such holder had retained such rights, options or warrants), made to all holders of Common Stock as of the date of such redemption or purchase, and (2) in the case of such rights, options or warrants that shall have expired or been
terminated without exercise by any holders thereof, the Conversion Rate shall be readjusted as if such rights, options and warrants had not been issued. 

For purposes of Section 4.05(a), Section 4.05(b) and this Section 4.05(c), any dividend or distribution to which this
Section 4.05(c) is applicable that also includes one or both of: 
 (A) a dividend or distribution of shares of Common Stock to which
Section 4.05(a) is applicable (the “Clause A Distribution”); or 
 (B) a dividend or distribution of rights, options or
warrants to which Section 4.05(b) is applicable (the “Clause B Distribution”), 
 then (1) such dividend or distribution, other
than the Clause A Distribution and the Clause B Distribution, shall be deemed to be a dividend or distribution to which this Section 4.05(c) is applicable (the “Clause C Distribution”) and any Conversion Rate adjustment
required by this Section 4.05(c) with respect to such Clause C Distribution shall then be made, and (2) the Clause A Distribution and Clause B Distribution shall be deemed to immediately follow the Clause C Distribution and any Conversion
Rate adjustment required by Section 4.05(a) and Section 4.05(b) with respect thereto shall then be made, except that, if determined by the Company, (I) the “Ex-Dividend Date” of the
Clause A Distribution and the Clause B Distribution shall be deemed to be the Ex-Dividend Date of the Clause C Distribution and (II) any shares of Common Stock included in the Clause A Distribution or
Clause B Distribution shall be deemed not to be “outstanding immediately prior to the open of business on such Ex-Dividend Date or effective date” within the meaning of Section 4.05(a) or
“outstanding immediately prior to the open of business on such Ex-Dividend Date” within the meaning of Section 4.05(b). 

(d) If the Company makes any cash dividend or distribution to all or substantially all holders of the Common Stock, the Conversion Rate shall
be adjusted based on the following formula: 
  
 

 
  

					
	where:	  		  	
			
	CR0	  	=	  	the Conversion Rate in effect immediately prior to the open of business on the Ex-Dividend Date for such dividend or distribution;
			
	CR’	  	=	  	the Conversion Rate in effect immediately after the open of business on the Ex-Dividend Date for such dividend or distribution;
	SP0	  	=	  	the Last Reported Sale Price of the Common Stock on the Trading Day immediately preceding the Ex-Dividend Date for such dividend or distribution; and
			
	C	  	=	  	the amount in cash per share of Common Stock the Company distributes to holders of its Common Stock.
		  		  	

  
 36 

 Any increase pursuant to this Section 4.05(d) shall become effective immediately after the open of business
on the Ex-Dividend Date for such dividend or distribution. If such dividend or distribution is not so paid, the Conversion Rate shall be decreased, effective as of the date the Board of Directors determines
not to make or pay such dividend or distribution, to the Conversion Rate that would then be in effect if such dividend or distribution had not been declared. Notwithstanding the foregoing, if “C” (as defined above) is equal to or greater
than “SP0” (as defined above), in lieu of the foregoing increase, each Holder of a Security shall receive, for each $1,000 principal amount of Securities, at the same time and upon
the same terms as holders of shares of the Common Stock, the amount of cash that such Holder would have received if such Holder owned a number of shares of Common Stock equal to the Conversion Rate on the
Ex-Dividend Date for such cash dividend or distribution. 
 (e) If the Company or any of its
Subsidiaries makes a payment in respect of a tender or exchange offer for the Common Stock, to the extent that the cash and value of any other consideration included in the payment per share of the Common Stock exceeds the average of the Last
Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer, as
the case may be, the Conversion Rate shall be increased based on the following formula: 
  
 

 
  

					
	where:	  		  	
			
	CR0	  	=	  	the Conversion Rate in effect immediately prior to the close of business on the 10th Trading Day immediately following, and including, the Trading Day next succeeding the date
such tender or exchange offer expires;
			
	CR’	  	=	  	the Conversion Rate in effect immediately after the close of business on the 10th Trading Day immediately following, and including, the Trading Day next succeeding the date such
tender or exchange offer expires;
			
	AC	  	=	  	the aggregate value of all cash and any other consideration (as determined by the Board of Directors) paid or payable for shares of Common Stock purchased in such tender or exchange offer;
			
	OS0	  	=	  	the number of shares of Common Stock outstanding immediately prior to the date such tender or exchange offer expires (prior to giving effect to the purchase of all shares of Common Stock accepted for purchase or exchange in such
tender or exchange offer);
			
	OS’	  	=	  	the number of shares of Common Stock outstanding immediately after the date such tender or exchange offer expires (after giving effect to the purchase of all shares of Common Stock accepted for purchase or exchange in such tender or
exchange offer); and
			
	SP’	  	=	  	the average of the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the date such tender or exchange offer expires.

  
 37 

 The adjustment to the Conversion Rate under this Section 4.05(e) shall occur at the close of business on the
10th Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange offer expires; provided that in respect of any conversion of
Securities within the 10 Trading Days immediately following, and including, the Trading Day next succeeding the expiration date of any tender or exchange offer, references with respect to 10 Trading Days shall be deemed replaced with such lesser
number of Trading Days as have elapsed between the expiration date of such tender or exchange offer and the Conversion Date in determining the Conversion Rate. 

(f) Notwithstanding this Section 4.05 or any other provision of this Indenture or the Securities, if a Conversion Rate adjustment becomes
effective on any Ex-Dividend Date, and a Holder that has converted its Securities on or after such Ex-Dividend Date and on or prior to the related Record Date would be
treated as the record holder of the Common Stock as of the related Conversion Date based on an adjusted Conversion Rate for such Ex-Dividend Date, then, notwithstanding the Conversion Rate adjustment
provisions in this Section 4.05, the Conversion Rate adjustment relating to such Ex-Dividend Date shall not be made for such converting Holder. Instead, such Holder shall be treated as if such Holder were
the record owner of the shares of Common Stock on an unadjusted basis and participate in the related dividend, distribution or other event giving rise to such adjustment. 

(g) Except as stated herein, the Company shall not adjust the Conversion Rate for the issuance of shares of its Common Stock or any securities
convertible into or exchangeable for shares of its Common Stock or the right to purchase shares of its Common Stock or such convertible or exchangeable securities. In addition, the Company shall not adjust the Conversion Rate for guarantees issued
in respect of any of its outstanding securities. 
 (h) In addition to those adjustments required by subsections (a), (b), (c), (d) and
(e) of this Section 4.05, and to the extent permitted by applicable law and subject to the applicable rules of The Nasdaq Capital Market, the Company from time to time may increase the Conversion Rate by any amount for any period of at
least 20 Business Days if the Board of Directors has determined that such increase would be in the Company’s best interest. In addition, the Company may (but is not required to) increase the Conversion Rate, as the Board of Directors considers
advisable, to avoid or diminish any income tax to holders of Common Stock or rights to purchase Common Stock resulting from any dividend or distribution of stock (or rights to acquire stock) or from any event treated as such for tax purposes.
Whenever the Conversion Rate is increased pursuant to either of the preceding two sentences, the Company shall mail to the Holder of each Security at its last address appearing on the register of the Primary Registrar a notice of the increase at
least 15 days prior to the date the increased Conversion Rate takes effect, and such notice shall state the increased Conversion Rate and the period during which it will be in effect. 

  
 38 

 (i) Notwithstanding anything to the contrary in this Section 4.05, the Conversion Rate shall
not be adjusted: 
 (i) upon the issuance of any shares of Common Stock pursuant to any present or future plan providing for
the reinvestment of dividends or interest payable on the Company’s securities and the investment of additional optional amounts in shares of Common Stock under any plan; 

(ii) upon the issuance of any shares of Common Stock or options or rights to purchase those shares pursuant to any present or
future employee, director or consultant benefit plan or program of or assumed by the Company or any of its Subsidiaries; 

(iii) upon the issuance of any shares of Common Stock pursuant to any option, warrant, right (other than rights under a
shareholder rights plan as described in Section 4.09) or exercisable, exchangeable or convertible security not described in clause (ii) of this subsection (i) and outstanding as of the date the Securities were first issued; or 

(iv) solely for a change in the par value of the Common Stock. 

(j) All calculations and other determinations in respect of the Conversion Rate shall be made by the Company to the nearest 1/10,000th of a
share. 
 (k) Whenever the Conversion Rate is adjusted pursuant to this Section 4.05, the Company shall compute the adjusted Conversion
Rate in accordance with this Section 4.05 and shall prepare an Officers’ Certificate setting forth: (i) the adjusted Conversion Rate; (ii) the subsection of this Section 4.05 pursuant to which such adjustment has been made,
showing in reasonable detail the facts upon which such adjustment is based; (iii) the calculation of such adjustment; and (iv) the date as of which such adjustment is effective, and such Officers’ Certificate shall promptly be
delivered to the Trustee and Conversion Agent (which certificates shall be conclusive evidence of the accuracy of such adjustment absent manifest error). As soon as practicable after each such adjustment, the Company shall deliver to the Holders a
notice stating that the Conversion Rate has been adjusted and setting forth the adjusted Conversion Rate. Unless and until a Responsible Officer of the Trustee and each Conversion Agent shall receive an Officers’ Certificate with respect to an
adjustment of the Conversion Rate, the Trustee and each Conversion Agent may assume without inquiry that the Conversion Rate has not been adjusted and that the last Conversion Rate of which it has knowledge remains in effect. Neither the Trustee nor
any Conversion Agent shall be under any duty or responsibility with respect to any such certificate or the information and calculations contained therein, except to exhibit the same to any Holder of Securities desiring inspection thereof at its
office during normal business hours. Simultaneously with an adjustment of the Conversion Rate, the Company shall disseminate a press release detailing the new Conversion Rate and other relevant information. 

  
 39 

 (l) For purposes of this Section 4.05, the number of shares of Common Stock at any time
outstanding shall not include shares held in the treasury of the Company so long as the Company does not pay any dividend or make any distribution on shares of Common Stock held in the treasury of the Company, but shall include shares issuable in
respect of scrip certificates issued in lieu of fractions of shares of Common Stock. 
 (m) The Company shall not take any voluntary action
that would result in an adjustment pursuant to any of the provisions described in clauses (b) through (e) of Section 4.05 without complying, if applicable, with the shareholder approval rules of the Nasdaq Capital Market (including Nasdaq
Stock Market Rule 5635, which requires shareholder approval of certain issuances of Common Stock) or any similar rule of any other stock exchange on which the Common Stock is listed at the relevant time. 

Section 4.06. Adjustments of Prices. Whenever any provision of this Indenture requires the Company to calculate the
Last Reported Sale Prices or the Daily VWAPs over a span of multiple days, the Board of Directors shall make appropriate adjustments to each to account for any adjustment to the Conversion Rate that becomes effective, or any event requiring an
adjustment to the Conversion Rate where the Ex-Dividend Date of the event occurs, at any time during the relevant period. 

Section 4.07. Effect of Recapitalizations, Reclassifications and Changes of the Common Stock. (a) In the
case of: 
 (i) any recapitalization, reclassification or change of the Common Stock (other than changes resulting from a
subdivision or combination); 
 (ii) any consolidation, merger or combination involving the Company; 

(iii) any sale, lease or other transfer to a third party of the consolidated assets of the Company and the Company’s
Subsidiaries substantially as an entirety; or 
 (iv) any statutory share exchange; 

in each case, as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other property or assets (including
cash or any combination thereof) (any such event, a “Merger Event”), then, at and after the effective time of such Merger Event, the right to convert each $1,000 principal amount of Securities shall be changed into a right to
convert such principal amount of Securities into the kind and amount of shares of stock, other securities or other property or assets (including cash or any combination thereof) that a holder of a number of shares of Common Stock equal to the
Conversion Rate immediately prior to such Merger Event would have owned or been entitled to receive (the “Reference Property,” with each “unit of Reference Property” meaning the kind and amount of Reference Property
that a holder of one share of Common Stock is entitled to receive) upon such Merger Event and, prior to or at the effective time of such Merger Event, the Company or the successor or purchasing Person, as the case may be, shall execute with the
Trustee a supplemental indenture permitted under Section 4.07(b) providing for such change in the right to convert each $1,000 principal amount of Securities; provided, however, that at and after the effective time of the Merger
Event, (A) any shares of Common Stock that the Company would have been required to deliver upon conversion of the Securities in accordance with Section 4.02 shall instead be deliverable in the

  
 40 

 
amount and type of Reference Property that a holder of that number of shares of Common Stock would have been entitled to receive in such Merger Event and (B) the Daily VWAP shall be
calculated based on the value of a unit of Reference Property. If the Merger Event causes the Common Stock to be converted into, or exchanged for, the right to receive more than a single type of consideration (determined based in part upon any form
of shareholder election), then the Reference Property into which the Securities will be convertible shall be deemed to be (i) the weighted average of the types and amounts of consideration received by the holders of Common Stock that
affirmatively make such an election or (ii) if no holders of Common Stock affirmatively make such an election, the types and amounts of consideration actually received by the holders of Common Stock. The Company shall notify Holders, the
Trustee and the Conversion Agent (if other than the Trustee) of the weighted average as soon as practicable after the determination is made. 

If the holders of Common Stock receive only cash in such Merger Event, then for all conversions of Securities that occur after the effective
date of such Merger Event (x) the consideration due upon conversion of each $1,000 principal amount of Securities shall be solely cash in an amount equal to the Conversion Rate in effect on the Conversion Date, multiplied by the price
paid per share of Common Stock in such Merger Event and (y) the Company shall satisfy the Conversion Obligation by paying cash to converting Holders on the earlier of the third Business Day immediately following the Conversion Date and the
closing date of the Merger Event. 
 Such supplemental indenture described in the second immediately preceding paragraph shall provide for
adjustments that shall be as nearly equivalent as is possible to the adjustments provided for in this Article 4. If, in the case of any Merger Event, the Reference Property includes shares of stock, securities or other property or assets (including
cash or any combination thereof) of a Person other than the successor or purchasing corporation, as the case may be, in such Merger Event, then such supplemental indenture shall also be executed by such other Person and shall contain such additional
provisions to protect the interests of the Holders of the Securities as the Board of Directors shall reasonably consider necessary by reason of the foregoing, including to the extent required by the Board of Directors and practicable the provisions
providing for the repurchase rights set forth in Article 3. 
 (b) In the event the Company shall be required to execute a supplemental
indenture pursuant to subsection (a) of this Section 4.07, the Company shall promptly file with the Trustee an Officers’ Certificate briefly stating the reasons therefor, the kind or amount of cash, securities or property or asset
that will comprise the Reference Property after any such Merger Event, any adjustment to be made with respect thereto and that all conditions precedent have been complied with, and shall promptly mail notice thereof to all Holders. The Company shall
cause notice of the execution of such supplemental indenture to be mailed to each Holder, at its address appearing on the register of the Primary Registrar provided for in this Indenture, within 20 days after execution thereof. Failure to deliver
such notice shall not affect the legality or validity of such supplemental indenture. 

  
 41 

 (c) The Company shall not become a party to any Merger Event unless its terms are consistent with
this Section 4.07. None of the foregoing provisions shall affect the right of a Holder of Securities to convert its Securities as set forth in Section 4.01 and Section 4.02 prior to the effective date of such Merger Event. 

(d) The above provisions of this Section 4.07 shall similarly apply to successive Merger Events. 

Section 4.08. Cancellation of Converted Securities. All Certificated Securities delivered for conversion shall be
delivered to the Trustee or its agent to be canceled by or at the direction of the Trustee, which shall dispose of the same as provided in this Indenture. Upon conversions of beneficial interests in any Global Security, the Trustee or the Securities
Custodian, at the direction of the Trustee, shall reduce the aggregate principal amount of outstanding Securities represented by such Global Security to reflect the conversion. 

Section 4.09. Shareholders Rights. If the Company has a shareholder rights plan in effect upon conversion of the
Securities, each share of Common Stock, if any, issued upon such conversion shall be entitled to receive the appropriate number of rights, if any, and the certificates representing the Common Stock issued upon such conversion shall bear such
legends, if any, in each case as may be provided by the terms of any such shareholder rights plan, as the same may be amended from time to time (such rights prior to separation from the Common Stock,
“Non-Separate Rights”). However, if prior to any conversion the rights have separated from the shares of Common Stock in accordance with the provisions of the applicable shareholder rights
plan so that the Holders would not be entitled to receive any rights in respect of Common Stock issuable upon conversion of the Securities, the Conversion Rate shall be increased at the time of separation as if the Company distributed to all or
substantially all holders of Common Stock shares of Capital Stock of the Company, evidences of its indebtedness, other assets or property or rights, options or warrants to acquire its Capital Stock or other securities as provided in
Section 4.05(c), subject to decrease in the event of the expiration, termination or redemption of such rights. A distribution of rights pursuant to such a shareholder rights plan shall not trigger a Conversion Rate adjustment pursuant to
Section 4.05(c) if Holders of the Securities participate in such distribution on an as-converted basis in accordance with the first paragraph of Section 4.05. 

Section 4.10. Trustee’s Disclaimer. The Trustee shall have no duty to determine when an
adjustment under this Article 4 should be made, how it should be made or what such adjustment should be, but may accept as conclusive evidence of that fact or the correctness of any such adjustment, and shall be protected in relying upon, the
Officers’ Certificate that the Company is obligated to deliver to the Trustee pursuant to Section 4.05(k). The Trustee makes no representation as to the validity or value of any securities or assets issued upon conversion of Securities,
and the Trustee shall not be responsible for the Company’s failure to comply with any provisions of this Article 4. In no event shall the Trustee or Conversion Agent be responsible for making any calculations under this Indenture or for
determining amounts to be paid. For the avoidance of doubt, the Trustee and Conversion Agent shall rely conclusively on the calculations and information provided to them by the Company as to the Daily VWAP and Last Reported Sale Price. 

  
 42 

 The Trustee shall not be under any responsibility to determine the correctness of any provisions
contained in any supplemental indenture executed pursuant to Section 6.01, but may accept as conclusive evidence of the correctness thereof, and shall be fully protected in relying upon, the Officers’ Certificate with respect thereto which
the Company is obligated to file with the Trustee pursuant to Section 6.01. 
 ARTICLE 5 

COVENANTS 

Section 5.01. Payment on the Securities. The Company shall promptly make all payments in respect of the Securities
on the dates and in the manner provided in the Securities and this Indenture. Principal (including the Fundamental Change Repurchase Price, if applicable) of the Securities shall be considered paid on the date it is due, if the Paying Agent (if
other than the Company or an Affiliate thereof) holds as of 11:00 a.m., New York City time, on the due date money, deposited by the Company or an Affiliate thereof in immediately available funds, designated for and sufficient to pay all principal
(including the Fundamental Change Repurchase Price) and interest then due on the Securities. 
 Payment of the principal of the Securities
shall be made at the office or agency of the Company maintained for that purpose in the Borough of Manhattan, The City of New York (which shall initially be an office or agency of the Trustee in the Borough of Manhattan, The City of New York);
provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address appears in the Register; provided further that a Holder with an
aggregate principal amount in excess of $2,000,000 will be paid by wire transfer in immediately available funds at the election of such Holder if such Holder has provided wire transfer instructions to the Company and the Trustee at least five
Business Days prior to the payment date, it being understood that as long as the Securities are Global Securities, payment will be made by wire transfer to DTC. 

Section 5.02. SEC Reports and Rule 144A Information Requirement. (a) The Company shall file with the Trustee,
within five days after the same are required to be filed with the SEC, copies of any documents or reports that the Company is required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act (giving effect to any grace period
provided by Rule 12b-25 under the Exchange Act). Any such document or report that the Company files with the SEC via the EDGAR system shall be deemed to be filed with the Trustee for purposes of this
Section 5.02 at the time such documents are filed via EDGAR. 
 (b) Delivery of such reports, information and documents to the Trustee
is for informational purposes only and the Trustee’s receipt of such shall not constitute actual or constructive notice of any information contained therein or determinable from information contained therein, including the Company’s
compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officers’ Certificates). 

  
 43 

 (c) At any time the Company is not subject to Section 13 or 15(d) of the Exchange Act, the
Company shall, so long as any of the Securities or any shares of Common Stock issuable upon conversion thereof shall, at such time, constitute “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act, promptly
provide to the Trustee and, upon written request, any Holder, beneficial owner or prospective purchaser of such Securities or any shares of Common Stock issuable upon conversion of such Securities, the information required to be delivered pursuant
to Rule 144A(d)(4) under the Securities Act to facilitate the resale of such Securities or shares of Common Stock. The Company shall take such further action as the Holder may reasonably request to the extent from time to time required to enable
such Holder to sell such Securities or shares of Common Stock in accordance with Rule 144A, as such rule may be amended from time to time. 

Section 5.03. Compliance Certificates. (a) The Company shall deliver to the Trustee, within 120 days after the
end of each fiscal year during which any Securities were outstanding, an Officers’ Certificate stating whether or not the signer thereof knows of any Default or Event of Default that occurred during such fiscal year. Such Officers’
Certificate shall contain a certification from the principal executive officer, principal financial officer or principal accounting officer of the Company that a review has been conducted of the activities of the Company and the Company’s
performance under this Indenture and that the Company has complied with all conditions and covenants under this Indenture. For purposes of this Section 5.03, such compliance shall be determined without regard to any period of grace or
requirement of notice provided under this Indenture. If the officer of the Company signing such Officers’ Certificate has knowledge of such a Default or Event of Default, the Officers’ Certificate shall describe any such Default or Event
of Default and its status. 
 (b) The Company shall, so long as any of the Securities are outstanding, deliver to the Trustee, promptly, and
in any event within five days, upon any Officer becoming aware of any Default or Event of Default, an Officers’ Certificate specifying such Default or Event of Default and what action the Company is taking or proposes to take with respect
thereto. 
 Section 5.04. Further Instruments and Acts. Upon request of the Trustee, the Company will execute and
deliver such further instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purposes of this Indenture. 

Section 5.05. Maintenance of Corporate Existence. Subject to Article 6, the Company will do or cause to be done all
things necessary to preserve and keep in full force and effect its corporate existence. 
 Section 5.06. Stay,
Extension and Usury Laws. The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law
or other law which would prohibit or forgive the Company from paying all or any portion of the principal of the Securities as contemplated herein, wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the
performance of this Indenture, and the Company (to the extent it may lawfully do so) hereby expressly waives all benefit or advantage of any such law and covenants that it will not, by resort to any such law, hinder, delay or impede the execution of
any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had been enacted. 

  
 44 

 Section 5.07. Additional Amounts. (a) If the Company
consolidates with or merges into, or sells, conveys, transfers or leases all or substantially all of the Company’s properties and assets to, another Person pursuant to Section 6.01, and the Successor Company is not organized and existing
under the laws of the United States of America, any State thereof or the District of Columbia, then all payments and deliveries made by, or on behalf of, the Successor Company under or with respect to the Securities, including, but not limited to,
payments of principal (including the Fundamental Change Repurchase Price, if applicable) and deliveries of Common Stock or other Reference Property and/or payments of cash, in each case, upon conversion, shall be made without withholding or
deduction for, or on account of, any present or future taxes, duties, assessments or governmental charges of whatever nature (each, a “Tax”) imposed or levied by a taxing authority within any jurisdiction in which the Successor
Company is, for tax purposes, organized or resident or doing business or through which payment is made or deemed to be made (or any political subdivision or taxing authority thereof or therein) (each, as applicable, a “Relevant Taxing
Jurisdiction”), unless such withholding or deduction is required by law or by the official interpretation or administration thereof. In the event that any such withholding or deduction is so required, the Successor Company shall pay such
additional amounts (the “Additional Amounts”) as may be necessary to ensure that the net amount received by the beneficial owner after such withholding or deduction (and after deducting or withholding any Taxes on the Additional
Amounts) shall equal the amounts that would have been received by such beneficial owner had no such withholding or deduction been required; provided that no Additional Amounts shall be payable: 

(i) for or on account of: 

(A) any Tax that would not have been imposed but for: 

(1) the existence of any present or former connection between the Holder or beneficial owner of such Security and the Relevant
Taxing Jurisdiction, other than merely holding such Security or the receipt of payments thereunder, including, without limitation, such Holder or beneficial owner being or having been a national, domiciliary or resident of such Relevant Taxing
Jurisdiction or treated as a resident thereof or being or having been physically present or engaged in a trade or business therein or having or having had a permanent establishment therein; 

(2) the presentation of such Security (in cases in which presentation is required) more than 30 days after the later of the
date on which the payment of the principal of (including the Fundamental Change Repurchase Price, if applicable) such Security or the delivery of Common Stock and other Reference Property and/or payments of cash, in each case, upon conversion of
such Security became due and payable pursuant to the terms thereof or was made or duly provided for; or 

  
 45 

 (3) the failure of the Holder or beneficial owner to comply with a timely request
from the Successor Company to provide certification, information, documents or other evidence concerning such Holder’s or beneficial owner’s nationality, residence, identity or connection with the Relevant Taxing Jurisdiction, or to make
any declaration or satisfy any other reporting requirement relating to such matters, if and to the extent that due and timely compliance with such request is required by statute, regulation or administrative practice of the Relevant Taxing
Jurisdiction in order to reduce or eliminate any withholding or deduction as to which Additional Amounts would have otherwise been payable to such Holder or beneficial owner; 

(B) any estate, inheritance, gift, sale, transfer, excise, personal property or similar Tax; 

(C) any Tax that is payable otherwise than by withholding or deduction from payments under or with respect to the Securities;

 (D) United States backup withholding; 

(E) any Taxes that could have been avoided by the presentation (where presentation is required) of such Security to another
Paying Agent; 
 (F) any Tax required by sections 1471 through 1474 of the United States Internal Revenue Code of 1986, as
amended (“FATCA”), any current or future Treasury Regulations or rulings promulgated thereunder, any law, regulation or other official guidance enacted in any jurisdiction implementing FATCA, any intergovernmental agreement between
the United States and any other jurisdiction to implement FATCA or any law enacted by such other jurisdiction to give effect to such agreement, or any agreement with the U.S. Internal Revenue Service under FATCA; or 

(G) any combination of Taxes referred to in the preceding clauses (A), (B), (C), (D), (E) or (F), or 

(ii) with respect to any payment of the principal of (including the Fundamental Change Repurchase Price, if applicable) such
Security or the delivery of Common Stock or other Reference Property and/or payments of cash, in each case, upon conversion of such Security to a Holder, if the Holder is a fiduciary, partnership or person other than the sole beneficial owner of
that payment to the extent that such payment would be required to be included in the income under the laws of the Relevant Taxing Jurisdiction, for tax purposes, of a beneficiary or settlor with respect to the fiduciary, a partner or member of that
partnership or a beneficial owner who would not have been entitled to such Additional Amounts had that beneficiary, settlor, partner, member or beneficial owner been the Holder thereof. 

  
 46 

 (b) If the Successor Company is required to make any deduction or withholding from any payments
with respect to the Securities, the Successor Company will deliver to the Trustee official tax receipts evidencing the remittance to the relevant tax authorities of the amounts so withheld or deducted or other evidence reasonably satisfactory to the
Trustee. 
 (c) Any reference in this Indenture or the Securities in any context to the delivery of Common Stock or other Reference Property
and/or payments of cash, in each case, upon conversion of any Security or the payment of principal of (including the Fundamental Change Repurchase Price, if applicable) any Security or any other amount payable with respect to such Security, shall be
deemed to include payment of Additional Amounts to the extent that, in such context, Additional Amounts are, were or would be payable in respect thereof pursuant to this Section 5.07. 

Section 5.08. Limitation on the Incurrence of Additional Indebtedness. The Company shall not, and shall not permit
any of its Subsidiaries to, incur any Indebtedness, except for Permitted Indebtedness, issue any Disqualified Stock or, in the case of the Company’s Subsidiaries, issue any preferred stock. 

Section 5.09. Limitation on the Prepayments, Etc. of Indebtedness. The Company shall not, and shall not permit any
of its Subsidiaries to, (i) prepay, redeem, purchase, defease or otherwise satisfy prior to the scheduled maturity thereof in any manner (it being understood that payments of regularly scheduled principal and interest shall be permitted) any
Indebtedness of the Company or its Subsidiaries that is unsecured or subordinated to the Securities expressly by its terms (other than Indebtedness among the Company and its Subsidiaries) (collectively, “Pari/Junior Financing”),
except (A) the refinancing thereof with the net cash proceeds of, or in exchange for, any Permitted Refinancing and (B) the conversion of any Pari/Junior Financing to Capital Stock (other than Disqualified Stock) of the Company or
(ii) make any payment in violation of any subordination terms of any Pari/Junior Financing Documentation. 

Section 5.10. Restricted Payments. 

(a) The Company shall not, and shall not permit any of its Subsidiaries to, directly or indirectly: 

(i) declare or pay any dividend or make any other payment or any distribution on account of the Company’s or any of its
Subsidiaries’ Capital Stock, including any dividend or distribution payable in connection with any merger or consolidation (other than (A) dividends or distributions by the Company payable solely in Capital Stock (other than Disqualified
Stock) of the Company or in options, warrants or other rights to purchase such Capital Stock (other than Disqualified Stock); or (B) dividends or distributions by a Subsidiary of the Company so long as, in the case of any dividend or
distribution payable on or in respect of any class or series of securities issued by a Subsidiary of the Company other than a Wholly Owned Subsidiary, the Company or any of its Subsidiaries receives at least its pro rata share of such dividend or
distribution in accordance with its Capital Stock in such class or series of securities); 

  
 47 

 (ii) purchase, redeem, defease or otherwise acquire or retire for value any
Capital Stock of the Company or any direct or indirect parent of the Company, including in connection with any merger or consolidation; 

(all such payments and other actions set forth in clauses (i) through (ii) above being collectively referred to as “Restricted
Payments”). 
 (b) Section 5.10(a) shall not prohibit: 

(i) redemptions, repurchases, retirements or other acquisitions of Capital Stock deemed to occur (a) upon exercise of
stock options or warrants if such Capital Stock represent a portion of the exercise price of such options or warrants and (b) in connection with the withholding portion of the Capital Stock granted or awarded to any future, present or former
employee, officer, director, member of management or consultant (or the estate, heirs, family members, spouse, former spouse, domestic partner or former domestic partner of any of the foregoing) of the Company or any of its Subsidiaries to pay for
the taxes payable by such Persons upon such grant or award; 
 (ii) so long as no Event of Default has occurred and is
continuing or would immediately result therefrom, Restricted Payments to redeem Capital Stock held by a future, present or former director, officer, manager, consultant or employee (or such Person’s estate, spouse, former spouse, successor,
executor, administrator, heir or legatee, or distributees of any of the foregoing) of the Company or any of its Subsidiaries upon the death, disability or retirement from, or termination of employment or office with, the Company or its Subsidiaries,
of such person, in an amount not to exceed $1,000,000 in any calendar year; and 
 (iii) cash payments in lieu of issuing
fractional shares in connection with the exercise of warrants, options or other securities convertible into or exchangeable for Capital Stock; provided, that any such cash payment shall not be for the purpose of evading the limitation of this
covenant. 
 Section 5.11. Asset Sales.  

(a) The Company shall not, and shall not permit any of its Subsidiaries to, consummate an Asset Sale, except for any Asset Sale for fair market
value if all of the following conditions are met: (a) cash consideration in respect of such Asset Sale is at least 75% of the consideration therefor, (b) no Event of Default has occurred and is continuing or shall result from such
disposition and (c) the aggregate amount of Asset Sales shall not exceed $2,000,000 in any calendar year. 

Section 5.12. Conduct of Business. 

(a) The Company shall not, and shall not permit any of its Subsidiaries to, engage in any business other than the businesses engaged in by the
Company and its Subsidiaries on the date hereof or other businesses that are reasonably similar, related or incidental thereto. 

  
 48 

 Section 5.13. Certain Tax Matters. In order to comply with applicable
tax laws (including rules, regulations, directives and published interpretations promulgated by competent authorities) in effect from time to time (“Applicable Tax Law”) that any foreign financial institution, issuer, Trustee,
Conversion Agent, Paying Agent, Holder or other institution is or has agreed to be subject to related to the Indenture and the Securities, the Company agrees (1) to use commercially reasonable efforts to provide to the Trustee sufficient
information about Holders or other applicable parties and/or transactions related to this Indenture and the Securities (including any modification to the terms of such transactions) so as to enable the determination of any tax-related obligations under Applicable Tax Law; and (2) that the Trustee, the Conversion Agent or Paying Agent shall be entitled to make, to the extent it is required to do so under Applicable Tax Law, any
withholding or deduction in respect of taxes from payments under the Indenture for which the Trustee shall not have any liability. Notwithstanding anything else in this Indenture, if the Company intends to enter into any Merger Event, Fundamental
Change or other reorganization, change in control or transaction otherwise permitted under this Indenture (including any acquisition of or by the Company of another entity or business), or take any other action (a “Company Action”)
that is reasonably expect to result in a “significant modification” of the Securities pursuant to Treasury Regulation section 1.1001-3 or otherwise result in a taxable exchange (or deemed exchange
for tax purposes) of the Securities or a disposition or retirement of the Securities, then (1) the Company shall notify the Purchaser as soon as reasonably practicable and in any event prior to any binding steps toward such Company Action being
taken and (2), at the request of the Purchaser, use reasonable efforts to restructure such Company Action in a manner that would not reasonably be expected to result in a “significant modification”, exchange, deemed exchange, disposition
or retirement of the Securities, but only to the extent such restructured Company Action would not have an adverse effect on the economic returns or outcome otherwise expected from such Company Action. The Purchaser may suspend the Company’s
compliance with this provision upon notice to the Company, in which case the Company shall not notify the Purchaser of a Company Action pursuant to clause (1) above during such suspension period. 

ARTICLE 6 
 CONSOLIDATION, MERGER,
SALE, CONVEYANCE, TRANSFER OR LEASE 
 Section 6.01. Company May Consolidate, Etc., Only on Certain Terms. The
Company shall not, directly or indirectly, consolidate with or merge into any other Person (in a transaction in which the Company is not the surviving corporation) or sell, convey, transfer or lease all or substantially all of its properties and
assets to another Person, unless: 
 (a) in case the Company shall consolidate with or merge into another Person (in a transaction in which
the Company is not the surviving corporation) or sell, convey, transfer or lease all or substantially all of its properties and assets to another Person, the Person formed by such consolidation or into which the Company is merged or the Person which
acquires by sale, conveyance or transfer, or which leases, all or substantially all of the properties and assets of the Company (in each case, the “Successor Company”) shall: 

  
 49 

 (i) be a corporation or limited liability company organized and validly existing
under the laws of the United States of America, any State thereof or the District of Columbia; provided, in each case, that the property into which the Securities shall be convertible shall be the stock or other equity of an entity that is a
corporation for U.S. federal income tax purposes; and 
 (ii) expressly assume, by an indenture supplemental hereto, executed
and delivered to the Trustee, in form reasonably satisfactory to the Trustee, the due and punctual payment of the principal of all the Securities and the performance or observance of every covenant of this Indenture on the part of the Company to be
performed or observed (including, for the avoidance of doubt, the covenant to pay Additional Amounts, as set forth in Section 5.07) and the conversion rights shall be provided for in accordance with Article 4, by supplemental indenture
satisfactory in form to the Trustee, executed and delivered to the Trustee, by such Successor Company (if other than the Company); 
 (b)
immediately after giving effect to such transaction, no Event of Default, and no event which, after notice or lapse of time or both, would become an Event of Default, shall have happened and be continuing; and 

(c) the Company has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that such consolidation,
merger, sale, conveyance, transfer or lease and, if a supplemental indenture is required in connection with such transaction, such supplemental indenture, comply with this Article 6 and that all conditions precedent herein provided for relating to
such transaction have been complied with. 
 Section 6.02. Successor Substituted. Upon any consolidation of the
Company with, or merger of the Company into, any other Person or any sale, conveyance, transfer or lease of all or substantially all of the properties and assets of the Company in accordance with Section 6.01, there shall be an adjustment to
the Conversion Rate and the Successor Company shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with the same effect as if such Successor Company had been named as the Company
herein, and thereafter, except in the case of a lease, the Company shall be relieved of all obligations and covenants under this Indenture and the Securities. 

ARTICLE 7 
 DEFAULT AND REMEDIES

 Section 7.01. Events Of Default. An “Event of Default” shall
occur if: 
 (1) the Company fails to pay the principal of any Security when due and payable at its stated maturity, upon
any required repurchase, upon declaration of acceleration or otherwise; 
 (2) [Reserved]. 

  
 50 

 (3) the Company fails to convert any Security in accordance with this Indenture
upon exercise of a Holder’s conversion right; 
 (4) the Company fails to provide timely notice pursuant to
Section 3.02(a), Section 3.02(b), Section 4.01(b) or Section 5.05, in each case when due, and such failure continues for 30 days; 

(5) the Company fails to comply with its obligations set forth in Section 5.08, Section 5.09, Section 5.10.
Section 5.11, Section 5.12 or Article 6; 
 (6) the Company fails to perform any other agreement required of it in
this Indenture or the Securities and such failure continues for 30 days after written notice is given in accordance with the immediately succeeding paragraph; 

(7) (A) the Company or any of its Subsidiaries fail to pay any Indebtedness within any applicable grace period after final
maturity or acceleration by the holders thereof because of a default or (B) or a default occurs with respect to any Indebtedness of the Company or its Subsidiaries, which default permits the holder or holders thereof (or any trustee or agent on
their behalf) to accelerate that Indebtedness (giving effect to any applicable grace period), and, in the case of (A) or (B) the total amount of such Indebtedness unpaid or accelerated or in default at the time exceeds $10,000,000 in the
aggregate for all such Indebtedness; 
 (8) the Company or any Significant Subsidiary, pursuant to or within the meaning of
any Bankruptcy Law: 
 (A) commences a voluntary case or proceeding; 

(B) consents to the entry of an order for relief against it in an involuntary case or proceeding; 

(C) consents to the appointment of a Custodian of it or for all or substantially all of its property; or 

(D) makes a general assignment for the benefit of its creditors; 

(9) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 

(A) is for relief against the Company or any Significant Subsidiary in an involuntary case or proceeding; 

(B) appoints a Custodian of the Company or any Significant Subsidiary or for all or substantially all of the property of the
Company or any Significant Subsidiary; or 

  
 51 

 (C) orders the liquidation of the Company or any Significant Subsidiary; 

and in each case the order or decree remains unstayed and in effect for 60 consecutive days; or 

(10) (A) the occurrence of (x) any material breach of the representations and warranties contained in Section 3.1 of
the Notes Exchange Agreement which do not contain materiality or material adverse effect qualifiers or (y) any breach of the representations and warranties contained in Section 3.1 of the Notes Exchange Agreement which contain materiality
or material adverse effect qualifiers or (B) the Company fails to perform any agreement required of it in the Notes Exchange Agreement and such failure continues for 30 days after written notice is given in accordance with the immediately
succeeding paragraph; or 
 (11) the Company withdraws or otherwise ceases to manufacture, market or sell AuryxiaTM (ferric citrate), including due to any mandatory action by any federal, state, local or foreign regulatory authorities, including without limitation the United States Food and Drug
Administration or any other federal, state or foreign agencies or bodies engaged in the regulation of pharmaceuticals or biohazardous materials. 

A default under clause (6) or clause (10)(B) above is not an Event of Default until the Trustee notifies the Company, or the Holders of
at least 25% in aggregate principal amount of the Securities then outstanding notify the Company and the Trustee, in writing of the default, and the Company does not cure the default within 30 days after receipt of such notice. The notice given
pursuant to this Section 7.01 must specify the default, demand that it be remedied and state that the notice is a “Notice of Default.” When any default under this Section 7.01 is cured, it ceases. 

The Trustee shall not be charged with knowledge of any Event of Default unless written notice thereof by the Company, a Paying Agent, any
Holder or any agent of any Holder shall have been actually received by a Responsible Officer at the Corporate Trust Office of the Trustee. 

Section 7.02. Acceleration. If an Event of Default (other than an Event of Default specified in clause (8) or
(9) of Section 7.01) occurs and is continuing, the Trustee may, by notice to the Company, or the Holders of at least 25% in aggregate principal amount of the Securities then outstanding may, by notice to the Company and the Trustee, declare all
unpaid principal to the date of acceleration on the Securities then outstanding (if not then due and payable) to be due and payable upon any such declaration, and the same shall become and be immediately due and payable. If an Event of Default
specified in clause (8) or (9) of Section 7.01 occurs, all unpaid principal of the Securities then outstanding shall ipso facto become and be immediately due and payable without any declaration or other act on the part of the
Trustee or any Holder. After any acceleration, but before a judgment or decree based on acceleration, the Holders of a majority in aggregate principal amount of the Securities may, except with respect to the nonpayment of principal or interest or
with respect to the failure to pay 

  
 52 

 
and/or deliver the consideration due upon conversion, rescind and annul such acceleration by notice to the Trustee if (a) all existing Events of Default, other than the non-payment of accelerated principal, have been cured or waived; (b) to the extent the payment of such interest is lawful, interest (calculated at the rate per annum borne by the Securities plus one percent) on
overdue installments of interest and overdue principal, which has become due otherwise than by such declaration of acceleration, has been paid; (c) the rescission would not conflict with any judgment or decree of a court of competent
jurisdiction; and (d) all payments due to the Trustee and any predecessor Trustee under Section 8.07 have been made. No such rescission shall affect any subsequent default or impair any right consequent thereto. 

Section 7.03. Other Remedies. If an Event of Default occurs and is continuing, the Trustee may, but shall not be
obligated to, pursue any available remedy by proceeding at law or in equity to collect the payment of the principal of the Securities or to enforce the performance of any provision of the Securities or this Indenture. 

The Trustee may maintain a proceeding even if it does not possess any of the Securities or does not produce any of them in the proceeding. A
delay or omission by the Trustee or any Holder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No remedy is exclusive of any
other remedy. All available remedies are cumulative to the extent permitted by law. 
 Section 7.04.
[Reserved]. 
 Section 7.05. Waiver of Defaults and Events of Default. Subject to Section 7.08
and Section 9.02, the Holders of a majority in aggregate principal amount of the Securities then outstanding by notice to the Trustee may waive an existing default or Event of Default and its consequence, except (a) a default or Event of
Default in the payment of the principal of any Security, (b) a failure by the Company to convert any Securities in accordance with the provisions of the Securities and this Indenture or (c) any default or Event of Default in respect of any
provision of this Indenture or the Securities that, under Section 10.02, cannot be modified or amended without the consent of the Holder of each Security affected. When a default or Event of Default is waived, it is cured and ceases. 

Section 7.06. Control by Majority. The Holders of a majority in aggregate principal amount of the outstanding
Securities will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee with respect to the Securities. However, the Trustee
may refuse to follow any direction that conflicts with law or this Indenture, that the Trustee, in its sole discretion, determines may be unduly prejudicial to the rights of another Holder or the Trustee, or that may involve the Trustee in personal
liability unless the Trustee is offered reasonable indemnity satisfactory to it; provided, however, that the Trustee may take any other action deemed proper by the Trustee that is not inconsistent with such direction. 

  
 53 

 Section 7.07. Limitations on Suits. A Holder may not pursue any
remedy with respect to this Indenture or the Securities (except actions for the enforcement of payment of the principal of any Security on or after the applicable due date or the right to convert the Securities in accordance with Article 4) unless:

 (1) the Holder has previously given the Trustee written notice of a continuing Event of Default; 

(2) the Holders of at least 25% in aggregate principal amount of the Securities then outstanding have made a written request
and have offered to the Trustee reasonable indemnity satisfactory to the Trustee to institute such proceeding as Trustee; and 

(3) the Trustee has failed to institute such proceeding within 60 days after such notice, request and offer, and has not
received from the Holders of a majority in aggregate principal amount of the Securities then outstanding a direction inconsistent with such request within 60 days after such notice, request and offer. 

A Holder may not use this Indenture to prejudice the rights of another Holder or to obtain a preference or priority over such other Holder.

 Section 7.08. Rights of Holders to Receive Payment and to Convert. Each Holder shall have the right to receive
payment or delivery, as the case may be, of (a) the principal (including the Fundamental Change Repurchase Price) of and (b) the consideration due upon conversion of, its Securities, on or after the respective due dates expressed or
provided for in this Indenture, or to institute suit for the enforcement of any such payment or delivery, as the case may be, and such right to receive payment or delivery, as the case may be, on or after such respective dates shall not be impaired
or affected without the consent of such Holder. 
 Section 7.09. Collection Suit By Trustee. If an Event of
Default in the payment of principal specified in clause (1) of Section 7.01 occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company or another obligor on the
Securities for the whole amount of principal and accrued interest remaining unpaid, together with, to the extent that payment of such interest is lawful, interest on overdue principal at the rate per annum equal to one percent and such further
amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel. 

Section 7.10. Trustee May File Proofs of Claim. The Trustee may file such proofs of claim and other papers or
documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Holders allowed in any
judicial proceedings relative to the Company (or any other obligor on the Securities), its creditors or its property and shall be entitled and 

  
 54 

 
empowered to collect and receive any money or other property payable or deliverable on any such claims and to distribute the same, and any Custodian in any such judicial proceeding is hereby
authorized by each Holder to make such payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the reasonable compensation,
expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 8.07, and to the extent that such payment of the reasonable compensation, expenses, disbursements and advances in
any such proceedings shall be denied for any reason, payment of the same shall be secured by a lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other property which the Holders may be entitled to receive
in such proceedings, whether in liquidation or under any plan of reorganization or arrangement or otherwise. Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to, or, on behalf of any Holder, to authorize,
accept or adopt, any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding. 

Section 7.11. Priorities. If the Trustee collects any money pursuant to this Article 7, it shall pay out the money
in the following order: 
 FIRST, to the Trustee for amounts due under Section 8.07; 

SECOND, to Holders for amounts due and unpaid on the Securities for principal, ratably, without preference or priority of any
kind, according to the amounts due and payable on the Securities for principal; and 
 THIRD, to the Company or such party as
a court of competent jurisdiction shall direct. 
 The Trustee may fix a record date and payment date for any payment to
Holders pursuant to this Section 7.11. 
 Section 7.12. Undertaking For Costs. In any suit for the
enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay
the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in the suit, having due regard to the merits and good faith of the claims or
defenses made by the party litigant. This Section 7.12 does not apply to a suit made by the Trustee, a suit by a Holder pursuant to Section 7.07 or a suit by Holders of more than 10% in aggregate principal amount of the Securities then
outstanding. 

  
 55 

 ARTICLE 8 

TRUSTEE 

Section 8.01. Duties of Trustee. (a) If an Event of Default has occurred and is continuing, the
Trustee shall exercise such of the rights and powers vested in it by this Indenture and use the same degree of care and skill in its exercise as a prudent Person would exercise or use under the circumstances in the conduct of his or her own affairs.

 (b) Except during the continuance of an Event of Default: 

(i) the duties of the Trustee shall be determined solely by the express provisions of this Indenture and the Trustee need
perform only those duties that are specifically set forth in this Indenture and no others, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 

(ii) in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the
correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture. The Trustee, however, shall examine any certificates and opinions which by any provision
hereof are specifically required to be delivered to the Trustee to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated
therein). 
 (c) The Trustee may not be relieved from liability for its own negligent action, its own negligent failure to act or its own
willful misconduct, except that: 
 (i) this paragraph does not limit the effect of subsection (b) of this
Section 8.01; 
 (ii) the Trustee shall not be liable for any error of judgment made in good faith by a Responsible
Officer, unless it is proved that the Trustee was negligent in ascertaining the pertinent facts; and 
 (iii) the Trustee
shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 7.06. 

(d) No provision of this Indenture shall require the Trustee to expend or risk its own funds or incur any liability unless the Company or
Holders shall have offered to the Trustee reasonable indemnity satisfactory to it against such cost or liability. The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or
direction of any of the Holders pursuant to this Indenture, unless such Holders shall have offered to the Trustee reasonable indemnity satisfactory to the Trustee against the costs, expenses and liabilities that might be incurred by it in compliance
with such request or direction. 
 (e) Every provision of this Indenture that in any way relates to the Trustee is subject to subsections
(a), (b), (c) and (d) of this Section 8.01. 
  

  
 56 

 (f) The Trustee shall not be liable for interest on any money received by it except as the
Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 

Section 8.02. Rights of Trustee. Subject to Section 8.01: 

(a) The Trustee may rely conclusively on any document believed by it to be genuine and to have been signed or presented by the proper Person.
The Trustee need not investigate any fact or matter stated in the document. 
 (b) Before the Trustee acts or refrains from acting, it may
require an Officers’ Certificate or an Opinion of Counsel, which shall conform to Section 11.04(b). The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers’ Certificate or
Opinion of Counsel. 
 (c) The Trustee may act through its agents and shall not be responsible for the misconduct or negligence of any agent
appointed with due care. 
 (d) The Trustee shall not be liable for any action it takes or omits to take in good faith which it believes to
be authorized or within its rights or the powers conferred upon it by this Indenture. 
 (e) The Trustee may consult with counsel of its
selection, and the advice or opinion of such counsel as to matters of law shall be full and complete authorization and protection from liability in respect of any such action taken, omitted or suffered by it hereunder in good faith and in accordance
with the advice or opinion of such counsel. 
 (f) The Trustee shall not be bound to make any investigation into the facts or matters stated
in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document, but the Trustee, in its discretion, may make such
further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company,
personally or by agent or attorney, at the sole cost of the Company, and shall incur no liability or additional liability of any kind by reason of such inquiry or investigation. 

(g) The Trustee shall not be deemed to have notice of any Default or Event of Default unless a Responsible Officer has actual knowledge thereof
or unless written notice of any event which is in fact such a default is received by a Responsible Officer of the Trustee at the Corporate Trust Office, and such notice references the Securities and this Indenture. 

(h) The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be
indemnified, are extended to, and shall be enforceable by, the Conversion Agent and any other agent hereunder, and to each custodian and other Person employed to act hereunder. The Agents shall be entitled to the same rights and protections as the
Trustee under this Article 8. 

  
 57 

 (i) The Trustee may request that the Company deliver an Officers’ Certificate setting forth
the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture, which Officers’ Certificate may be signed by any Person authorized to sign an Officers’ Certificate, including
any Person specified as so authorized in any such certificate previously delivered and not superseded. 
 (j) In no event shall the Trustee
be responsible or liable for special, punitive, indirect or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or
damage and regardless of the form of action. 
 Section 8.03. Individual Rights of Trustee. The Trustee in its
individual or any other capacity may become the owner or pledgee of Securities and may otherwise deal with the Company or an Affiliate of the Company with the same rights it would have if it were not Trustee. However, in the event that the Trustee
acquires any conflicting interest it must eliminate such conflict within 90 days, apply to the SEC for permission to continue as trustee or resign. Any Agent may do the same with like rights and duties. The Trustee is also subject to
Section 8.10. 
 Section 8.04. Trustee’s Disclaimer. The Trustee shall not be responsible
for and makes no representation as to the validity, priority or adequacy of this Indenture or the Securities, it shall not be accountable for the Company’s use of the proceeds from the Securities or any money paid to the Company or upon the
Company’s direction under any provision of this Indenture, it shall not be responsible for the use or application of any money received by any Paying Agent (other than the Trustee) and it shall not be responsible for any statement or recital
herein or any statement in the Securities or any other document in connection with the sale of the Securities or pursuant to this Indenture other than its certificate of authentication. 

Section 8.05. Notice of Default or Events of Default. If a Default or an Event of Default occurs and is continuing
and if it is known to the Trustee, the Trustee shall mail to each Holder notice of the Default or Event of Default within 90 days after it occurs. However, the Trustee may withhold the notice if and so long as a committee of its Responsible Officers
in good faith determines that withholding notice is in the interests of Holders, except in the case of a Default or an Event of Default in (a) payment of the principal of any Security or (b) payment or delivery, as the case may be, of the
consideration due upon conversion. 
 Section 8.06. [Reserved]. 

Section 8.07. Compensation and Indemnity. The Company shall pay to the Trustee from time to time such compensation
(as agreed to from time to time by the Company and the Trustee in writing) for its services (which compensation shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust). The Company shall reimburse
the Trustee promptly upon request for all reasonable disbursements, expenses and advances incurred or made by it in addition to the compensation for its services. Such expenses may include the reasonable compensation, disbursements and expenses of
the Trustee’s agents and counsel. 

  
 58 

 The Company shall indemnify each of the Trustee (which for purposes of this paragraph shall
include its officers, directors, employees, Agents and agents) and any predecessor Trustee against any and all losses, liabilities, damages, claims or expenses (including taxes, other than taxes based upon, measured by or determined by the income of
the Trustee) incurred by it arising out of or in connection with the acceptance or administration of its duties under this Indenture, including the costs and expenses of counsel and of enforcing this Indenture against the Company (including this
Section 8.07) and defending itself against any claim (whether asserted by the Company or any Holder or any other Person) or liability in connection with the exercise or performance of any of its powers or duties hereunder. The Trustee, upon
receiving written notice thereof, shall notify the Company promptly of any claim for which it may seek indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder. The Company shall defend
the claim and the Trustee shall cooperate in the defense. The Trustee may have separate counsel and the Company shall pay the reasonable fees and expenses of such counsel. The Company need not pay for any settlement made without its written consent,
which consent shall not be unreasonably withheld. This indemnity shall survive the resignation or removal of the Trustee, and the payment in full of the Securities and discharge of the Indenture. 

The Company need not reimburse the Trustee for any expense or indemnify it against any loss or liability incurred by it resulting from its
negligence or willful misconduct. 
 To secure the Company’s payment obligations in this Section 8.07, the Trustee shall have a
senior claim to which the Securities are hereby made subordinate on all money or property held or collected by the Trustee, except such money or property held in trust to pay the principal of, and amounts due upon conversion of, the Securities. 

When the Trustee incurs expenses or renders services after an Event of Default specified in Section 7.01 occurs, the expenses and the
compensation for the services (including the fees and expenses of its agents and counsel) are intended to constitute expenses of administration under any Bankruptcy Law. The obligations of the Company under this Section 8.07 shall survive the
termination or satisfaction and discharge of this Indenture or the resignation or removal of the Trustee for any reason. 

Section 8.08. Replacement of Trustee. The Trustee may resign by so notifying the Company in writing. The Holders of
a majority in aggregate principal amount of the Securities then outstanding may remove the Trustee by so notifying the Trustee and the Company in writing and may, with the Company’s written consent, appoint a successor Trustee. The Company may
remove the Trustee if: 
 (1) the Trustee fails to comply with Section 8.10; 

(2) the Trustee is adjudged bankrupt or insolvent or relief is entered with respect to the Trustee under any Bankruptcy Law;

  
 59 

 (3) a receiver or other public officer takes charge of the Trustee or its
property; or 
 (4) the Trustee becomes incapable of acting. 

If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint a
successor Trustee. The resignation or removal of a Trustee shall not be effective until a successor Trustee shall have delivered the written acceptance of its appointment as described below. 

If a successor Trustee does not take office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee, the Company
or the Holders of 10% in principal amount of the Securities then outstanding may petition any court of competent jurisdiction for the appointment of a successor Trustee at the expense of the Company. 

If the Trustee fails to comply with Section 8.10, any Holder who has been a Holder for at least six months may petition any court of
competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 
 A successor Trustee shall deliver a
written acceptance of its appointment to the retiring Trustee and to the Company. Immediately after that, the retiring Trustee shall transfer all property held by it as Trustee to the successor Trustee (provided that all sums owing to the
Trustee hereunder have been paid) and be released from its obligations (excluding any liabilities that the retiring Trustee may have incurred while acting as Trustee) hereunder, the resignation or removal of the retiring Trustee shall become
effective and the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. A successor Trustee shall mail notice of its succession to each Holder. 

A retiring Trustee shall not be liable for the acts or omissions of any successor Trustee after its succession. 

Notwithstanding replacement of the Trustee pursuant to this Section 8.08, the Company’s obligations under Section 8.07 shall
continue for the benefit of the retiring Trustee. 
 Section 8.09. Successor Trustee by Merger, Etc. If the
Trustee consolidates with, merges or converts into, or transfers all or substantially all of its corporate trust assets (including the administration of this Indenture) to, another corporation, by sale or otherwise, the resulting, surviving or
transferee corporation, without any further act, shall be the successor Trustee, provided such transferee corporation shall qualify and be eligible under Section 8.10. Such successor Trustee shall promptly mail notice of its succession to the
Company and each Holder. 
 Section 8.10. Eligibility; Disqualification. The Trustee (or its parent holding
company) shall have a combined capital and surplus of at least $50,000,000. If at any time the Trustee shall cease to satisfy such requirement, it shall resign immediately in the manner and with the effect specified in this Article 8. 

  
 60 

 ARTICLE 9 

SATISFACTION AND DISCHARGE OF INDENTURE 

Section 9.01. Satisfaction and Discharge of Indenture. This Indenture shall, upon request of the Company contained
in an Officers’ Certificate, cease to be of further effect, and the Trustee, at the expense of the Company, shall execute proper instruments acknowledging satisfaction and discharge of this Indenture, when (a) (i) all Securities
theretofore authenticated and delivered (other than Securities that have been destroyed, lost or stolen and which have been replaced or paid as provided in Section 2.07) have been delivered to the Trustee for cancellation; or (ii) the
Company has deposited with the Trustee or delivered to Holders, as applicable, after the Securities have become due and payable, whether at the Maturity Date, any Fundamental Change Repurchase Date, upon conversion or otherwise, shares of Common
Stock or a combination of such shares and cash, as applicable, solely to satisfy the Company’s Conversion Obligation, sufficient to pay all of the outstanding Securities and all other sums due and payable under this Indenture by the Company;
and (b) the Company has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent herein provided for relating to the satisfaction and discharge of this Indenture have been
complied with. 
 Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company to the Trustee under
Section 8.07 shall survive and, if money shall have been deposited with the Trustee pursuant to paragraph (a)(ii) of this Section 9.01, the provisions of Section 9.02 and Section 9.04 shall survive until the Securities have been
paid in full. 
 Section 9.02. Application of Trust Money. Subject to the provisions of Section 9.03, the
Trustee or a Paying Agent shall hold in trust, for the benefit of the Holders, all money and shares of Common Stock deposited with it pursuant to Section 9.01 and shall apply the deposited money and shares of Common Stock in accordance with
this Indenture and the Securities to the payment or delivery, as the case may be, of the principal of, and the consideration due upon conversion of, the Securities; provided that such money and shares of Common Stock need not be segregated
from other funds except to the extent required by law. 
 Section 9.03. Repayment to Company. The Trustee
and each Paying Agent shall promptly pay to the Company, upon request, any excess money or shares of Common Stock (i) deposited with them pursuant to Section 9.01 and (ii) held by them at any time. 

The Trustee and each Paying Agent shall pay to the Company, upon request, any money or shares of Common Stock held by them for the payment or
delivery, as the case may be, of principal or amounts due upon conversion that remains unclaimed for two years after a right to such money or shares of Common Stock has matured; provided, however, that the Trustee or such Paying Agent,
before being required to make any such payment or delivery, may at the expense of the Company cause to be mailed to each Holder entitled to such money or shares of Common Stock notice that such money or shares of Common Stock remains unclaimed and
that after a date specified therein, which shall be at least 30 days from the date of such mailing, any unclaimed balance of such money or shares of Common Stock then remaining will be repaid or 

  
 61 

 delivered to the Company. After payment or delivery to the Company, Holders entitled to money or shares of Common
Stock must look to the Company for payment as general creditors unless an applicable abandoned property law designates another Person. In the absence of a written request from the Company to return unclaimed funds or shares to the Company, the
Trustee shall from time to time deliver all unclaimed funds or shares to or as directed by applicable escheat authorities, as determined by the Trustee in its sole discretion, in accordance with the customary practices and procedures of the Trustee.
Any unclaimed funds or shares held by the Trustee pursuant to this Section 9.03 shall be held uninvested and without any liability for interest. 

Section 9.04. Reinstatement. If the Trustee or any Paying Agent is unable to apply any money or shares of Common
Stock in accordance with Section 9.02 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, then the Company’s
obligations under this Indenture and the Securities shall be revived and reinstated as though no deposit had occurred pursuant to Section 9.01 until such time as the Trustee or such Paying Agent is permitted to apply all such money or shares of
Common Stock in accordance with Section 9.02; provided, however, that if the Company has made any payment or delivery, as the case may be, of the principal of, or amounts due upon conversion of, any Securities because of the
reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Securities to receive any such payment or delivery from the money or shares of Common Stock held by the Trustee or such Paying Agent. 

ARTICLE 10 
 AMENDMENTS,
SUPPLEMENTS AND WAIVERS 
 Section 10.01. Without Consent of Holders. The Company and the Trustee may amend or
supplement this Indenture or the Securities without notice to, or the consent of, any Holder: 
 (a) to cure any ambiguity, defect or
inconsistency that does not adversely affect Holders; 
 (b) to provide for the assumption by a successor corporation of the Company’s
obligations under this Indenture pursuant to Article 6; 
 (c) to add guarantees with respect to the Securities; 

(d) to secure the Company’s obligations with respect to the Securities; 

(e) to add to the covenants of the Company for the benefit of the Holders or to surrender any right or power conferred upon the Company; and

 (f) in connection with any Merger Event, provide that the Securities are convertible into Reference Property, subject to the provisions of
Section 4.02, and make such related changes to the terms of the Securities to the extent expressly required by Section 4.07. 

  
 62 

 Upon the request of the Company accompanied by a resolution of its Board of Directors authorizing
the execution of any such amended or supplemental indenture, and upon receipt by the Trustee of the documents described in Section 10.02, the Trustee shall join with the Company in the execution of any amended or supplemental indenture
authorized or permitted by the terms of this Indenture and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into such amended or supplemental indenture that
affects its own rights, duties or immunities under this Indenture or otherwise. 
 Section 10.02. With Consent of
Holders. The Company and the Trustee may amend or supplement this Indenture or the Securities with the written consent of the Holders of at least a majority in aggregate principal amount of the Securities then outstanding. The Holders of at
least a majority in aggregate principal amount of the Securities then outstanding may waive compliance in a particular instance by the Company with any provision of this Indenture or the Securities without notice to any Holder. However,
notwithstanding the foregoing but subject to Section 10.04, without the written consent of each Holder affected, an amendment, supplement or waiver, including a waiver pursuant to Section 7.05, may not: 

(a) change the stated maturity of the principal of any Security; 

(b) reduce the principal amount of any Security; 

(c) reduce the amount of principal payable upon acceleration of the maturity of any Security; 

(d) change the place or currency of payment of principal of any Security; 

(e) impair the right to institute suit for the enforcement of any payment on, or with respect to, any Security; 

(f) modify the provisions with respect to the Company’s obligation to repurchase Securities pursuant to Article 3 upon a Fundamental
Change in a manner adverse to Holders; 
 (g) change the ranking of the Securities; 

(h) adversely affect the right of Holders to convert Securities other than as provided in or under Article 4; 

(i) reduce the percentage in principal amount of outstanding Securities required for modification or amendment of this Indenture; 

(j) reduce the percentage in principal amount of outstanding Securities necessary for waiver of compliance with certain provisions of this
Indenture or the waiver of certain defaults under this Indenture; 
 (k) change the provisions of Section 5.07 in a manner adverse to
the Holders; or 

  
 63 

 (l) modify provisions of this Section 10.02 or Section 7.05 in a manner adverse to the
Holders. 
 It shall not be necessary for the consent of the Holders under this Section 10.02 to approve the particular form of any
proposed amendment, supplement or waiver, but it shall be sufficient if such consent approves the substance thereof. 
 Upon the request of
the Company accompanied by a resolution of its Board of Directors authorizing the execution of any such amended or supplemental indenture, and upon the filing with the Trustee of evidence satisfactory to the Trustee of the consent of the Holders,
and upon receipt by the Trustee of the documents described in Section 10.06 and Section 11.04, the Trustee shall join with the Company in the execution of such amended or supplemental indenture unless such amended or supplemental indenture
directly affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such amended or supplemental indenture. 

After an amendment, supplement or waiver under this Section 10.02 becomes effective, the Company shall mail to the Holders affected
thereby a notice briefly describing the amendment, supplement or waiver. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such amendment, supplement or waiver.

 Section 10.03. [Reserved]. 

Section 10.04. Revocation and Effect of Consents. Until an amendment, supplement or waiver becomes effective, a
consent to it by a Holder is a continuing consent by the Holder and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder’s Security, even if notation of the consent is not made on
any Security. However, any such Holder or subsequent Holder may revoke the consent as to its Security or portion of a Security if the Trustee receives the notice of revocation before the date the amendment, supplement or waiver becomes effective.

 After an amendment, supplement or waiver becomes effective, it shall bind every Holder, unless it makes a change described in any of
clauses (a) through (l) of Section 10.02. In that case the amendment, supplement or waiver shall bind each Holder of a Security who has consented to it and every subsequent Holder of a Security or portion of a Security that evidences the
same debt as the consenting Holder’s Security. 
 Section 10.05. Notation on or Exchange of
Securities. The Trustee may place an appropriate notation about an amendment, supplement or waiver on any Security thereafter authenticated. The Company, in exchange for all Securities, may issue and the Trustee shall, upon receipt of a
Company Order, authenticate new Securities that reflect the amendment, supplement or waiver. Failure to make the appropriate notation or issue a new Security shall not affect the validity and effect of such amendment, supplement or waiver. 

  
 64 

 Section 10.06. Trustee to Sign Amendments, Etc. The Trustee
shall sign any amendment or supplemental indenture authorized pursuant to this Article 10 if the amendment or supplemental indenture does not adversely affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may,
in its sole discretion, but need not sign it. In signing or refusing to sign such amendment or supplemental indenture, the Trustee shall be provided with and, subject to Section 8.01, shall be fully protected in relying upon, in addition to the
documents required by Section 11.04, an Officers’ Certificate and an Opinion of Counsel stating that such amendment or supplemental indenture is authorized or permitted by this Indenture. The Company may not sign an amendment or supplement
indenture until the Board of Directors approves it. 
 Section 10.07. Effect of Supplemental Indentures.
Upon the execution of any supplemental indenture under this Article 10, this Indenture shall be modified in accordance therewith, and such supplemental indenture shall form a part of this Indenture for all purposes; and every Holder of Securities
theretofore or thereafter authenticated and delivered hereunder shall be bound thereby. 
 ARTICLE 11 

MISCELLANEOUS 

Section 11.01. [Reserved]. 

Section 11.02. Notices. Any notice or communication to the Company or the Trustee under this Indenture shall
be given in writing and delivered in Person or by first-class mail (registered or certified, return receipt requested), facsimile transmission (confirmed by delivery in Person or by first-class mail (registered or certified, return receipt
requested)) or guaranteed overnight courier, as follows: 
 If to the Company, to: 

Keryx Biopharmaceuticals, Inc. 

One Marina Park Drive, 10th Fl. 

Boston, MA 02210 

Office: (617) 466-3520 

Mobile: (617) 466-3500 

Attention: Scott Holmes, CFO 

With a copy to: 

Daniel Kajunski 

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. 

One Financial Center 

Boston, MA 02111 

Direct: +1.617.348.1715 

Fax: +1.617.542.2241 

Email: dtkajunski@mintz.com 

  
 65 

 If to the Trustee or Conversion Agent, to: 

The Bank of New York Mellon Trust Company, N.A. 

500 Ross Street, 12th Floor 

Pittsburgh, Pennsylvania 15262 

Facsimile No.: (412) 234-8377 

Attention: Michael Flickinger 

All notices and communications (other than those sent to Holders) shall be deemed to have been duly given at the time delivered by hand, if
personally delivered; five Business Days after being deposited in the mail, if mailed by first-class mail (registered or certified, return receipt requested); upon acknowledgment of receipt, if transmitted by facsimile; and the next Business Day
after timely delivery to the courier, if sent by guaranteed overnight courier. 
 The Company or the Trustee by notice to the other may
designate additional or different addresses for subsequent notices or communications. 
 Any notice or communication mailed to a Holder
shall be mailed by first-class mail or delivered by guaranteed overnight courier or by other electronic means to it at its address shown on the register kept by the Primary Registrar. To the extent required by the Trust Indenture Act of 1939, as
amended (the “TIA”), any notice or communication shall also be so mailed to any Person described in TIA Section 313(c). 

Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. If a
notice or communication to a Holder is mailed in the manner provided above, it is duly given, whether or not the addressee receives it. 

If the Company mails a notice or communication to Holders, it shall mail a copy to the Trustee and each Agent at the same time. 

Notwithstanding any other provision of this Indenture or any Security, where this Indenture or any Security provides for notice of any event
or any other communication to a Holder of a Global Security (whether by mail or otherwise), such notice shall be sufficiently given if given to the Depositary (or its designee) pursuant to the standing instructions from the Depositary (or its
designee), including by electronic mail in accordance with accepted practices at the Depositary, and in compliance with the Applicable Procedures. 

The Trustee shall have the right to accept and act upon instructions, including funds transfer instructions (“Instructions”),
given by the Company pursuant to this Indenture and delivered using unsecured e-mail, facsimile transmission or other similar unsecured electronic means (including pdf files) (“Electronic
Means”); provided, however, that the Company shall provide to the Trustee an incumbency certificate listing officers with the authority to provide such Instructions (each, an “Authorized Officer”) and
containing specimen signatures of such Authorized Officers, which incumbency certificate shall be amended by the Company whenever a person is to be added or deleted from the listing. If the Company elects to give the Trustee Instructions using
Electronic Means and the Trustee in its discretion elects to act upon such Instructions, the Trustee’s understanding of such Instructions shall be deemed controlling. The 

  
 66 

 Company understands and agrees that the Trustee cannot determine the identity of the actual sender of such
Instructions and that the Trustee shall conclusively presume that Instructions that purport to have been sent by an Authorized Officer listed on the incumbency certificate provided to the Trustee have been sent by such Authorized Officer. The
Company shall be responsible for ensuring that only Authorized Officers transmit such Instructions to the Trustee and that the Company and all Authorized Officers are solely responsible to safeguard the use and confidentiality of applicable user and
authorization codes, passwords and/or authentication keys upon receipt by the Company. The Trustee shall not be liable for any losses, costs or expenses arising directly or indirectly from the Trustee’s reliance upon and compliance with such
Instructions notwithstanding such Instructions conflict or are inconsistent with a subsequent written instruction. The Company agrees: (a) to assume all risks arising out of the use of Electronic Means to submit Instructions to the Trustee,
including without limitation the risk of the Trustee acting on unauthorized Instructions, and the risk of interception and misuse by third 
 parties; and
(b) to notify the Trustee immediately upon learning of any compromise or unauthorized use of the security procedures. 

Section 11.03. Communications by Holders With Other Holders. To the extent applicable, Holders may
communicate pursuant to TIA Section 312(b) with other Holders with respect to their rights under this Indenture or the Securities. The Company, the Trustee, the Registrar and any other Person shall have the protection of TIA
Section 312(c). 
 Section 11.04. Certificate and Opinion as to Conditions Precedent. 

(a) Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the
Trustee at the request of the Trustee: 
 (i) an Officers’ Certificate in form and substance reasonably satisfactory to
the Trustee stating that, in the opinion of the signers, all conditions precedent (including any covenants compliance with which constitutes a condition precedent), if any, provided for in this Indenture relating to the proposed action have been
complied with; and 
 (ii) an Opinion of Counsel in form and substance reasonably satisfactory to the Trustee stating that,
in the opinion of such counsel, all such conditions precedent (including any covenants compliance with which constitutes a condition precedent) have been complied with. 

(b) Each Officers’ Certificate and Opinion of Counsel with respect to compliance with a condition or covenant provided for in this
Indenture shall include: 
 (i) a statement that the Person making such certificate or opinion has read such covenant or
condition; 
 (ii) a brief statement as to the nature and scope of the examination or investigation upon which the statements
or opinions contained in such certificate or opinion are based; 

  
 67 

 (iii) a statement that, in the opinion of such Person, he or she has made such
examination or investigation as is necessary to enable him or her to express an informed opinion as to whether or not such covenant or condition has been complied with; and 

(iv) a statement as to whether or not, in the opinion of such Person, such condition or covenant has been complied with; 

provided, however, that with respect to matters of fact an Opinion of Counsel may rely on an Officers’ Certificate or certificates of
public officials. 
 Section 11.05. Record Date for Vote or Consent of Holders. The Company (or, in the event
deposits have been made pursuant to Section 9.01, the Trustee) may set a record date for purposes of determining the identity of Holders entitled to vote or consent to any action by vote or consent authorized or permitted under this Indenture,
which record date shall not be more than 30 days prior to the date of the commencement of solicitation of such action. Notwithstanding the provisions of Section 10.04, if a record date is fixed, those Persons who were Holders of Securities at
the close of business on such record date (or their duly designated proxies), and only those Persons, shall be entitled to take such action by vote or consent or to revoke any vote or consent previously given, whether or not such Persons continue to
be Holders after such record date. 
 Section 11.06. Rules by Trustee, Paying Agent, Registrar and Conversion
Agent. The Trustee may make reasonable rules (not inconsistent with the terms of this Indenture) for action by or at a meeting of Holders. Any Registrar, Paying Agent or Conversion Agent may make reasonable rules for its functions. 

Section 11.07. Legal Holidays. If a payment date is a Legal Holiday, payment shall be made on the next succeeding
day that is not a Legal Holiday, and no interest shall accrue for the intervening period. If a regular record date is a Legal Holiday, the record date shall not be affected. 

Section 11.08. Governing Law; Jurisdiction. THIS INDENTURE AND THE SECURITIES, AND ANY CLAIM, CONTROVERSY OR
DISPUTE ARISING UNDER OR RELATED TO THIS INDENTURE OR THE SECURITIES, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 

The Company irrevocably consents and agrees, for the benefit of the Holders from time to time of the Securities and the Trustee, that any
legal action, suit or proceeding against it with respect to obligations, liabilities or any other matter arising out of or in connection with this Indenture or the Securities may be brought in the courts of the State of New York or the courts of the
United States located in the Borough of Manhattan, New York City, New York and, until amounts due and to become due in respect of the Securities have been paid, hereby irrevocably consents and submits to the
non-exclusive jurisdiction of each such court in personam, generally and unconditionally with respect to any action, suit or proceeding for itself in respect of its properties, assets and revenues. 

  
 68 

 The Company irrevocably and unconditionally waives, to the fullest extent permitted by law, any
objection which it may now or hereafter have to the laying of venue of any of the aforesaid actions, suits or proceedings arising out of or in connection with this Indenture brought in the courts of the State of New York or the courts of the United
States located in the Borough of Manhattan, New York City, New York and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has
been brought in an inconvenient forum. 
 Section 11.09. No Personal Liability of Directors, Officers, Employees or
Shareholders. No past, present or future director, officer, employee, incorporator or shareholder of the Company, as such, shall have any liability for any obligations of the Company under the Securities, this Indenture or for any claim
based on, in respect of, or by reason of, such obligations or their creation. Each Holder, by accepting a Security, waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Securities. 

Section 11.10. Successors. All agreements of the Company in this Indenture and the Securities shall bind its
successor. All agreements of the Trustee in this Indenture shall bind its successor. 
 Section 11.11. Multiple
Counterparts. The parties may sign multiple counterparts of this Indenture. Each signed counterpart shall be deemed an original, but all of them together represent the same agreement. Delivery of an executed counterpart by facsimile or pdf shall
be effective as delivery of a manually executed counterpart thereof. 
 Section 11.12. Separability. In case any
provisions in this Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 

Section 11.13. Tax Treatment. The Company agrees, and by acceptance of beneficial ownership in the Securities each
beneficial holder of the Securities will be deemed to have agreed, for United States federal income tax purposes to treat the Securities as indebtedness that is not subject to the contingent payment debt instrument regulations under Treas. Reg. Sec.
1.1275-4. 
 Section 11.14. Table of Contents, Headings, Etc. The
table of contents, cross-reference sheet and headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the
terms or provisions hereof. 
 Section 11.15. Force Majeure. In no event shall the Trustee be responsible
or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or
terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; provided that the Trustee shall use
reasonable efforts consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances. 

  
 69 

 Section 11.16. Waiver of Jury Trial. EACH OF THE COMPANY AND THE
TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE SECURITIES OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 Section 11.17. Calculations. The Company shall be responsible for making all calculations called for under the
Securities or this Indenture. These calculations include, but are not limited to, determinations of the Last Reported Sale Prices of the Common Stock, the Daily VWAPs and the Conversion Rate of the Securities and any adjustments thereto. The Company
shall make all these calculations in good faith and, absent manifest error, the Company’s calculations shall be final and binding on Holders of Securities, the Trustee and the Conversion Agent. The Company shall provide a schedule of its
calculations to each of the Trustee and the Conversion Agent, and each of the Trustee and Conversion Agent is entitled to rely conclusively upon the accuracy of the Company’s calculations without independent verification. The Trustee will
forward the Company’s calculations to any Holder of Securities upon the request of that Holder at the sole cost and expense of the Company. 

[SIGNATURE PAGE FOLLOWS] 

  
 70 

 IN WITNESS WHEREOF, the parties hereto have hereunto set their hands as of the date and year
first above written. 
  

			
	KERYX BIOPHARMACEUTICALS, INC.
		
	By:	 	 /s/ Scott A. Holmes

		 	Name: Scott A. Holmes
		 	Title:   Chief Financial Officer
	
	 THE BANK OF NEW YORK MELLON
TRUST COMPANY, N.A., as Trustee

		
	By:	 	 /s/ Karen Yu

		 	Name: Karen Yu
		 	Title: Vice President

 [Signature page to Indenture] 

  
 71 

 EXHIBIT A 

[FORM OF FACE OF SECURITY] 

[UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE COMPANY OR ITS AGENT FOR
REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY PAYMENT HEREON
IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE THEREOF. THIS SECURITY IS
EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND, UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN
DEFINITIVE FORM, THIS SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH
NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.]1 

[INCLUDE FOLLOWING LEGEND IF A RESTRICTED SECURITY] 

[THIS SECURITY AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER: 

(1) AGREES FOR THE BENEFIT OF KERYX BIOPHARMACEUTICALS, INC. (THE “COMPANY”) THAT IT WILL NOT OFFER, SELL, PLEDGE OR
OTHERWISE TRANSFER THIS SECURITY OR ANY BENEFICIAL INTEREST HEREIN PRIOR TO THE DATE THAT IS THE LATER OF (X) ONE YEAR AFTER THE LAST ORIGINAL ISSUE DATE HEREOF OR SUCH SHORTER PERIOD OF TIME AS PERMITTED BY RULE 144 UNDER THE SECURITIES ACT OR
ANY SUCCESSOR PROVISION THERETO AND (Y) SUCH LATER DATE, IF ANY, AS MAY BE REQUIRED BY APPLICABLE LAW, EXCEPT: 
  

	1 	This bracketed text should be included only if the Security is a Global Security. 

  
 A-1 

 (A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF; OR 

(B) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT; OR 

(C) TO A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT; OR 

(D) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT OR ANY OTHER AVAILABLE EXEMPTION
FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. 
 PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (1)(D)
ABOVE, THE COMPANY AND THE TRUSTEE RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH LEGAL OPINIONS, CERTIFICATIONS OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE
SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.] 

  
 A-2 

 KERYX BIOPHARMACEUTICALS, INC. 

ZERO COUPON CONVERTIBLE SENIOR NOTES DUE 2021 
  

			
	No. [        ]	  	[Initially]2 $            

 CUSIP No.: [            ] 

Keryx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”, which term shall include any successor corporation
under the Indenture referred to on the reverse hereof), promises to pay to [Cede & Co.]3 [        ], or registered assigns, or its custodian or
nominee, the principal sum [of                  DOLLARS ($                )] [or such
lesser amount as set forth in the “Schedule of Exchanges of Securities” attached hereto]4 on October 15, 2021. 

This Security shall bear no interest. 

Any Defaulted Amounts shall accrue interest per annum at a rate of one percent, subject to the enforceability thereof under applicable law,
from, and including, the relevant payment date to, but excluding, the date on which such Defaulted Amounts shall have been paid by the Company, at its election, in accordance with Section 2.02(d) of the Indenture. 

The Company shall pay the principal of this Security so long as such Security is a Global Security, in immediately available funds to the
Depositary or its nominee, as the case may be, as the registered Holder of such Security. As provided in and subject to the provisions of the Indenture, the Company shall pay the principal of any Securities (other than Securities that are Global
Securities) at the office or agency designated by the Company for that purpose. The Company has initially designated the Trustee as Paying Agent, Primary Registrar, Securities Custodian and Conversion Agent and each of the Corporate Trust Office of
the Trustee and the office or agency of the Trustee in the Borough of Manhattan, The City of New York, as an office or agency of the Company for each of the aforesaid purposes. 

Reference is made to the further provisions of this Security set forth on the reverse hereof, including, without limitation, provisions giving
the Holder of this Security the right to convert this Security into cash and shares of Common Stock, on the terms and subject to the limitations set forth in the Indenture. Such further provisions shall for all purposes have the same effect as
though fully set forth at this place. 
 This Security shall not be valid or become obligatory for any purpose until the certificate of
authentication hereon shall have been manually signed by the Trustee or a duly authorized authenticating agent under the Indenture. 
  

 

	2 	This bracketed text should be included only if the Security is a Global Security. 

	3 	This bracketed text should be included only if the Security is a Global Security. 

	4 	This bracketed text should be included only if the Security is a Global Security. 

  
 A-3 

 [SIGNATURE PAGE FOLLOWS] 

IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. 

 

			
	KERYX BIOPHARMACEUTICALS, INC.

 
			
		
	By:	 	  

		 	Name:
		 	Title:

 Attest: 
  

			
	By:	 	  

		 	Name:
		 	Title:

 Dated: [            ],
20[      ] 
  

			
	 TRUSTEE’S CERTIFICATE OF AUTHENTICATION

 
 This is one of the Securities referred to in the within-mentioned
Indenture.

	
	 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee

		
	By:	 	  

		 	Authorized Signatory

  
 A-4 

 [FORM OF REVERSE OF SECURITY] 

KERYX BIOPHARMACEUTICALS, INC. 

ZERO COUPON CONVERTIBLE SENIOR NOTES DUE 2021 

This Security is one of a duly authorized issuance of Securities of the Company, designated as its Zero Coupon Convertible Senior Notes due
2021 (the “Securities”), limited in aggregate principal amount of up to $164,746,000, all issued or to be issued under and pursuant to an Indenture dated as of May 9, 2018 (the “Indenture”), between the Company
and The Bank of New York Mellon Trust Company, N.A. (the “Trustee”), to which Indenture and all indentures supplemental thereto reference is hereby made for a description of the rights, limitations of rights, obligations, duties and
immunities thereunder of the Trustee, the Company and the Holders of the Securities. 
 In case an Event of Default, as defined in the
Indenture, shall have occurred and be continuing, the principal of all Securities may be declared, by either the Trustee or Holders of at least 25% in aggregate principal amount of Securities then outstanding, and upon said declaration shall become,
due and payable, in the manner, with the effect and subject to the conditions and certain exceptions set forth in the Indenture. In case an Event of Default occurs as a result of certain events of bankruptcy, insolvency or reorganization of the
Company, the principal of all Securities then outstanding shall ipso facto become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holder. 

Subject to the terms and conditions of the Indenture, the Company will make all payments and deliveries in respect of the Fundamental Change
Repurchase Price and the principal amount on the Maturity Date, as the case may be, to the Holder who surrenders a Security to a Paying Agent to collect such payments in respect of the Security. The Company will pay cash amounts in money of the
United States that at the time of payment is legal tender for payment of public and private debts. 
 The Indenture contains provisions
permitting the Company and the Trustee in certain circumstances, without the consent of the Holders of the Securities, and in certain other circumstances, with the consent of the Holders of not less than a majority in aggregate principal amount of
the Securities at the time outstanding, evidenced as in the Indenture provided, to execute supplemental indentures modifying the terms of the Indenture and the Securities as described therein. It is also provided in the Indenture that, subject to
certain exceptions, the Holders of a majority in aggregate principal amount of the Securities at the time outstanding may, on behalf of the Holders of all of the Securities, waive any past Default or Event of Default under the Indenture and its
consequences. 
 The Securities are issuable in registered form without coupons in denominations of $1,000 principal amount and integral
multiples thereof. At the office or agency of the Company referred to on the face hereof, and in the manner and subject to the limitations provided in the Indenture, Securities may be exchanged for a like aggregate principal amount of Securities of
other authorized denominations, without payment of any service charge but, if required by the Company or Trustee, with payment of a sum sufficient to cover any transfer or similar tax that may be imposed in connection therewith as a result of the
name of the Holder of the new Securities issued upon such exchange of Securities being different from the name of the Holder of the old Securities surrendered for such exchange. 

  
 A-5 

 The Securities are not subject to redemption through the operation of any sinking fund or
otherwise. 
 Upon the occurrence of a Fundamental Change, the Holder has the right, at such Holder’s option, to require the Company to
repurchase for cash all of such Holder’s Securities or any portion thereof (in principal amounts of $1,000 or integral multiples thereof) on the Fundamental Change Repurchase Date at a price equal to the Fundamental Change Repurchase Price.

 Subject to the provisions of the Indenture, the Holder hereof has the right, at its option, to convert any of its Securities or portion
thereof that is $1,000 or an integral multiple thereof into cash and shares of Common Stock. 
 All terms used in this Security but not
specifically defined herein are defined in the Indenture and are used herein as so defined. 
 In the case of any conflict between the
provisions of this Security and the Indenture, the provisions of the Indenture shall control. 
 This Security shall not be valid until an
authorized signatory of the Trustee manually signs the certificate of authentication on this Security. 
 THE INDENTURE AND THIS SECURITY,
AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THE INDENTURE OR THIS SECURITY, SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 

The Company will furnish to any Holder, upon written request and without charge, a copy of the Indenture. Requests may be made to: Keryx
Biopharmaceuticals, Inc., One Marina Park Drive, 12th Floor, Boston, MA 02210, Attention: Investor Relations. 

  
 A-6 

 ABBREVIATIONS AND DEFINITIONS 

Customary abbreviations may be used in the name of the Holder or an assignee, such as: 

TEN COM (= tenants in common) 

TEN ENT (= tenants by the entireties) 

JT TEN (= joint tenants with right of survivorship and not as tenants in common) 

CUST (= Custodian) 
 UGMA (=
Uniform Gifts to Minors Act). 
 Additional abbreviations may also be used though not in the above list. 

  
 A-7 

 FORM OF ASSIGNMENT AND TRANSFER 

To assign this Security, fill in the form below: 

I or we assign and transfer this Security to: 
  

                          
                                         
                                         
                             

(Insert assignee’s social security or tax I.D. number) 
  

                          
                                         
                                         
                             

                          
                                         
                                         
                             

                          
                                         
                                         
                             

                          
                                         
                                         
                             

                          
                                         
                                         
                             

(Print or type assignee’s name, address and zip code) 
 and
irrevocably appoint 
  

                          
                                         
                                         
                 
 agent to transfer this Security on the books of the
Company. The agent 
 may substitute another to act for him or her. 

In connection with any transfer of the within Security occurring prior to the Resale Restriction Termination Date, as defined in the Indenture governing such
Security, the undersigned confirms that such Security is being transferred: 
 ☐ To Keryx Biopharmaceuticals, Inc. or a subsidiary thereof; or 

☐ Pursuant to a registration statement that has become or been declared effective under the Securities Act of 1933, as amended; or 

☐ Pursuant to and in compliance with Rule 144A under the Securities Act of 1933, as amended; or 

☐ Pursuant to and in compliance with Rule 144 under the Securities Act of 1933, as amended, or any other available exemption from the registration
requirements of the Securities Act of 1933, as amended. 

  
 A-8 

					
	Date: Your Signature:	  	                            	  	
	  
	  		  	  

		  		  	 (Sign exactly as your name appears on
 the other
side of this Security)

	*	Signature guaranteed by: 

By:                         
                                         
             
  

	*	The signature must be guaranteed by an institution that is a member of one of the following recognized signature guaranty programs: (i) the Securities Transfer Agent Medallion Program (STAMP); (ii) the New York
Stock Exchange Medallion Program (MSP); (iii) the Stock Exchange Medallion Program (SEMP); or (iv) such other guaranty program acceptable to the Trustee. 

  
 A-9 

 CONVERSION NOTICE 

To convert this Security in accordance with the terms of this Indenture, check the box: ☐ 

To convert only part of this Security, state the principal amount to be converted (which must be $1,000 or an integral multiple of $1,000): $

 Certificate numbers of Certificated Securities to be converted: 
  

                          
                                         
                                         
                             

If you want the stock certificate made out in another Person’s name, fill in the form below: 

 

                          
                                         
                                         
                             

(Insert assignee’s social security or tax I.D. number) 
  

                          
                                         
                                         
                             

                          
                                         
                                         
                             

                          
                                         
                                         
                             

                          
                                         
                                         
                             

                          
                                         
                                         
                             

(Print or type assignee’s name, address and zip code) 
  

					
	 Date:
  
	 	                            	  	 Your Signature:
  

		 		  	 (Sign exactly as your name appears on
 the other
side of this Security)

  

	*	Signature guaranteed by: 

  

	
	 By:
                                         
                                         
                                         
             

  

	*	The signature must be guaranteed by an institution that is a member of one of the following recognized signature guaranty programs: (i) the Securities Transfer Agent Medallion Program (STAMP); (ii) the New York
Stock Exchange Medallion Program (MSP); (iii) the Stock Exchange Medallion Program (SEMP); or (iv) such other guaranty program acceptable to the Trustee. 

  
 A-10 

 REPURCHASE EXERCISE NOTICE UPON A FUNDAMENTAL CHANGE 

To: Keryx Biopharmaceuticals, Inc. 

The undersigned registered owner of this Security hereby irrevocably acknowledges receipt of a notice from Keryx Biopharmaceuticals, Inc. (the
“Company”) as to the occurrence of a Fundamental Change with respect to the Company and requests and instructs the Company to repurchase the entire principal amount of this Security, or the portion thereof (which is $1,000 or an
integral multiple thereof) below designated, in accordance with the terms of the Indenture referred to in this Security at the Fundamental Change Repurchase Price, to the registered Holder hereof. 

Principal Amount to be
repurchased:                                       
                                         
                                         
                         

Certificate
Numbers:                                       
                                         
                                         
                                         
        
  

							
	Dated:	 	  
	 		 	  

				
	Dated:	 	  
	 		 	  

				
	Dated:	 	  
	 	        	 	  

		 		 		 	Signature(s)
				
		 		 		 	Signature(s) must be guaranteed by a qualified guarantor institution with membership in an approved signature guarantee program pursuant to Rule 17Ad-15 under the Securities Exchange Act of
1934, as amended.
				
		 		 		 	  

		 		 		 	Signature Guaranty

 Principal amount to be repurchased (in an integral multiple of $1,000, if less than all): 

NOTICE: The signature to the foregoing Election must correspond to the name as written upon the face of the Security in every particular, without alteration
or any change whatsoever. 

  
 A-11 

 SCHEDULE OF EXCHANGES OF SECURITIES5

 The following exchanges, repurchases or conversions of a part of this Global Security have been made: 

 

									
	 Date of

Exchange,
 Repurchase or

Conversion
	  	 Amount of

Decrease in
 Principal

Amount of this
 Global
Security
	  	 Amount of

Increase in
 Principal

Amount of this
 Global
Security
	  	 Principal

Amount of this
 Global Security

Following Such
 Decrease or

Increase
	  	 Signature of

Authorized
 Signatory of

Securities

Custodian

  

 

	5 	This schedule should be included only if the Security is a Global Security. 

  
 A-12EX-10.3

 Exhibit 10.3 

Execution Version 
  

 
  

REGISTRATION RIGHTS AGREEMENT 

BY AND AMONG 
 KERYX
BIOPHARMACEUTICALS, INC. 
 AND 

BAUPOST GROUP SECURITIES, L.L.C. 

DATED AS OF MAY 9, 2018 
  

 
  

 TABLE OF CONTENTS 

 

							
	ARTICLE I EFFECTIVENESS	  	 	1	 
			
	 Section 1.1.
	  	Effectiveness	  	 	1	 
		
	ARTICLE II DEFINITIONS	  	 	1	 
			
	 Section 2.1.
	  	Definitions	  	 	1	 
			
	 Section 2.2.
	  	Other Interpretive Provisions	  	 	5	 
		
	ARTICLE III REGISTRATION RIGHTS	  	 	5	 
			
	 Section 3.1.
	  	Demand Registration	  	 	5	 
			
	 Section 3.2.
	  	Shelf Registration	  	 	7	 
			
	 Section 3.3.
	  	Piggyback Registration	  	 	10	 
			
	 Section 3.4.
	  	Lock-Up Agreements	  	 	11	 
			
	 Section 3.5.
	  	Registration Procedures	  	 	11	 
			
	 Section 3.6.
	  	Underwritten Offerings	  	 	17	 
			
	 Section 3.7.
	  	No Inconsistent Agreements; Additional Rights	  	 	18	 
			
	 Section 3.9.
	  	Registration Expenses	  	 	18	 
			
	 Section 3.9.
	  	Indemnification	  	 	19	 
			
	 Section 3.10.
	  	Rules 144 and 144A and Regulation S	  	 	22	 
			
	 Section 3.11.
	  	Existing Registration Statements	  	 	23	 
		
	ARTICLE IV GOVERNANCE	  	 	23	 
			
	 Section 4.1.
	  	Composition of the Board of Directors	  	 	23	 
		
	ARTICLE V MISCELLANEOUS	  	 	24	 
			
	 Section 5.1.
	  	Authority; Effect	  	 	24	 
			
	 Section 5.2.
	  	Notices	  	 	24	 
			
	 Section 5.3.
	  	Termination and Effect of Termination	  	 	25	 
			
	 Section 5.4.
	  	Permitted Transferees	  	 	26	 
			
	 Section 5.5.
	  	Remedies	  	 	26	 
			
	 Section 5.6.
	  	Amendments	  	 	26	 
			
	 Section 5.7.
	  	Governing Law	  	 	26	 
			
	 Section 5.8.
	  	Consent to Jurisdiction	  	 	26	 
			
	 Section 5.9.
	  	WAIVER OF JURY TRIAL	  	 	27	 
			
	 Section 5.10.
	  	Merger; Binding Effect, Etc.	  	 	27	 
			
	 Section 5.11.
	  	Counterparts	  	 	27	 
			
	 Section 5.12
	  	Severability	  	 	28	 
			
	 Section 5.13.
	  	No Recourse	  	 	28	 
			
	 Section 5.14.
	  	Existing Registration Rights Waivers	  	 	28	 

  

  
 - i - 

 This REGISTRATION RIGHTS AGREEMENT (as it may be amended from time to time in accordance with the
terms hereof, the “Agreement”), dated as of May 9, 2018, is made by and among: 
 i. Keryx Biopharmaceuticals, Inc., a
Delaware corporation (the “Company”); and 
 ii. Baupost Group Securities, L.L.C. (together with its Permitted Transferees
that become party hereto, the “Investor”). 
 RECITALS 

WHEREAS, pursuant to the Notes Exchange Agreement dated May 8, 2018 among the Company and the Investor (the “Purchase
Agreement”), the Investor is purchasing $164.746 million principal amount of zero-coupon senior convertible notes (the “Notes”) which will be convertible into shares of common
stock of the Company, par value $0.001 per share (“Common Stock”); and 
 WHEREAS, the parties believe that it is in the
best interests of the Company and the other parties hereto set forth their agreements regarding registration rights. 
 NOW, THEREFORE, in
consideration of the foregoing and the mutual promises, covenants and agreements of the parties hereto, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 ARTICLE I 

EFFECTIVENESS 

Section 1.1. Effectiveness. This Agreement shall become effective as of the date hereof. 

ARTICLE II 
 DEFINITIONS

 Section 2.1. Definitions. As used in this Agreement, the following terms shall have the following meanings: 

“Adverse Disclosure” means public disclosure of material non-public information that,
in the good faith judgment of the board of directors of the Company: (i) would be required to be made in any Registration Statement filed with the SEC by the Company so that such Registration Statement, from and after its effective date, does
not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; (ii) would not be required to be made at such time but for the filing,
effectiveness or continued use of such Registration Statement; and (iii) the Company has a bona fide business purpose for not disclosing publicly. 

 “Affiliate” means, with respect to any specified Person, (a) any Person
that directly or indirectly through one or more intermediaries controls, or is controlled by, or is under common control with, such specified Person (b) in the event that the specified Person is a natural Person, a Member of the Immediate
Family of such Person or (c) any investment fund advised or managed by, or under common control or management with, such person; provided that the Company and each of its subsidiaries shall be deemed not to be Affiliates of any Investor.
As used in this definition, the term “control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities, by
contract or otherwise. 
 “Agreement” shall have the meaning set forth in the preamble. 

“Annual Meeting” shall have the meaning set forth in Section 4.1. 

“Board” shall have the meaning set forth in Section 4.1. 

“Business Day” means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by law
to be closed in the City of New York. 
 “Common Stock” shall have the meaning set forth in the recitals. 

“Demand Registration” shall have the meaning set forth in Section 3.1.1(a). 

“Demand Registration Request” shall have the meaning set forth in Section 3.1.1(a). 

“Demand Registration Statement” shall have the meaning set forth in Section 3.1.1(c). 

“Demand Suspension” shall have the meaning set forth in Section 3.1.5. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and any successor thereto, and any rules and
regulations promulgated thereunder, all as the same shall be in effect from time to time. 
 “FINRA” means the Financial
Industry Regulatory Authority. 
 “Holder” means the Investors who then hold Registrable Securities under this Agreement.

 “Indenture” means the indenture, dated as of May 9, 2018, by and among the Company and the Trustee, pursuant to
which the Notes are to be issued, as such Indenture is amended or supplemented from time to time in accordance with the terms thereof. 

“Investor” shall have the meaning set forth in the preamble. 

“Investor Approval” means the prior written consent of the Investor. 

“Investor Designee” shall have the meaning set forth in Section 4.1. 

“Investor Observer” shall have the meaning set forth in Section 4.1. 

  
 - 2 - 

 “Issuer Free Writing Prospectus” means an issuer free writing prospectus,
as defined in Rule 433 under the Securities Act, relating to an offer of the Registrable Securities. 
 “Loss” shall have
the meaning set forth in Section 3.9.1. 
 “Member of the Immediate Family” means, with respect to any Person who is
an individual, (a) each parent, spouse (but not including a former spouse or a spouse from whom such Person is legally separated) or child (including those adopted) of such individual and (b) each trustee, solely in his or her capacity as
trustee, for a trust naming only one or more of the Persons listed in sub-clause (a) as beneficiaries. 

“Permitted Transferee” means (i) any Affiliate of an Investor, (ii) any other Person to whom the Investor Transfers
Registrable Securities in exchange for proceeds of at least $25,000,000 and (iii) any custodian or nominee that holds Registrable Securities for the account of Purchaser or any Permitted Transferee described in clause (i) or (ii). 

“Person” means any individual, partnership, corporation, company, association, trust, joint venture, limited liability
company, unincorporated organization, entity or division, or any government, governmental department or agency or political subdivision thereof. 

“Piggyback Notice” shall have the meaning set forth in Section 3.3.1. 

“Piggyback Registration” shall have the meaning set forth in Section 3.3.1. 

“Pro Rata Portion” means, with respect to each Holder requesting that its shares be registered or sold in an Underwritten
Public Offering, a number of such shares equal to the aggregate number of Registrable Securities to be registered or sold (excluding any shares to be registered or sold for the account of the Company) multiplied by a fraction, the numerator of which
is the aggregate number of Registrable Securities held by such Holder, and the denominator of which is the aggregate number of Registrable Securities held by all Holders requesting that their Registrable Securities be registered or sold. 

“Prospectus” means (i) the prospectus included in any Registration Statement, all amendments and supplements to such
prospectus, including post-effective amendments and supplements, and all other material incorporated by reference in such prospectus, and (ii) any Issuer Free Writing Prospectus. 

“Public Offering” means the offer and sale of Registrable Securities for cash pursuant to an effective Registration Statement
under the Securities Act (other than a Registration Statement on Form S-4 or Form S-8 or any successor form). 

“Registrable Securities” means (i) all shares of Common Stock that are not then subject to forfeiture to the Company,
(ii) all shares of Common Stock issuable upon exercise, conversion or exchange of any option, warrant or convertible security not then subject to vesting or forfeiture to the Company, (iii) all shares of Common Stock directly or indirectly
issued or then issuable with respect to the securities referred to in clauses (i) or (ii) above by way of a stock dividend or stock split, or in connection with a combination of shares, recapitalization, merger, consolidation or other
reorganization and (iv) the Notes. As to any particular Registrable 

  
 - 3 - 

 
Securities, such securities shall cease to be Registrable Securities when (w) a Registration Statement with respect to the sale of such securities shall have become effective under the
Securities Act and such securities shall have been disposed of in accordance with such Registration Statement, (x) such securities shall have been Transferred pursuant to Rule 144, (y) such holder is able to immediately sell such securities
under Rule 144 without any restrictions on transfer (including without application of paragraphs (c), (d), (e), (f) and (h) of Rule 144), as reasonably determined by the Holder, or (z) such securities shall have ceased to be outstanding.

 “Registration” means registration under the Securities Act of the offer and sale to the public of any Registrable
Securities under a Registration Statement. The terms “register”, “registered” and “registering” shall have correlative meanings. 

“Registration Expenses” shall have the meaning set forth in Section 3.8. 

“Registration Statement” means any registration statement of the Company filed with, or to be filed with, the SEC under the
Securities Act, including the related Prospectus, amendments and supplements to such registration statement, including pre- and post-effective amendments, and all exhibits and all material incorporated by
reference in such registration statement other than a registration statement (and related Prospectus) filed on Form S-4 or Form S-8 or any successor form thereto. 

“Representatives” means, with respect to any Person, any of such Person’s officers, directors, employees, agents,
attorneys, accountants, actuaries, consultants, equity financing partners or financial advisors or other Person associated with, or acting on behalf of, such Person. 

“Rule 144” means Rule 144 under the Securities Act (or any successor rule). 

“SEC” means the Securities and Exchange Commission or any successor agency having jurisdiction under the Securities Act. 

“Securities Act” means the Securities Act of 1933, as amended, and any successor thereto, and any rules and regulations
promulgated thereunder, all as the same shall be in effect from time to time. 
 “Shelf Period” shall have the meaning set
forth in Section 3.2.2. 
 “Shelf Registration” shall have the meaning set forth in Section 3.2.1(a). 

“Shelf Registration Request” shall have the meaning set forth in Section 3.2.1(a). 

“Shelf Registration Statement” shall have the meaning set forth in Section 3.2.1(a). 

“Shelf Suspension” shall have the meaning set forth in Section 3.2.3. 

“Shelf Takedown Request” shall have the meaning set forth in Section 3.2.4(a). 

  
 - 4 - 

 “Transfer” means, with respect to any Registrable Security, any interest
therein, or any other securities or equity interests relating thereto, a direct or indirect transfer, sale, exchange, assignment, pledge, hypothecation or other encumbrance or other disposition thereof, including the grant of an option or other
right, whether directly or indirectly, whether voluntarily, involuntarily, by operation of law, pursuant to judicial process or otherwise. “Transferred” shall have a correlative meaning. 

“Trustee” means The Bank of New York Mellon Trust Company, N.A. 

“Underwritten Public Offering” means an underwritten Public Offering, including any bought deal or block sale to a financial
institution conducted as an underwritten Public Offering. 
 “Underwritten Shelf Takedown” means an Underwritten Public
Offering pursuant to an effective Shelf Registration Statement. 
 “WKSI” means any Securities Act registrant that is a
well-known seasoned issuer as defined in Rule 405 under the Securities Act at the most recent eligibility determination date specified in paragraph (2) of that definition. 

Section 2.2. Other Interpretive Provisions. (a) The meanings of defined terms are equally applicable to the singular and plural
forms of the defined terms. 
 (b) The words “hereof”, “herein”, “hereunder” and similar words refer to this
Agreement as a whole and not to any particular provision of this Agreement; and any subsection and section references are to this Agreement unless otherwise specified. 

(c) The term “including” is not limiting and means “including without limitation.” 

(d) The captions and headings of this Agreement are for convenience of reference only and shall not affect the interpretation of this
Agreement. 
 (e) Whenever the context requires, any pronouns used herein shall include the corresponding masculine, feminine or neuter
forms. 
 ARTICLE III 

REGISTRATION RIGHTS 
 The
Company will perform and comply, and cause each of its subsidiaries to perform and comply, with such of the following provisions as are applicable to it. Each Holder will perform and comply with such of the following provisions as are applicable to
such Holder. 
 Section 3.1. Demand Registration. 

Section 3.1.1. Request for Demand Registration. 

 

	 	(a)	At any time after the date hereof, the Investors shall have the right to make a written request from time to time (a “Demand Registration Request”) to the Company for Registration of all or part of the
Registrable Securities held by such Investors. Any such Registration pursuant to a Demand Registration Request shall hereinafter be referred to as a “Demand Registration.” 

  
 - 5 - 

	 	(b)	Each Demand Registration Request shall specify (x) the kind and aggregate amount of Registrable Securities to be registered, and (y) the intended method or methods of disposition thereof. 

 

	 	(c)	Upon receipt of a Demand Registration Request, the Company shall as promptly as practicable file a Registration Statement (a “Demand Registration Statement”) relating to such Demand Registration, and
use its reasonable best efforts to cause such Demand Registration Statement to be promptly declared effective under the Securities Act. 

Section 3.1.2. Limitation on Demand Registrations. The Company shall not be obligated to take any action to
effect any Demand Registration if a Demand Registration pursuant to Section 3.1 was declared effective or an Underwritten Shelf Takedown pursuant to Section 3.2 was consummated within the preceding one hundred eighty (180) days
(unless otherwise consented to by the Company). 
 Section 3.1.3. Demand Withdrawal. The Investors may withdraw
all or any portion of its Registrable Securities included in a Demand Registration from such Demand Registration at any time prior to the effectiveness of the applicable Demand Registration Statement. Upon receipt of a notice to such effect from
with respect to all of the Registrable Securities included in such Demand Registration, the Company shall cease all efforts to secure effectiveness of the applicable Demand Registration Statement and such Demand Registration shall not count as such
pursuant to Section 3.1.2 above. 
 Section 3.1.4. Effective Registration. The Company shall use
reasonable best efforts to cause the Demand Registration Statement to become effective and remain effective for not less than one hundred eighty (180) days (or such shorter period as will terminate when all Registrable Securities covered by
such Demand Registration Statement have been sold or withdrawn), or, if such Demand Registration Statement relates to an Underwritten Public Offering, such longer period as in the opinion of counsel for the underwriter or underwriters a Prospectus
is required by law to be delivered in connection with sales of Registrable Securities by an underwriter or dealer. 

Section 3.1.5. Delay in Filing; Suspension of Registration. If the filing, initial effectiveness or
continued use of a Demand Registration Statement at any time would require the Company to make an Adverse Disclosure, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or
suspend use of, the Demand Registration Statement (a “Demand Suspension”); provided, however, that the Company shall not be permitted to exercise a Demand Suspension more than once during any twelve (12)-month period
or for a period exceeding sixty (60) days. In the case of a Demand Suspension, the Holders agree to suspend use of the applicable Prospectus in connection with any sale or purchase, or offer 

  
 - 6 - 

 
to sell or purchase, Registrable Securities, upon receipt of the notice referred to above. The Company shall immediately notify the Holders in writing upon the termination of any Demand
Suspension, amend or supplement the Prospectus, if necessary, so it does not contain any untrue statement or omission and furnish to the Holders such numbers of copies of the Prospectus as so amended or supplemented as the Holders may reasonably
request. The Company shall, if necessary, supplement or amend the Demand Registration Statement, if required by the registration form used by the Company for the Demand Registration or by the instructions applicable to such registration form or by
the Securities Act or the rules or regulations promulgated thereunder or as may reasonably be requested by the Investors. 

Section 3.1.6. Priority of Securities Registered Pursuant to Demand Registrations. If the managing
underwriter or underwriters of a proposed Underwritten Public Offering of the Registrable Securities included in a Demand Registration advise the Company in writing that, in its or their opinion, the number of securities requested to be included in
such Demand Registration exceeds the number that can be sold in such offering without being likely to have an adverse effect on the price, timing or distribution of the securities offered or the market for the securities offered, then the securities
to be included in such Registration shall be, in the case of any Demand Registration, (x) first, allocated to each Holder that has requested to participate in such Demand Registration an amount equal to the lesser of (i) the number of such
Registrable Securities requested to be registered or sold by such Holders, and (ii) a number of such shares equal to such Holder’s Pro Rata Portion, and (y) second, and only if all the securities referred to in clause (x) have
been included, the number of other securities that, in the opinion of such managing underwriter or underwriters can be sold without having such adverse effect. 

Section 3.1.7. Resale Rights. In the event that the Investor requests to participate in a Registration pursuant to
this Section 3.1 in connection with a distribution of Registrable Securities to its partners or members, the Registration shall provide for resale by such partners or members, if requested by such Investor. 

Section 3.2. Shelf Registration. 

Section 3.2.1. Request for Shelf Registration. 

 

	 	(a)	Upon the written request of the Investors from time to time (a “Shelf Registration Request”), the Company shall promptly file with the SEC a shelf Registration Statement pursuant to Rule 415 under the
Securities Act (“Shelf Registration Statement”) relating to the offer and sale of Registrable Securities by any Holders thereof from time to time in accordance with the methods of distribution elected by such Holders, and the
Company shall use its reasonable best efforts to cause such Shelf Registration Statement to promptly become effective under the Securities Act. Any such Registration pursuant to a Shelf Registration Request shall hereinafter be referred to as a
“Shelf Registration.” 

  
 - 7 - 

	 	(b)	If on the date of the Shelf Registration Request the Company is a WKSI, then the Shelf Registration Request may request Registration of an unspecified amount of Registrable Securities to be sold by unspecified Holders.
If on the date of the Shelf Registration Request the Company is not a WKSI, then the Shelf Registration Request shall specify the aggregate amount of Registrable Securities to be registered. The Company shall provide to the Investors the information
necessary to determine the Company’s status as a WKSI upon request. 

 Section 3.2.2. Continued
Effectiveness. The Company shall use its reasonable best efforts to keep such Shelf Registration Statement continuously effective under the Securities Act in order to permit the Prospectus forming part of the Shelf Registration Statement to be
usable by the Holders until the earlier of: (i) the date as of which all Registrable Securities have been sold pursuant to the Shelf Registration Statement or another Registration Statement filed under the Securities Act (but in no event prior
to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder); and (ii) the date as of which no Holder holds Registrable Securities (such period of effectiveness, the “Shelf
Period”). Subject to Section 3.2.3, the Company shall be deemed not to have used its reasonable best efforts to keep the Shelf Registration Statement effective during the Shelf Period if the Company voluntarily takes any action or
omits to take any action that would result in the Holders of the Registrable Securities covered thereby not being able to offer and sell any Registrable Securities pursuant to such Shelf Registration Statement during the Shelf Period, unless such
action or omission is required by applicable law. 
 Section 3.2.3. Suspension of Registration. If the
continued use of such Shelf Registration Statement at any time would require the Company to make an Adverse Disclosure, the Company may, upon giving prompt written notice of such action to the Holders, suspend use of the Shelf Registration Statement
(a “Shelf Suspension”); provided, however, that the Company shall not be permitted to exercise a Shelf Suspension more than one time during any twelve (12)-month period or for a period exceeding sixty (60) days.
In the case of a Shelf Suspension, the Holders agree to suspend use of the applicable Prospectus in connection with any sale or purchase of, or offer to sell or purchase, Registrable Securities, upon receipt of the notice referred to above. The
Company shall immediately notify the Holders in writing upon the termination of any Shelf Suspension, amend or supplement the Prospectus, if necessary, so it does not contain any untrue statement or omission and furnish to the Holders such numbers
of copies of the Prospectus as so amended or supplemented as the Holders may reasonably request. The Company shall, if necessary, supplement or amend the Shelf Registration Statement, if required by the registration form used by the Company for the
Shelf Registration Statement or by the instructions applicable to such registration form or by the Securities Act or the rules or regulations promulgated thereunder or as may reasonably be requested by the Holders of a majority of Registrable
Securities that are included in such Shelf Registration Statement. 

  
 - 8 - 

 Section 3.2.4. Shelf Takedown. 

 

	 	(a)	At any time the Company has an effective Shelf Registration Statement with respect to a Holder’s Registrable Securities, by notice to the Company specifying the intended method or methods of disposition thereof,
the Investors may make a written request (a “Shelf Takedown Request”) to the Company to effect a Public Offering, including an Underwritten Shelf Takedown, of all or a portion of the such Holder’s Registrable Securities that
may be registered under such Shelf Registration Statement, and as soon as practicable the Company shall amend or supplement the Shelf Registration Statement as necessary for such purpose. 

 

	 	(b)	All determinations as to whether to complete any Underwritten Shelf Takedown and as to the timing, manner, price and other terms of any Underwritten Shelf Takedown contemplated by this Section 3.2.4 shall be
determined by the participating Investors. 

  

	 	(c)	The Company shall not be obligated to take any action to effect any Underwritten Shelf Takedown if a Demand Registration pursuant to Section 3.1 was declared effective or an Underwritten Shelf Takedown pursuant to
Section 3.2 was consummated within the preceding one hundred eighty (180) days (unless otherwise consented to by the Company). 

Section 3.2.5. Priority of Securities Sold Pursuant to Shelf Takedowns. If the managing underwriter or underwriters
of a proposed Underwritten Shelf Takedown pursuant to Section 3.2.4 advise the Company in writing that, in its or their opinion, the number of securities requested to be included in the proposed Underwritten Shelf Takedown exceeds the number
that can be sold in such Underwritten Shelf Takedown without being likely to have an adverse effect on the price, timing or distribution of the securities offered or the market for the securities offered, the number of Registrable Securities to be
included in such offering shall be (x) first, allocated to each Holder that has requested to participate in such Underwritten Shelf Takedown an amount equal to the lesser of (i) the number of such Registrable Securities requested to be
registered or sold by such Holder, and (ii) a number of such shares equal to such Holder’s Pro Rata Portion, and (y) second, and only if all the securities referred to in clause (x) have been included, the number of other
securities that, in the opinion of such managing underwriter or underwriters can be sold without having such adverse effect. 

Section 3.2.6. Resale Rights. In the event that an Investor elects to request a Registration pursuant to this
Section 3.2 in connection with a distribution of Registrable Securities to its partners or members, the Registration shall provide for resale by such partners or members, if requested by such Investor. 

  
 - 9 - 

 Section 3.3. Piggyback Registration. 

Section 3.3.1. Participation. If the Company at any time proposes to file a Registration Statement under the
Securities Act or to conduct a Public Offering with respect to any offering of its equity securities for its own account or for the account of any other Persons (other than (i) a Registration under Sections 3.1 or 3.2, (ii) a Registration
on Form S-4 or Form S-8 or any successor form to such forms or (iii) a Registration of securities solely relating to an offering and sale to employees or directors
of the Company or its subsidiaries pursuant to any employee stock plan or other employee benefit plan arrangement), then, as soon as practicable (but in no event less than ten (10) Business Days prior to the proposed date of filing of such
Registration Statement or, in the case of a Public Offering under a Shelf Registration Statement, the anticipated pricing or trade date), the Company shall give written notice (a “Piggyback Notice”) of such proposed filing or Public
Offering to all Holders, and such Piggyback Notice shall offer the Holder the opportunity to register under such Registration Statement, or to sell in such Public Offering, such number of Registrable Securities as each such Holder may request in
writing (a “Piggyback Registration”). Subject to Section 3.3.2, the Company shall include in such Registration Statement or in such Public Offering as applicable, all such Registrable Securities that are requested to be
included therein within five (5) Business Days after the receipt by such Holder of any such notice; provided, however, that if at any time after giving written notice of its intention to register or sell any securities and prior
to the effective date of the Registration Statement filed in connection with such Registration, or the pricing or trade date of a Public Offering under a Shelf Registration Statement, the Company determines for any reason not to register or sell or
to delay the Registration or sale of such securities, the Company shall give written notice of such determination to each Holder and, thereupon, (i) in the case of a determination not to register or sell, shall be relieved of its obligation to
register or sell any Registrable Securities in connection with such Registration or Public Offering (but not from its obligation to pay the Registration Expenses in connection therewith), without prejudice, however, to the rights of any Holder
entitled to request that such Registration or sale be effected as a Demand Registration under Section 3.1 or an Underwritten Shelf Takedown under Section 3.2, as the case may be, and (ii) in the case of a determination to delay
Registration or sale, in the absence of a request for a Demand Registration or an Underwritten Shelf Takedown, as the case may be, shall be permitted to delay registering or selling any Registrable Securities, for the same period as the delay in
registering or selling such other securities. Any Holder shall have the right to withdraw all or part of its request for inclusion of its Registrable Securities in a Piggyback Registration by giving written notice to the Company of its request to
withdraw. 
 Section 3.3.2. Priority of Piggyback Registration. If the managing underwriter or
underwriters of any proposed offering of Registrable Securities included in a Piggyback Registration informs the Company and the participating Holders in writing that, in its or their opinion, the number of securities that such Holders and any other
Persons intend to include in such offering exceeds the number that can be sold in such offering without being likely to have a significant adverse effect on the price, timing or distribution of the securities offered or the market for the securities
offered, then the securities to be included in such Registration shall be (i) first, one hundred percent (100%) of the securities that the Company proposes to sell, and (ii) second, and only if all the securities referred to in clause
(i) have been included, the number of Registrable Securities requested to be sold by such Holder that, in the opinion of such managing underwriter or underwriters, can be sold without having such adverse effect, with such number to be

  
 - 10 - 

 
allocated among the Holders that have requested to participate in such Registration based on an amount equal to the lesser of (x) the number of such Registrable Securities requested to be
sold by such Holder, and (y) a number of such shares equal to such Holder’s Pro Rata Portion, and (iii) third, and only if all of the Registrable Securities referred to in clause (ii) have been included in such Registration, any
other securities eligible for inclusion in such Registration. 
 Section 3.3.3. No Effect on Other Registrations.
No Registration of Registrable Securities effected pursuant to a request under this Section 3.3 shall be deemed to have been effected pursuant to Sections 3.1 and 3.2 or shall relieve the Company of its obligations under Sections 3.1 and 3.2.

 Section 3.4. Lock-Up Agreements. In connection with each Registration or sale of
Registrable Securities pursuant to Section 3.1, 3.2 or 3.3 conducted as an Underwritten Public Offering, the Company agrees, if requested, to cause its directors and officers to become bound by and to execute and deliver a lock-up agreement with the underwriter(s) of such Underwritten Public Offering restricting such directors’ and officers’ right to (a) Transfer, directly or indirectly, any equity securities of the
Company held by such directors and officers or (b) enter into any swap or other arrangement that transfers to another any of the economic consequences of ownership of such securities during the period commencing on the date of the final
Prospectus relating to the Underwritten Public Offering and ending on the date specified by the underwriters (such period not to exceed ninety (90) days in the case of any registration or sale, plus such additional period as may be requested by
the Company or an underwriter to accommodate regulatory restrictions on the publication or other distribution of research reports and analyst recommendations and opinions, if applicable). The terms of such
lock-up agreements shall be negotiated among the Investors, the Company and the underwriters and shall include customary carve-outs from the restrictions on Transfer set forth therein. 

Section 3.5. Registration Procedures. 

Section 3.5.1. Requirements. In connection with the Company’s obligations under Sections 3.1 – 3.4 (and
in the case of 3.5.1(z) below, in connection with the Company’s obligations under Sections 3.1 – 3.4 and 3.10) the Company shall use its reasonable best efforts to effect such Registration and to permit the sale of such Registrable
Securities in accordance with the intended method or methods of distribution thereof as expeditiously as reasonably practicable, and in connection therewith the Company shall: 
  

	 	(a)	 As promptly as practicable prepare the required Registration Statement, including all exhibits and financial
statements required under the Securities Act to be filed therewith and Prospectus, and, before filing a Registration Statement or Prospectus or any amendments or supplements thereto, (x) furnish to the underwriters, if any, and to the Holders
of the Registrable Securities covered by such Registration Statement, copies of all documents prepared to be filed, which documents shall be subject to the review of such underwriters and such Holders and their respective counsel, (y) make such
changes in such documents concerning the Holders 

  
 - 11 - 

	 	
prior to the filing thereof as such Holders, or their counsel, may reasonably request and (z) except in the case of a Registration under Section 3.3 not file any Registration Statement
or Prospectus or amendments or supplements thereto to which the Holders, in such capacity, or the underwriters, if any, shall reasonably object; 

  

	 	(b)	prepare and file with the SEC such amendments and post-effective amendments to such Registration Statement and supplements to the Prospectus as may be (x) reasonably requested by any Holder with Registrable
Securities covered by such Registration Statement, (y) reasonably requested by any participating Holder (to the extent such request relates to information relating to such Holder), or (z) necessary to keep such Registration Statement
effective for the period of time required by this Agreement, and comply with provisions of the applicable securities laws with respect to the sale or other disposition of all securities covered by such Registration Statement during such period in
accordance with the intended method or methods of disposition by the sellers thereof set forth in such Registration Statement; 

  

	 	(c)	notify the participating Holders and the managing underwriter or underwriters, if any, and (if requested) confirm such notice in writing and provide copies of the relevant documents, as soon as reasonably practicable
after notice thereof is received by the Company (a) when the applicable Registration Statement or any amendment thereto has been filed or becomes effective, and when the applicable Prospectus or any amendment or supplement thereto has been
filed, (b) of any written comments by the SEC, or any request by the SEC or other federal or state governmental authority for amendments or supplements to such Registration Statement or such Prospectus, or for additional information (whether
before or after the effective date of the Registration Statement) or any other correspondence with the SEC relating to, or which may affect, the Registration, (c) of the issuance by the SEC of any stop order suspending the effectiveness of such
Registration Statement or any order by the SEC or any other regulatory authority preventing or suspending the use of any preliminary or final Prospectus or the initiation or threatening of any proceedings for such purposes, (d) if, at any time,
the representations and warranties of the Company in any applicable underwriting agreement cease to be true and correct in all material respects and (e) of the receipt by the Company of any notification with respect to the suspension of the
qualification of the Registrable Securities for offering or sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; 

  

	 	(d)	 promptly notify each selling Holder and the managing underwriter or underwriters, if any, when the Company
becomes aware of the happening of any event as a result of which the applicable Registration Statement or the Prospectus included in such Registration Statement (as then in effect) 

  
 - 12 - 

	 	
contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements therein (in the case of such Prospectus or any preliminary Prospectus, in light
of the circumstances under which they were made) not misleading, when any Issuer Free Writing Prospectus includes information that may conflict with the information contained in the Registration Statement, or, if for any other reason it shall be
necessary during such time period to amend or supplement such Registration Statement or Prospectus in order to comply with the Securities Act and, as promptly as reasonably practicable thereafter, prepare and file with the SEC, and furnish without
charge to the selling Holders and the managing underwriter or underwriters, if any, an amendment or supplement to such Registration Statement or Prospectus, which shall correct such misstatement or omission or effect such compliance;

  

	 	(e)	to the extent the Company is eligible under the relevant provisions of Rule 430B under the Securities Act, if the Company files any Shelf Registration Statement, the Company shall include in such Shelf Registration
Statement such disclosures as may be required by Rule 430B under the Securities Act (referring to the unnamed selling security holders in a generic manner by identifying the initial offering of the securities to the Holders) in order to ensure that
the Holders may be added to such Shelf Registration Statement at a later time through the filing of a Prospectus supplement rather than a post-effective amendment; 

 

	 	(f)	use its reasonable best efforts to prevent, or obtain the withdrawal of, any stop order or other order or notice preventing or suspending the use of any preliminary or final Prospectus; 

 

	 	(g)	promptly incorporate in a Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment such information as the managing underwriter or underwriters and the Investors agree should be included therein
relating to the plan of distribution with respect to such Registrable Securities; and make all required filings of such Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment as soon as reasonably practicable after being
notified of the matters to be incorporated in such Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment; 

  

	 	(h)	furnish to each selling Holder and each underwriter, if any, without charge, as many conformed copies as such Holder or underwriter may reasonably request of the applicable Registration Statement and any amendment or
post-effective amendment or supplement thereto, including financial statements and schedules, all documents incorporated therein by reference and all exhibits (including those incorporated by reference); 

  
 - 13 - 

	 	(i)	deliver to each selling Holder and each underwriter, if any, without charge, as many copies of the applicable Prospectus (including each preliminary Prospectus) and any amendment or supplement thereto and such other
documents as such Holder or underwriter may reasonably request in order to facilitate the disposition of the Registrable Securities by such Holder or underwriter (it being understood that the Company shall consent to the use of such Prospectus or
any amendment or supplement thereto by each of the selling Holders and the underwriters, if any, in connection with the offering and sale of the Registrable Securities covered by such Prospectus or any amendment or supplement thereto);

  

	 	(j)	on or prior to the date on which the applicable Registration Statement becomes effective, use its reasonable best efforts to register or qualify, and cooperate with the selling Holders, the managing underwriter or
underwriters, if any, and their respective counsel, in connection with the Registration or qualification of such Registrable Securities for offer and sale under the securities or “Blue Sky” laws of each state and other jurisdiction as any
such selling Holder or managing underwriter or underwriters, if any, or their respective counsel reasonably request in writing and do any and all other acts or things reasonably necessary or advisable to keep such Registration or qualification in
effect for such period as required by Section 3.1 or Section 3.2, as applicable, provided that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified or to take
any action which would subject it to taxation or general service of process in any such jurisdiction where it is not then so subject; 

  

	 	(k)	cooperate with the selling Holders and the managing underwriter or underwriters, if any, to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold and not bearing
any restrictive legends and enable such Registrable Securities to be in such denominations and registered in such names as the managing underwriters may request prior to any sale of Registrable Securities to the underwriters; 

 

	 	(l)	use its reasonable best efforts to cause the Registrable Securities covered by the applicable Registration Statement to be registered with or approved by such other governmental agencies or authorities as may be
necessary to enable the seller or sellers thereof or the underwriter or underwriters, if any, to consummate the disposition of such Registrable Securities, including, if requested, to qualify the Indenture under the Trust Indenture Act of 1939;

  

	 	(m)	not later than the effective date of the applicable Registration Statement, provide a CUSIP number for applicable Registrable Securities and, as applicable, provide the Trustee under the Indenture with printed
certificates for the applicable Registrable Securities which are in a form eligible for deposit with The Depository Trust Company (in the case of a Registration Statement); 

  
 - 14 - 

	 	(n)	make such representations and warranties to the Holders being registered, and the underwriters or agents, if any, in form, substance and scope as are customarily made by issuers in public offerings similar to the
offering then being undertaken; 

  

	 	(o)	enter into such customary agreements (including underwriting and indemnification agreements) and take all such other actions as the Investors or the managing underwriter or underwriters, if any, reasonably request in
order to expedite or facilitate the Registration and disposition of such Registrable Securities; 

  

	 	(p)	obtain for delivery to the Holders being registered and to the underwriter or underwriters, if any, an opinion or opinions from counsel for the Company dated the most recent effective date of the Registration Statement
or, in the event of an Underwritten Public Offering, the date of the closing under the underwriting agreement, in customary form, scope and substance, which opinions shall be reasonably satisfactory to such Holders or underwriters, as the case may
be, and their respective counsel; 

  

	 	(q)	in the case of an Underwritten Public Offering, obtain for delivery to the Company and the managing underwriter or underwriters, with copies to the Holders included in such Registration or sale, a comfort letter from
the Company’s independent certified public accountants or independent auditors (and, if necessary, any other independent certified public accountants or independent auditors of any subsidiary of the Company or any business acquired by the
Company for which financial statements and financial data are, or are required to be, included in the Registration Statement) in customary form and covering such matters of the type customarily covered by comfort letters as the managing underwriter
or underwriters reasonably request, dated the date of execution of the underwriting agreement and brought down to the closing under the underwriting agreement; 

  

	 	(r)	cooperate with each seller of Registrable Securities and each underwriter, if any, participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings required to
be made with FINRA; 

  

	 	(s)	use its reasonable best efforts to comply with all applicable securities laws and, if a Registration Statement was filed, make available to its security holders, as soon as reasonably practicable, an earnings statement
satisfying the provisions of Section 11(a) of the Securities Act and the rules and regulations promulgated thereunder; 

  

	 	(t)	provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by the applicable Registration Statement; 

  
 - 15 - 

	 	(u)	use its reasonable best efforts to cause all Registrable Securities covered by the applicable Registration Statement to be listed on each securities exchange on which any of the Company’s equity securities are then
listed or quoted and on each inter-dealer quotation system on which any of the Company’s equity securities are then quoted; 

  

	 	(v)	make available upon reasonable notice at reasonable times and for reasonable periods for inspection by a representative appointed by the Investors, by any underwriter participating in any disposition to be effected
pursuant to such Registration Statement and by any attorney, accountant or other agent retained by such Holders or any such underwriter, all pertinent financial and other records and pertinent corporate documents and properties of the Company, and
cause all of the Company’s officers, directors and employees and the independent public accountants who have certified its financial statements to make themselves available to discuss the business of the Company and to supply all information
reasonably requested by any such Person in connection with such Registration Statement; 

  

	 	(w)	in the case of an Underwritten Public Offering, cause the senior executive officers of the Company to participate in the customary “road show” presentations that may be reasonably requested by the managing
underwriter or underwriters in any such offering and otherwise to facilitate, cooperate with, and participate in each proposed offering contemplated herein and customary selling efforts related thereto; 

 

	 	(x)	take no direct or indirect action prohibited by Regulation M under the Exchange Act; 

  

	 	(y)	take all reasonable action to ensure that any Issuer Free Writing Prospectus utilized in connection with any Registration complies in all material respects with the Securities Act, is filed in accordance with the
Securities Act to the extent required thereby, is retained in accordance with the Securities Act to the extent required thereby and, when taken together with the related Prospectus, will not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; and 

  

	 	(z)	take all such other commercially reasonable actions as are necessary or advisable in order to expedite or facilitate the disposition of such Registrable Securities in accordance with the terms of this Agreement.

 Section 3.5.2. Company Information Requests. The Company may require each seller of Registrable
Securities as to which any Registration or sale is being effected to furnish to the Company such information regarding the distribution of such securities and such other information relating to such Holder and its ownership of Registrable Securities

  
 - 16 - 

 
as the Company may from time to time reasonably request in writing and the Company may exclude from such Registration or sale the Registrable Securities of any such Holder who unreasonably fails
to furnish such information within a reasonable time after receiving such request. Each Holder agrees to furnish such information to the Company and to cooperate with the Company as reasonably necessary to enable the Company to comply with the
provisions of this Agreement. 
 Section 3.5.3. Discontinuing Registration. Each Holder agrees that, upon receipt
of any notice from the Company of the happening of any event of the kind described in Section 3.5.1(d), such Holder will discontinue disposition of Registrable Securities pursuant to such Registration Statement until such Holder’s receipt
of the copies of the supplemented or amended Prospectus contemplated by Section 3.5.1(d), or until such Holder is advised in writing by the Company that the use of the Prospectus may be resumed, and has received copies of any additional or
supplemental filings that are incorporated by reference in the Prospectus, or any amendments or supplements thereto, and if so directed by the Company, such Holder shall deliver to the Company (at the Company’s expense) all copies, other than
permanent file copies then in such Holder’s possession, of the Prospectus covering such Registrable Securities current at the time of receipt of such notice. In the event the Company shall give any such notice, the period during which the
applicable Registration Statement is required to be maintained effective shall be extended by the number of days during the period from and including the date of the giving of such notice to and including the date when each seller of Registrable
Securities covered by such Registration Statement either receives the copies of the supplemented or amended Prospectus contemplated by Section 3.5.1(d) or is advised in writing by the Company that the use of the Prospectus may be resumed. 

Section 3.6. Underwritten Offerings. 

Section 3.6.1. Shelf and Demand Registrations. If requested by the underwriters for any Underwritten Public
Offering, pursuant to a Registration or sale under Sections 3.1 or 3.2, the Company shall enter into an underwriting agreement with such underwriters, such agreement to be reasonably satisfactory in substance and form to each of the Company, the
Investors and the underwriters, and to contain such representations and warranties by the Company and such other terms as are generally prevailing in agreements of that type, including indemnities no less favorable to the recipient thereof than
those provided in Section 3.9 of this Agreement. The Holders of the Registrable Securities proposed to be distributed by such underwriters shall cooperate with the Company in the negotiation of the underwriting agreement and shall give
consideration to the reasonable suggestions of the Company regarding the form thereof, and such Holders shall complete and execute all questionnaires, powers of attorney and other documents reasonably requested by the underwriters and required under
the terms of such underwriting arrangements. Any such Holder shall not be required to make any representations or warranties to or agreements with the Company or the underwriters other than representations, warranties or agreements regarding such
Holder, such Holder’s title to the Registrable Securities, such Holder’s intended method of distribution and any other representations to be made by the Holder as are generally prevailing in agreements of that type, and the aggregate
amount of the liability of such Holder under such agreement shall not exceed such Holder’s proceeds from the sale of its Registrable Securities in the offering, net of underwriting discounts and commissions but before expenses. 

  
 - 17 - 

 Section 3.6.2. Piggyback Registrations. If the Company proposes to
register or sell any of its securities under the Securities Act as contemplated by Section 3.3 and such securities are to be distributed through one or more underwriters, the Company shall, if requested by any Holder pursuant to
Section 3.3 and, subject to the provisions of Section 3.3.2, use its reasonable best efforts to arrange for such underwriters to include on the same terms and conditions that apply to the other sellers in such Registration or sale all the
Registrable Securities to be offered and sold by such Holder among the securities of the Company to be distributed by such underwriters in such Registration or sale. The Holders of Registrable Securities to be distributed by such underwriters shall
be parties to the underwriting agreement between the Company and such underwriters and shall complete and execute all questionnaires, powers of attorney and other documents reasonably requested by the underwriters and required under the terms of
such underwriting arrangements. Any such Holder shall not be required to make any representations or warranties to or agreements with the Company or the underwriters other than representations, warranties or agreements regarding such Holder, such
Holder’s title to the Registrable Securities, such Holder’s intended method of distribution and any other representations to be made by the Holder as are generally prevailing in agreements of that type, and the aggregate amount of the
liability of such Holder shall not exceed such Holder’s proceeds from the sale of its Registrable Securities in the offering, net of underwriting discounts and commissions but before expenses. 

Section 3.6.3. Selection of Underwriters; Selection of Counsel. In the case of an Underwritten Public Offering
under Sections 3.1 or 3.2, the managing underwriter or underwriters to administer the offering shall be determined by the Investors; provided that such underwriter or underwriters shall be reasonably acceptable to the Company. In the case of
an Underwritten Public Offering under Section 3.3, the managing underwriter or underwriters to administer the offering shall be determined by the Company; provided that such underwriter or underwriters shall be reasonably acceptable to
the Investor. In the case of an Underwritten Public Offering under Sections 3.1, 3.2 or 3.3, counsel to the Holders shall be selected by the Investors. 

Section 3.7. No Inconsistent Agreements; Additional Rights. Neither the Company nor any of its subsidiaries shall hereafter enter
into, and neither the Company nor any of its subsidiaries is currently a party to, any agreement with respect to its securities that is inconsistent with the rights granted to the Holders by this Agreement. Neither the Company nor any of its
subsidiaries shall enter into any agreement granting registration or similar rights to any Person, and the Company hereby represents and warrants that, as of the date hereof, no registration or similar rights have been granted to any other Person
other than pursuant to this Agreement. 
 Section 3.8. Registration Expenses. All expenses incident to the Company’s
performance of or compliance with this Agreement shall be paid by the Company, including (i) all registration and filing fees, and any other fees and expenses associated with filings required to be made with the SEC or FINRA, (ii) all fees
and expenses in connection with 

  
 - 18 - 

 
compliance with any securities or “Blue Sky” laws (including reasonable fees and disbursements of counsel for the underwriters in connection with blue sky qualifications of the
Registrable Securities), (iii) all printing, duplicating, word processing, messenger, telephone, facsimile and delivery expenses (including expenses of printing certificates for the Registrable Securities in a form eligible for deposit with The
Depository Trust Company and of printing Prospectuses), (iv) all fees and disbursements of counsel for the Company and of all independent certified public accountants or independent auditors of the Company and any subsidiaries of the Company
(including the expenses of any special audit and comfort letters required by or incident to such performance), (v) Securities Act liability insurance or similar insurance if the Company so desires or the underwriters so require in accordance
with then-customary underwriting practice, (vi) all fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange or quotation of the Registrable Securities on any inter-dealer quotation
system, (viii) all reasonable fees and disbursements of legal counsel for the selling Holders, (ix) any reasonable fees and disbursements of underwriters customarily paid by issuers or sellers of securities, (x) all fees and expenses
incurred in connection with the distribution or Transfer of Registrable Securities to or by a Holder or its Permitted Transferees in connection with a Public Offering, (xi) all fees and expenses of any special experts or other Persons retained
by the Company in connection with any Registration or sale, (xii) all of the Company’s internal expenses (including all salaries and expenses of its officers and employees performing legal or accounting duties) and (xiii) all expenses
related to the “road show” for any Underwritten Public Offering, including the reasonable out-of-pocket expenses of the Holders and underwriters, if so
requested. All such expenses are referred to herein as “Registration Expenses”. The Company shall not be required to pay any fees and disbursements to underwriters not customarily paid by the issuers of securities in an offering
similar to the applicable offering, including underwriting discounts and commissions and transfer taxes, if any, attributable to the sale of Registrable Securities. 

Section 3.9. Indemnification. 

Section 3.9.1. Indemnification by the Company. The Company shall indemnify and hold harmless, to the full
extent permitted by law, each Holder, each shareholder, member, limited or general partner of such Holder, each shareholder, member, limited or general partner of each such shareholder, member, limited or general partner, each of their respective
Affiliates, officers, directors, shareholders, employees, advisors, and agents and each Person who controls (within the meaning of the Securities Act or the Exchange Act) such Persons and each of their respective Representatives from and against any
and all losses, penalties, judgments, suits, costs, claims, damages, liabilities and expenses, joint or several (including reasonable costs of investigation and legal expenses and any indemnity and contribution payments made to underwriters ) (each,
a “Loss” and collectively “Losses”) arising out of or based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement under which such Registrable Securities are
registered or sold under the Securities Act (including any final, preliminary or summary Prospectus contained therein or any amendment thereof or supplement thereto or any documents incorporated by reference therein) or any other disclosure document
produced by or on behalf of the Company or any of its subsidiaries including, without limitation any report and other document filed under the Exchange Act and any preliminary or final offering memorandum prepared in connection with any Rule

  
 - 19 - 

 
144A or Regulation S offering pursuant to Section 3.10 of this Agreement, (ii) any omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein (in the case of a Prospectus or preliminary Prospectus, in light of the circumstances under which they were made) not misleading or (iii) any violation or alleged violation by the Company or any of its
subsidiaries of any federal, state, foreign or common law rule or regulation applicable to the Company or any of its subsidiaries and relating to action or inaction in connection with any such registration, disclosure document or other document or
report; provided, that no selling Holder shall be entitled to indemnification pursuant to this Section 3.9.1 in respect of any untrue statement or omission contained in any information relating to such seller Holder furnished in writing
by such selling Holder to the Company specifically for inclusion in a Registration Statement and used by the Company in conformity therewith (such information “Selling Stockholder Information”). This indemnity shall be in addition
to any liability the Company may otherwise have. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Holder or any indemnified party and shall survive the Transfer of such securities by
such Holder and regardless of any indemnity agreed to in the underwriting agreement that is less favorable to the Holders. The Company shall also indemnify underwriters, initial purchasers, selling brokers, dealer managers and similar securities
industry professionals participating in the distribution, their officers and directors and each Person who controls such Persons (within the meaning of the Securities Act and the Exchange Act) to the same extent as provided above (with appropriate
modification) with respect to the indemnification of the indemnified parties. 
 Section 3.9.2. Indemnification by
the Selling Holders. Each selling Holder agrees (severally and not jointly) to indemnify and hold harmless, to the fullest extent permitted by law, the Company, its directors and officers and each Person who controls the Company (within the
meaning of the Securities Act or the Exchange Act) from and against any Losses resulting from (i) any untrue statement of a material fact in any Registration Statement under which such Registrable Securities were registered or sold under the
Securities Act (including any final, preliminary or summary Prospectus contained therein or any amendment thereof or supplement thereto or any documents incorporated by reference therein) or (ii) any omission to state therein a material fact
required to be stated therein or necessary to make the statements therein (in the case of a Prospectus or preliminary Prospectus, in light of the circumstances under which they were made) not misleading, in each case to the extent, but only to the
extent, that such untrue statement or omission is contained in such selling Holder’s Selling Stockholder Information. In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the proceeds
from the sale of its Registrable Securities in the offering giving rise to such indemnification obligation, net of underwriting discounts and commissions but before expenses, less any amounts paid by such Holder pursuant to Section 3.9.4 and
any amounts paid by such Holder as a result of liabilities incurred under the underwriting agreement, if any, related to such sale. 

  
 - 20 - 

 Section 3.9.3. Conduct of Indemnification Proceedings. Any Person
entitled to indemnification hereunder shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that any delay or failure to so notify the indemnifying party
shall relieve the indemnifying party of its obligations hereunder only to the extent, if at all, that it forfeits substantive legal rights by reason of such delay or failure) and (ii) permit such indemnifying party to assume the defense of such
claim with counsel reasonably satisfactory to the indemnified party; provided, however, that any Person entitled to indemnification hereunder shall have the right to select and employ separate counsel and to participate in the defense
of such claim, but the fees and expenses of such counsel shall be at the expense of such Person unless (i) the indemnifying party has agreed in writing to pay such fees or expenses, (ii) the indemnifying party shall have failed to assume
the defense of such claim within a reasonable time after receipt of notice of such claim from the Person entitled to indemnification hereunder and employ counsel reasonably satisfactory to such Person, (iii) the indemnified party has reasonably
concluded (based upon advice of its counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, or (iv) in the reasonable judgment
of any such Person (based upon advice of its counsel) a conflict of interest may exist between such Person and the indemnifying party with respect to such claims (in which case, if the Person notifies the indemnifying party in writing that such
Person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such Person). If the indemnifying party assumes the defense, the
indemnifying party shall not have the right to settle such action without the consent of the indemnified party. No indemnifying party shall consent to entry of any judgment or enter into any settlement which does not include as an unconditional term
thereof the giving by the claimant or plaintiff to such indemnified party of an unconditional release from all liability in respect to such claim or litigation without the prior written consent of such indemnified party. If such defense is not
assumed by the indemnifying party, the indemnifying party will not be subject to any liability for any settlement made without its prior written consent, but such consent may not be unreasonably withheld. It is understood that the indemnifying party
or parties shall not, except as specifically set forth in this Section 3.9.3, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements or other charges of more than one
separate firm admitted to practice in such jurisdiction at any one time unless (x) the employment of more than one counsel has been authorized in writing by the indemnifying party or parties, (y) an indemnified party has reasonably
concluded (based on the advice of counsel) that there may be legal defenses available to it that are different from or in addition to those available to the other indemnified parties or (z) a conflict or potential conflict exists or may exist
(based upon advice of counsel to an indemnified party) between such indemnified party and the other indemnified parties, in each of which cases the indemnifying party shall be obligated to pay the reasonable fees and expenses of such additional
counsel or counsels. 
 Section 3.9.4. Contribution. If for any reason the indemnification provided for in
Section 3.9.1 and Section 3.9.2 is unavailable to an indemnified party or insufficient in respect of any Losses referred to therein (other than as a result of exceptions or limitations on indemnification contained in Section 3.9.1 and
Section 3.9.2), then the indemnifying party shall contribute to the amount paid or payable by the indemnified party as a result of such Loss in such proportion as is appropriate to reflect the relative

  
 - 21 - 

 
fault of the indemnifying party on the one hand and the indemnified party or parties on the other hand in connection with the acts, statements or omissions that resulted in such Losses, as well
as any other relevant equitable considerations. In connection with any Registration Statement filed with the SEC by the Company, the relative fault of the indemnifying party on the one hand and the indemnified party on the other hand shall be
determined by reference to, among other things, whether any untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the
indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would not be just or equitable if contribution pursuant to
this Section 3.9.4 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in this Section 3.9.4. No Person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. The amount paid or payable by an indemnified party as
a result of the Losses referred to in Sections 3.9.1 and 3.9.2 shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or
defending any such action or claim. Notwithstanding the provisions of this Section 3.9.4, in connection with any Registration Statement filed by the Company, a selling Holder shall not be required to contribute any amount in excess of the
dollar amount of the proceeds from the sale of its Registrable Securities in the offering giving rise to such indemnification obligation, net of underwriting discounts and commissions but before expenses, less any amounts paid by such Holder
pursuant to Section 3.9.2 and any amounts paid by such Holder as a result of liabilities incurred under the underwriting agreement, if any, related to such sale. If indemnification is available under this Section 3.9, the indemnifying
parties shall indemnify each indemnified party to the full extent provided in Sections 3.9.1 and 3.9.2 hereof without regard to the provisions of this Section 3.9.4. The remedies provided for in this Section 3.9 are not exclusive and
shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in equity. 
 Section 3.10.
Rules 144 and 144A and Regulation S. The Company shall file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder (or, if the
Company is not required to file such reports, it will, upon the request of the Holders, make publicly available such necessary information for so long as necessary to permit sales that would otherwise be permitted by this Agreement pursuant to Rule
144, Rule 144A or Regulation S under the Securities Act, as such rules may be amended from time to time or any similar rule or regulation hereafter adopted by the SEC), and it will take such further action as any Holder may reasonably request, all
to the extent required from time to time to enable such Holder to sell Registrable Securities without Registration under the Securities Act in transactions that would otherwise be permitted by this Agreement and within the limitation of the
exemptions provided by (i) Rule 144, Rule 144A or Regulation S under the Securities Act, as such rules may be amended from time to time, or (ii) any similar rule or regulation hereafter adopted by the SEC. Upon the request of any Holder,
the Company will deliver to such Holder a written statement as to whether it has complied with such requirements and, if not, the specifics thereof. 

  
 - 22 - 

 Section 3.11. Existing Registration Statements. Notwithstanding anything
herein to the contrary and subject to applicable law and regulation, the Company may satisfy any obligation hereunder to file a Registration Statement or to have a Registration Statement become effective by a specified date by designating, by notice
to the Holders, a Registration Statement that previously has been filed with the SEC or become effective, as the case may be, as the relevant Registration Statement for purposes of satisfying such obligation, and all references to any such
obligation shall be construed accordingly; provided that such previously filed Registration Statement may be, and is, amended or, subject to applicable securities laws, supplemented to add the number of Registrable Securities, and, to the
extent necessary, to identify as a selling stockholders those Holders demanding the filing of a Registration Statement pursuant to the terms of this Agreement. To the extent this Agreement refers to the filing or effectiveness of other Registration
Statements, by or at a specified time and the Company has, in lieu of then filing such Registration Statements or having such Registration Statements become effective, designated a previously filed or effective Registration Statement as the relevant
Registration Statement for such purposes, in accordance with the preceding sentence, such references shall be construed to refer to such designated Registration Statement, as amended or supplemented in the manner contemplated by the immediately
preceding sentence. 
 ARTICLE IV 

GOVERNANCE 

Section 4.1. Composition of the Board of Directors. Upon written request of the Investors, the Company shall appoint one
individual designated by the Investor (the “Investor Designee”) to the Company’s board of directors (the “Board”) with a term expiring at the Company’s next annual meeting of its shareholders (the
“Annual Meeting”). 
 For so long as the Investor beneficially owns twenty percent (20%) or more of the Company’s
outstanding Common Stock, the Company shall nominate and recommend the Investor Designee in the Company’s proxy statement at each Annual Meeting at which the Investor Designee’s term is set to expire. The Company shall take all actions
necessary to ensure there is a vacancy on the Board as of the effectiveness of this Agreement to permit the appointment of the Investor Designee. 

The Investors may remove the Investor Designee from the Board, and appoint another person as the Investor Designee. In the event of the death,
resignation, retirement or vacation of office of the Investor Designee due to any other reason, then the Investors may appoint another person as the Investor Designee. 

If there is a vacancy on the Board as a result of the Investor Designee’s failure to obtain the requisite approval of the Company’s
shareholders necessary for election at any annual or special meeting of the Company’s shareholders, and where no other individual is elected to fill such vacancy, the Investors shall have the right to designate another Investor Designee to fill
such vacancy, and the Company shall take all actions necessary to appoint such individual to the Board. 

  
 - 23 - 

 During the period that an Investor Designee is a director of the Board, such director shall be
entitled to the same benefits, including benefits under any director and officer indemnification or insurance policy maintained by the Company, as any other director of the Board. 

During the period between the effectiveness of this Agreement and the date the Investor has beneficial ownership of less than ten percent
(10%) of the Company’s outstanding Common Stock, the Investor shall have the right to appoint one (1) non-voting board observer (the “Investor Observer”) who shall have the right to
attend and participate in all Board and committee meetings (other than portions of such meetings in which the Board reasonably believes in good faith that the Investor has a conflict of interest). The Investor Observer shall be entitled to receive
copies of all notices, minutes, consents and other materials that the Company provides to its directors at the same time and in the same manner as provided to such directors. 

ARTICLE V 

MISCELLANEOUS 

Section 5.1. Authority; Effect. Each party hereto represents and warrants to and agrees with each other party that the execution
and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized on behalf of such party and do not violate any agreement or other instrument applicable to such party or by which its assets are
bound. This Agreement does not, and shall not be construed to, give rise to the creation of a partnership among any of the parties hereto, or to constitute any of such parties members of a joint venture or other association. The Company and its
subsidiaries shall be jointly and severally liable for all obligations of each such party pursuant to this Agreement. 
 Section 5.2.
Notices. Any notices, requests, demands and other communications required or permitted in this Agreement shall be effective if in writing and (i) delivered personally, (ii) sent by facsimile or
e-mail, or (iii) sent by overnight courier, in each case, addressed as follows: 
 If to the Company,
to: 
 Keryx Biopharmaceuticals, Inc. 

One Marina Park Drive 

Tenth Floor 

Boston, MA 02210 

Attention:                 Scott Holmes, CFO

 Facsimile:                 (617) 466-3520 
 E-mail:
                     scott.holmes@keryx.com 
 with
a copy (which shall not constitute notice) to: 
 Daniel Kajunski 

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. 

One Financial Center 

Boston, MA 02111 

  
 - 24 - 

 Direct: +1.617.348.1715 

Fax: +1.617.542.2241 

Email: dtkajunski@mintz.com 
 If
to the Investor, to: 
 Baupost Group Securities, L.L.C. 

c/o The Baupost Group, L.L.C. 

10 St. James Avenue, Suite 1700 

Boston, MA 02116 

Attention: Gregory A. Ciongoli, Michael Sperling, Frederick H. Fogel and 

John F. Harvey 

Facsimile:             (617)
451-7331 
 E-mail:
                 gac@baupost.com, msperling@baupost.com, ffogel@baupost.com 

and jharvey@baupost.com 

with a copy (which shall not constitute notice) to: 

Ropes & Gray LLP 

Three Embarcadero Center 

San Francisco, CA 94111 

Attention:             Thomas Holden 

Office:                  (415) 315-2355 
 Facsimile:
            (415) 315-4823 

E-mail:
                 thomas.holden@ropesgray.com 
 Notice
to the holder of record of any Registrable Securities shall be deemed to be notice to the holder of such securities for all purposes hereof. 

Unless otherwise specified herein, such notices or other communications shall be deemed effective (i) on the date received, if personally
delivered, (ii) on the date received, if delivered by facsimile or e-mail on a Business Day, or if not delivered on a Business Day, on the first Business Day thereafter and (iii) two (2) Business
Days after being sent by overnight courier. Each of the parties hereto shall be entitled to specify a different address by giving notice as aforesaid to each of the other parties hereto. 

Section 5.3. Termination and Effect of Termination. This Agreement shall terminate upon the date on which no Holder holds any
Registrable Securities, except for the provisions of Sections 3.9 and 3.10, which shall survive any such termination. No termination under this Agreement shall relieve any Person of liability for breach or Registration Expenses incurred prior
to termination. In the event this Agreement is terminated, each Person entitled to indemnification rights pursuant to Section 3.9 hereof shall retain such indemnification rights with respect to any matter that (i) may be an indemnified
liability thereunder and (ii) occurred prior to such termination. 

  
 - 25 - 

 Section 5.4. Permitted Transferees. The rights of a Holder hereunder may be assigned
(but only with all related obligations as set forth below) in connection with a Transfer of Registrable Securities to a Permitted Transferee of that Holder. Without prejudice to any other or similar conditions imposed hereunder with respect to any
such Transfer, no assignment permitted under the terms of this Section 5.4 will be effective unless the Permitted Transferee to which the assignment is being made, if not a Holder, has delivered to the Company a written acknowledgment and
agreement in form and substance reasonably satisfactory to the Company that the Permitted Transferee will be bound by, and will be a party to, this Agreement. A Permitted Transferee to whom rights are transferred pursuant to this Section 5.4
may not again transfer those rights to any other Permitted Transferee, other than as provided in this Section 5.4. 
 Section 5.5.
Remedies. The parties to this Agreement shall have all remedies available at law, in equity or otherwise in the event of any breach or violation of this Agreement or any default hereunder. The parties acknowledge and agree that in the
event of any breach of this Agreement, in addition to any other remedies that may be available, each of the parties hereto shall be entitled to specific performance of the obligations of the other parties hereto and, in addition, to such other
equitable remedies (including preliminary or temporary relief) as may be appropriate in the circumstances. No delay of or omission in the exercise of any right, power or remedy accruing to any party as a result of any breach or default by any other
party under this Agreement shall impair any such right, power or remedy, nor shall it be construed as a waiver of or acquiescence in any such breach or default, or of any similar breach or default occurring later; nor shall any such delay, omission
nor waiver of any single breach or default be deemed a waiver of any other breach or default occurring before or after that waiver. 

Section 5.6. Amendments. This Agreement may not be orally amended, modified, extended or terminated, nor shall any oral waiver of
any of its terms be effective. This Agreement may be amended, modified, extended or terminated, and the provisions hereof may be waived, only by an agreement in writing signed by the Company and the Investors. Each such amendment, modification,
extension or termination shall be binding upon each party hereto. In addition, each party hereto may waive any right hereunder by an instrument in writing signed by such party. 

Section 5.7. Governing Law. This Agreement and all claims arising out of or based upon this Agreement or relating to the subject
matter hereof shall be governed by and construed in accordance with the domestic substantive laws of the State of New York without giving effect to any choice or conflict of laws provision or rule that would cause the application of the domestic
substantive laws of any other jurisdiction. 
 Section 5.8. Consent to Jurisdiction. Each party to this Agreement, by its
execution hereof, (i) hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the State of New York for the purpose of any action, claim, cause of action or suit (in contract, tort or otherwise),
inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter hereof, (ii) hereby waives to the extent not prohibited by applicable law, and agrees not to assert, and agrees not to allow any
of its subsidiaries to assert, by way of motion, as a defense or otherwise, in any such action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or
execution, that any such proceeding brought in one of the above-

  
 - 26 - 

 
named courts is improper, or that this Agreement or the subject matter hereof or thereof may not be enforced in or by such court and (iii) hereby agrees not to commence or maintain any
action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation arising out of or based upon this Agreement or relating to the subject matter hereof or thereof other than before one of the above-named
courts nor to make any motion or take any other action seeking or intending to cause the transfer or removal of any such action, claim, cause of action or suit (in contract, tort or otherwise), inquiry, proceeding or investigation to any court other
than one of the above-named courts whether on the grounds of inconvenient forum or otherwise. Notwithstanding the foregoing, to the extent that any party hereto is or becomes a party in any litigation in connection with which it may assert
indemnification rights set forth in this Agreement, the court in which such litigation is being heard shall be deemed to be included in clause (i) above. Notwithstanding the foregoing, any party to this Agreement may commence and maintain an
action to enforce a judgment of any of the above-named courts in any court of competent jurisdiction. Each party hereto hereby consents to service of process in any such proceeding in any manner permitted by New York law, and agrees that service of
process by registered or certified mail, return receipt requested, at its address specified pursuant to Section 5.2 hereof is reasonably calculated to give actual notice. 

Section 5.9. WAIVER OF JURY TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH PARTY HERETO HEREBY
WAIVES AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY,
PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER
ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 5.9 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH THEY ARE RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT. ANY PARTY HERETO MAY
FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 5.9 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 

Section 5.10. Merger; Binding Effect, Etc. This Agreement constitutes the entire agreement of the parties with respect to its
subject matter, supersedes all prior or contemporaneous oral or written agreements or discussions with respect to such subject matter, and shall be binding upon and inure to the benefit of the parties hereto and thereto and their respective heirs,
representatives, successors and permitted assigns. Except as otherwise expressly provided herein, no Holder or other party hereto may assign any of its respective rights or delegate any of its respective obligations under this Agreement without the
prior written consent of the other parties hereto, and any attempted assignment or delegation in violation of the foregoing shall be null and void. 

Section 5.11. Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original,
but all of which taken together shall constitute one instrument. 

  
 - 27 - 

 Section 5.12. Severability. In the event that any provision hereof would, under
applicable law, be invalid or unenforceable in any respect, such provision shall be construed by modifying or limiting it so as to be valid and enforceable to the maximum extent compatible with, and possible under, applicable law. The provisions
hereof are severable, and in the event any provision hereof should be held invalid or unenforceable in any respect, it shall not invalidate, render unenforceable or otherwise affect any other provision hereof. 

Section 5.13. No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, the Company and each
Holder covenant, agree and acknowledge that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any current or future director, officer, employee, general or limited
partner or member of any Holder or of any Affiliate or assignee thereof, as such, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable law, it being
expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any current or future officer, agent or employee of any Holder or any current or future member of any Holder or any
current or future director, officer, employee, partner or member of any Holder or of any Affiliate or assignee thereof, as such, for any obligation of any Holder under this Agreement or any documents or instruments delivered in connection with this
Agreement for any claim based on, in respect of or by reason of such obligations or their creation. 
 Section 5.14. Existing
Registration Rights Waivers. Notwithstanding anything that may be expressed or implied in this Agreement, any registration rights waivers that are in effect under that certain Registration Rights Agreement, dated October 15, 2015, by and
between the Company and the Investor immediately prior to the effectiveness of this Agreement shall remain in effect in accordance with their terms as if made with respect to this Agreement, including, without limitation, (i) the Registration
Rights Waiver, dated July 26, 2017, between the Company and the Investor, and (ii) the Registration Rights Waiver, dated on November 4, 2016, between the Company and the Investor. 

[Signature pages follow] 

  
 - 28 - 

 IN WITNESS WHEREOF, each of the undersigned has duly executed this Agreement as of the
date first above written. 
  

					
	Company:	 	KERYX BIOPHARMACEUTICALS, INC.
			
		 	By:	 	 /s/ Scott A. Holmes

Name: Scott A. Holmes
 Title: Chief Financial
Officer

		
	Investor:	 	BAUPOST GROUP SECURITIES, L.L.C.
			
		 	By:	 	 /s/ Gregory A. Ciongoli

		 		 	 Name: Gregory A. Ciongoli
 Title:
Partner

 [Signature Page to Registration Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00283-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00283-of-00352.parquet"}]]